
<html lang="en"     class="pb-page"  data-request-id="ffc27208-855f-4523-95a3-08cd9acf86f0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.6b01245;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-6"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors" /></meta><meta name="dc.Creator" content="Yifu  Liu" /></meta><meta name="dc.Creator" content="Zuoquan  Xie" /></meta><meta name="dc.Creator" content="Dan  Zhao" /></meta><meta name="dc.Creator" content="Jin  Zhu" /></meta><meta name="dc.Creator" content="Fei  Mao" /></meta><meta name="dc.Creator" content="Shuai  Tang" /></meta><meta name="dc.Creator" content="Hui  Xu" /></meta><meta name="dc.Creator" content="Cheng  Luo" /></meta><meta name="dc.Creator" content="Meiyu  Geng" /></meta><meta name="dc.Creator" content="Min  Huang" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Description" content="Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metabolism. We previously described bis(4-morpholinyl thiocarbonyl)-disulfide (..." /></meta><meta name="Description" content="Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metabolism. We previously described bis(4-morpholinyl thiocarbonyl)-disulfide (..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 6, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01245" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01245" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01245" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01245" /></link>
        
    
    

<title>Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01245" /></meta><meta property="og:title" content="Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0018.jpeg" /></meta><meta property="og:description" content="Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metabolism. We previously described bis(4-morpholinyl thiocarbonyl)-disulfide (JX06, 16) as the first covalent inhibitor of PDK1. Here, on the basis of  the scaffold of 16, we identify two novel types of disulfide-based PDK1 inhibitors. The most potent analogue, 3a, effectively inhibits PDK1 both at the molecular (kinact/Ki = 4.17 × 103 M–1 s–1) and the cellular level (down to 0.1 μM). In contrast to 16, 3a is a potent and subtype-selective inhibitor of PDK1 with &gt;40-fold selectivity for PDK2–4. 3a also significantly alters glucose metabolic pathways in A549 cells by decreasing ECAR and increasing ROS. Moreover, in the xenograft models, 3a shows significant antitumor activity with no negative effect to the mice weight. Collectively, these data demonstrate that 3a may be an excellent lead compound for the treatment of cancer as a first-generation subtype-selective and covalent PDK1 inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01245"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01245">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01245&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01245&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01245&amp;href=/doi/10.1021/acs.jmedchem.6b01245" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2227-2244</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01576" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01262" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yifu++Liu">Yifu Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zuoquan++Xie">Zuoquan Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Zhao">Dan Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Zhu">Jin Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Mao">Fei Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuai++Tang">Shuai Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Xu">Hui Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Luo">Cheng Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meiyu++Geng">Meiyu Geng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Huang">Min Huang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>For J.L.: phone, +86-21-64252584; fax, +86-21-64252584; E-mail, <a href="/cdn-cgi/l/email-protection#90faf9f1fefcf9d0f5f3e5e3e4bef5f4e5bef3fe"><span class="__cf_email__" data-cfemail="6b01020a0507022b0e081e181f450e0f1e450805">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For M.H.: phone, +86-21-50806600-2431; E-mail, <a href="/cdn-cgi/l/email-protection#1875706d79767f586b71757536797b367b76"><span class="__cf_email__" data-cfemail="3a57524f5b545d7a49535757145b59145954">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01245&amp;href=/doi/10.1021%2Facs.jmedchem.6b01245" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2227–2244</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 August 2016</li><li><span class="item_label"><b>Published</b> online</span>6 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01245</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2227%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYifu%2BLiu%252C%2BZuoquan%2BXie%252C%2BDan%2BZhao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D6%26contentID%3Dacs.jmedchem.6b01245%26title%3DDevelopment%2Bof%2Bthe%2BFirst%2BGeneration%2Bof%2BDisulfide-Based%2BSubtype-Selective%2Band%2BPotent%2BCovalent%2BPyruvate%2BDehydrogenase%2BKinase%2B1%2B%2528PDK1%2529%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2244%26publicationDate%3DMarch%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01245"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2451</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01245" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yifu&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Zuoquan&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Shuai&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Meiyu&quot;,&quot;last_name&quot;:&quot;Geng&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2227-2244&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01245&quot;},&quot;abstract&quot;:&quot;Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metabolism. We previously described bis(4-morpholinyl thiocarbonyl)-disulfide (JX06, 16) as the first covalent inhibitor of PDK1. Here, on the basis of the scaffold of 16, we identify two novel types of disulfide-based PDK1 inhibitors. The most potent analogue, 3a, effectively inhibits PDK1 both at the molecular (kinact/Ki = 4.17 × 103 M–1 s–1) and the cellular level (down to 0.1 μM). In contrast to 16, 3a is a potent and subtype-selective inhibitor of PDK1 with &gt;40-fold selectivity for PDK2–4. 3a also significantly alters glucose metabolic pathways in A549 cells by decreasing ECAR and increasing ROS. Moreover, in the xenograft models, 3a shows significant antitumor activity with no negative effect to the mice weight. Collectively, these data demonstrate that 3a may be an excellent lead compound for the treatment of cancer as a first-generation subtype-selective and covalent PDK1 inhibitor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01245" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01245&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01245" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01245&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01245" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01245&amp;href=/doi/10.1021/acs.jmedchem.6b01245" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01245" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01245" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01245%26sid%3Dliteratum%253Aachs%26pmid%3D28230989%26genre%3Darticle%26aulast%3DLiu%26date%3D2017%26atitle%3DDevelopment%2Bof%2Bthe%2BFirst%2BGeneration%2Bof%2BDisulfide-Based%2BSubtype-Selective%2Band%2BPotent%2BCovalent%2BPyruvate%2BDehydrogenase%2BKinase%2B1%2B%2528PDK1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D6%26spage%3D2227%26epage%3D2244%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/jmcmar.2017.60.issue-6/20170323/jmcmar.2017.60.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pyruvate dehydrogenase kinases (PDKs) are overexpressed in most cancer cells and are responsible for aberrant glucose metabolism. We previously described bis(4-morpholinyl thiocarbonyl)-disulfide (JX06, <b>16</b>) as the first covalent inhibitor of PDK1. Here, on the basis of  the scaffold of <b>16</b>, we identify two novel types of disulfide-based PDK1 inhibitors. The most potent analogue, <b>3a</b>, effectively inhibits PDK1 both at the molecular (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 4.17 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>) and the cellular level (down to 0.1 μM). In contrast to <b>16</b>, <b>3a</b> is a potent and subtype-selective inhibitor of PDK1 with >40-fold selectivity for PDK2–4. <b>3a</b> also significantly alters glucose metabolic pathways in A549 cells by decreasing ECAR and increasing ROS. Moreover, in the xenograft models, <b>3a</b> shows significant antitumor activity with no negative effect to the mice weight. Collectively, these data demonstrate that <b>3a</b> may be an excellent lead compound for the treatment of cancer as a first-generation subtype-selective and covalent PDK1 inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a major public health problem worldwide, cancer is a very complex set of diseases. Unlike their normal counterparts, most cancer cells have a preference for cytoplasm-based glycolysis rather than mitochondrial oxidative phosphorylation, even under normoxia. This unique reprograming of cellular metabolic pathways, first recognized by Otto Warburg in 1924, meets the survival and proliferation needs during the process of tumor progression.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In recent years, a more intricate understanding of the metabolic alterations and adaptations of cancer cells has refocused efforts to target tumor metabolism as a selective anticancer strategy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The pyruvate dehydrogenase complex (PDC) is a gatekeeper of glucose oxidation, and by converting pyruvate to acetyl-CoA, it links glycolysis to the Krebs cycle.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> An emerging concept suggests that the Warburg effect may be partly due to the attenuation of mitochondrial function, which results from the inhibition of PDC via an increased expression of pyruvate dehydrogenase kinase.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Four pyruvate dehydrogenase kinase isoenzymes (PDK1–4) have been identified in mammals with tissue-specific expression. They negatively regulate the activity of the PDC by reversible phosphorylation, which occurs independently on three different serines (Ser232, Ser293, and Ser300).<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> PDK1 is the only isoform reported to phosphorylate all three serines and is closely associated with cancer malignancy.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> In cancer cells, the expression of the PDK1 gene is upregulated by the oncogenes c-Myc, hypoxia-inducible factor-1α (HIF-1α), and BRAFV-600E to control metabolic and malignant phenotypes.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> A recent study revealed that PDK1 is regulated by Wnt/β-catenin signaling in colon cancer cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, PDK1 activity is increased at the post-transcriptional level by diverse oncogenic tyrosine kinases. This enhancement of PDK1 activity results in a promotion of the Warburg effect and tumor growth.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, overexpression of PDK1 or PDK4 protects cells from anoikis, while depletion of the enzymes restores the susceptibility to anoikis and lowers the metastatic potential.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These evidence suggest that the inhibition of PDK (especially PDK1) may offer a new therapeutic option for the treatment of cancer.</div><div class="NLM_p">Before our recent publications on two new classes of PDK inhibitors,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> three major classes of PDK inhibitors had been reported and distinguished by different binding sites (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The well-known PDK inhibitor dichloroacetate (DCA, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), an analogue of pyruvate, rapidly entered phase II clinical trials after its anticancer activity was first reported.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, the high effective dosage limits its further clinical application.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Although there are several ingenious modifications of DCA, the results are far from satisfactory.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> Nov3r<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and AZD7545<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) represent a class of PDK inhibitors that target the lipoyl-binding pocket of the enzymes, and recently, CPI613<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a lipoate derivative, demonstrated certain anticancer effects in an in vivo human xenograft tumor, and it has been investigated in phase I clinical trials for patients with relapsed or refractory hematological malignancies.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> Radicicol,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> M77976<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and its analogues, and PS10<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) belong to a class of ATP-competitive inhibitors that target the GHKL (gyrase, Hsp90, histidine kinase, MutL) domain in PDKs.<a onclick="showRef(event, 'ref16 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref16 ref26 ref27">(16, 26, 27)</a> However, the high similarity of the ATP-binding pocket of kinases may lead to off-target effects, resulting in side effects and toxicity issues.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the PDK1 inhibitors reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As the starting point of our efforts to discover a new type of PDK1 inhibitors, an in-house library of ∼600 old drugs was screened using an enzymatic screening assay. Thiram<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), an existing pesticide with anticancer activity, was found to be capable of remarkably inhibiting PDK1 activity, and further chemical efforts led to the discovery of a more potent PDK1 inhibitor, <b>16</b> (JX06,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Using <b>16</b> as a chemical probe, we found that the covalent inhibitory action mode of <b>16</b> and its analogues was through targeting a highly conserved cysteine residue (Cys240), and we identified the cancer subset responsive to PDK1 inhibition based on the ECAR (extracellular acidification rate)/OCR(oxygen consumption rate) ratio.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">On the basis of the therapeutic potential of <b>16</b>, to obtain novel analogues with independent intellectual property rights and to explore the SAR (structure–activity relationship) of the <b>16</b> analogues, we designed two types of novel disulfide-based analogues, bis(thiazolyl)disulfides (<b>1a</b>–<b>m</b>) and bis(thiocarbonyl)disulfides (<b>2a</b>–<b>s</b>, <b>3a</b>–<b>j</b>), derived from <b>16</b>, under the premise minimizing the structural changes (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Finally, a potent homomorpholinyl-derived PDK1 inhibitor with enhanced enzymatic, cellular inhibitory activities, and better performance in vivo, that is, <b>3a</b>, was identified as a unique lead compound for the development of antitumor drugs through the selective and covalent inhibition of PDK1.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffold hopping (<b>1</b>) and three chemical modification strategies (<b>2</b>–<b>3</b>) of lead compound <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To further improve the pharmacologic activity of the lead compound <b>16</b> and to obtain novel analogues, chemical modifications were performed in three cycles (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). First, 13 bis(thiazolyl)disulfides <b>1a</b>–<b>m</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were designed to determine whether the thiocarbamyl moiety of <b>16</b> was necessary for PDK1 inhibitory activity. Second, we substituted the morpholine with various steric and polar groups to design 18 analogues (<b>2a</b>–<b>f</b> and <b>2h</b>–<b>s</b>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Third, 11 ring contraction and ring expansion analogues (<b>2g</b> and <b>3a</b>–<b>f</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) were prepared to determine whether the ring size affected PDK1 inhibitory activity.</div><div class="NLM_p">In this study, all the disulfides were obtained through oxidation of the corresponding thiols or dithiocarboxylic acids. The synthesis of analogues <b>1b</b>–<b>m</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, and the procedure generally followed the method reported by K. Ramadas.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Treatment of commercially available thiols <b>4a</b>–<b>c</b> with ammonium persulfate yielded target analogues <b>1b</b> and <b>1d</b>–<b>e</b>. Then, nitration of <b>1b</b> afforded target analogue <b>1c</b>. Ring closure of α-bromo ketones <b>5a</b>–<b>g</b> with ammonium dithiocarbamate gave rise to intermediates <b>4d</b>–<b>k</b> (hydrolysis of <b>4i</b> produced <b>4j</b>), and the subsequent oxidation led to target analogues <b>1f</b>–<b>m</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Analogues <b>1b</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 0 °C to rt; (c) ammonium dithiocarbamate, EtOH, reflux, 1 h; (d) LiOH, H<sub>2</sub>O, THF, rt, 1 h.</p></p></figure><div class="NLM_p">Synthesis of target analogues <b>2a</b>–<b>g</b> and <b>3a</b> started from commercially available morpholine derivatives <b>6a</b>–<b>f</b> and <b>7</b> and is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The synthesis generally followed the method developed by Neelakantan.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As an exception, target analogue <b>2g</b> used ammonium persulfate as the oxidant. Furthermore, acid <b>2c</b> underwent esterification to provide target analogue <b>2d</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Analogues <b>2a</b>–<b>g</b> and <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (b) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (c) H<sub>2</sub>SO<sub>4</sub>, MeOH, rt, overnight.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> depicts the synthetic route for the preparation of target analogues <b>2h</b>, <b>2j</b>–<b>k</b>, and <b>2s</b>. <i>O</i>-Ethylation of compound <b>8a</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> formed <b>8b</b>, and chlorination of <b>8a</b> provided compound <b>9</b>, which was further converted to <b>8c</b> by alcoholysis. Debenzylation of <b>8a</b>–<b>c</b> was performed by conventional catalytic hydrogenation using palladium. The resulting secondary amines were treated with CS<sub>2</sub> without further purification, and the following oxidation by ammonium persulfate afforded target analogues <b>2h</b> and <b>2j</b>–<b>k</b>. The synthesis of <b>2s</b> was used the same route of <b>2k</b>, except for the different chiral material <b>8d</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Analogues <b>2h</b>, <b>2j</b>, <b>2k</b>, and <b>2s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) iodoethane, NaH, DMF, 80 °C, overnight; (b) SOCl<sub>2</sub>, DCM, rt, 2 h; (c) MeONa, NaI, MeOH, reflux, overnight; (d) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (e) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h.</p></p></figure><div class="NLM_p">Synthesis of <b>2i</b> and <b>2l</b>–<b>r</b> started from compound <b>10</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Nucleophilic substitution of compound <b>10</b> by sodium methoxide, phenols, and water generated intermediates <b>11a</b>, <b>11b</b>–<b>d</b>, and <b>11e</b>, respectively. Reaction of <b>11e</b> with iodoethane or acetyl chloride in the presence of base produced <b>11f</b> and <b>11g</b>. Replacement of the benzyl of <b>11e</b> with <i>t</i>-butyloxy carbonyl led to <b>12</b>, which was converted to <b>11h</b> by acylation with dimethylcarbamic chloride. Deprotection of <b>11a</b>–<b>h</b> yielded the corresponding secondary amines, which were used without further purification. Finally, target analogues <b>2i</b>, <b>2l</b>–<b>m</b>, and <b>2p</b>–<b>r</b> were prepared in the same manner described in the preparation of <b>2a</b>; however, target analogues <b>2n</b>–<b>o</b> were obtained by oxidation of the dithiocarboxylic acids, as described in the preparation of <b>2h</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Analogues <b>2i</b> and <b>2l</b>–<b>r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeONa, NaI, MeOH, reflux overnight; (b) R<sup>4</sup>OH, NaH, DMF, 120 °C, overnight; (c) formamide, H<sub>2</sub>O, 190 °C, overnight; (d) iodoethane, NaH, DMF, 80 °C, overnight; (e) acetyl chloride, TEA, DCM, rt, overnight; (f) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (g) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (h) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (i) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, rt, overnight; (j) dimethylcarbamic chloride, TEA, DCM, rt, overnight; (k) HCl, dioxane, rt, 1 h.</p></p></figure><div class="NLM_p">Target analogues <b>3b</b>–<b>j</b> were prepared in parallel, as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Nucleophilic substitution of compound <b>13</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf" class="ext-link">Supporting Information</a>) by sodium methoxide, phenols, and water gave <b>14a</b>, <b>14b</b>–<b>c</b>, and <b>14d</b>, respectively. The subsequent modification of <b>14d</b> resulted in <b>14e</b>–<b>i</b>. Deprotection of intermediates <b>14a</b>–<b>i</b> led to the free secondary amines, which were used as nucleophiles in the reaction with CS<sub>2</sub>. Oxidation by NaNO<sub>2</sub>/HCl or ammonium persulfate yielded target analogues <b>3b</b>–<b>j</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Analogues <b>3b</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeONa, NaI, MeOH, reflux overnight; (b) R<sup>5</sup>OH, NaH, DMF, 120 °C, overnight; (c) formamide, H<sub>2</sub>O, 190 °C, overnight; (d) R<sup>5</sup>-I, NaH, DMF, 80 °C, overnight; (e) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (f) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (g) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (h) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub>,THF, H<sub>2</sub>O, rt, overnight; (i) dimethylcarbamic chloride, TEA, DCM, rt, overnight; (j) HCl, dioxane, rt, 1 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Design and Synthesis of Disulfide-Based Analogues of <b>16</b></h3><div class="NLM_p">In total, 32 novel analogues of <b>16</b> (<b>1a</b>–<b>m</b>, <b>2a</b>–<b>s</b>, and <b>3a</b>–<b>j</b>) were designed and synthesized. Their chemical structures are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. These analogues were synthesized through the routes outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>, and the details of the synthetic procedures and structural characterization are described in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. All analogues were confirmed to be ≥95% purity (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chemical Structures of Analogues <b>1a</b>–<b>m</b> and Their PDK1 Inhibitory Activities in the ELISA Assay<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> was calculated from two independent experimental measurements. The values are reported as the average ± SD.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Chemical Structures of Analogues <b>2a</b>–<b>s</b> and <b>3a</b>–<b>j</b> and Their PDK1 Inhibitory Activities in the ELISA Assay<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0016.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0017.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The IC<sub>50</sub> was calculated from two independent experimental measurements. The values are reported as the average ± SD.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> The IC<sub>50</sub> Values of Analogues <b>1a</b>–<b>m</b>, <b>2a</b>–<b>r</b>, and <b>3a</b>–<b>j</b> against PDK1</h3><div class="NLM_p">For the primary assay, the disulfide-based analogues were analyzed for their inhibitory activity against PDK1 using enzyme-linked immunosorbent assay (ELISA), and <b>16</b> was used as the reference compound. The half-maximal inhibitory concentration (IC<sub>50</sub>) values of the bis(thiazolyl)disulfides (<b>1a</b>–<b>m</b>) are shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. On the basis of the bioisosterism strategy, thiazoles with different substituents were induced to replace the thiocarbamyl moiety in <b>16</b>. This set of heteroaryl disulfides displayed promising PDK1 inhibitory activity (IC<sub>50</sub> < 0.5 μM), inheriting the activity of <b>16</b> (IC<sub>50</sub> = 0.049 μM).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Fusing aryl or cycloalkyl onto the thiazole can be tolerated (<b>1a</b> vs <b>1b</b>–<b>m</b>). For the aryl analogues, introduction of a phenyl ring (<b>1b</b>, IC<sub>50</sub> = 0.379 μM) and pyridine ring (<b>1e</b>, IC<sub>50</sub> = 0.476 μM) produced activities similar to <b>1a</b> (IC<sub>50</sub> = 0.326 μM). An electron-withdrawing group or electron-donating group at the aryl ring improved the activity (<b>1c</b>–<b>d</b> vs <b>1b</b>). For the cycloalkyl analogues, the substituent type on the cycloalkyl ring had little impact on the activity (<b>1h</b> vs <b>1i</b>–<b>l</b>); however, the introduction of a large cycloalkyl ring was favorable. In the studied set of the cycloalkyl rings, the potency increased in the order cycloheptyl > cyclohexyl > cyclopentyl (<b>1m</b> > <b>1h</b> > <b>1g</b>). Notably, the inhibitory activity of analogue <b>1m</b> (IC<sub>50</sub> = 0.039 μM) increased a lot compare to that of <b>1a</b>, even more potent than that of <b>16</b>. We also tested the inhibitory activities of two free thiols (the intermediates <b>4a</b> and <b>4i</b>) against PDK1, but no inhibition was observed at up to 10 μM, demonstrating that the disulfide bond is a critical pharmacophore for PDK1 inhibitory activity.</div><div class="NLM_p last">Because of the difficulty of the structural modification of morpholinyl rings, we explored a limited range of substituent types. Analysis of the data in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> revealed that the introduction of substituents at the 2 or 3 position of the morpholinyl ring of <b>16</b> substantially affected the activity (<b>2a</b>–<b>s</b>). Generally, fused ring substituents (<b>2e</b>–<b>f</b> vs <b>16</b>) or bulky groups (<b>2p</b>–<b>r</b> vs <b>16</b>) were not beneficial, and the terminal polar substituents (<b>2g</b>–<b>i</b> and <b>2o</b> vs <b>16</b>) led to a loss of activity. To our delight, small steric hydrophobic substituents on the morpholinyl ring maintained the potency (<b>2a</b>–<b>b</b>, <b>2d</b>, and <b>2i</b>–<b>m</b> vs <b>16</b>); especially, the inhibitory activity of analogue <b>2k</b> (IC<sub>50</sub> = 0.024 μM) was greater than that of <b>16</b>. Ring contraction (<b>2g</b> vs <b>16</b>) of the morpholinyl ring was not beneficial, but ring expansion of the morpholinyl ring led to a homomorpholinyl analogue (<b>3a</b>, IC<sub>50</sub> = 0.026 μM) that was favorable. Moreover, the effects of substituents on the homomorpholinyl ring were similar to the morpholinyl ring analogues.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SAR of Disulfide-Based Analogues</h3><div class="NLM_p">The SAR analysis of a set of 31 disulfide-based analogues provided important insight into the essential structural requirements for effective PDK1 inhibition. A preliminary analysis base on the IC<sub>50</sub> data shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> reveals some noteworthy observations of the SAR for analogues <b>1a</b>–<b>m</b>, <b>2a</b>–<b>r</b>, and <b>3a</b>–<b>j</b>: (1) the disulfide bond rather than the thiocarbamyl moiety of <b>16</b> is indispensable for PDK1 inhibitory activity; replacement of the thiocarbamyl moiety with a thiazolyl ring can be tolerated (<b>16</b> vs <b>1a</b>–<b>m</b>); (2) fusing a cycloalkyl (especially a larger ring) onto thiazole is favorable for high potency (<b>1g</b>, <b>1h</b>, and <b>1m</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), leading to identification of the most potent PDK1 inhibitor (<b>1m</b>) in the thiazole series; (3) among the different <i>N</i>,<i>O</i>-containing aliphatic rings, the potency increases in the order homomorpholinyl > morpholinyl > azetidinyl (<b>3a</b> > <b>16</b> > <b>2g</b>); (4) the effects of substituents on the morpholinyl or homomorpholinyl ring are similar. Generally, fused ring substituents (<b>2e</b>–<b>f</b>), bulky groups (<b>2p</b>–<b>r</b>), and terminal polar substituents (<b>2g</b>–<b>i</b> and <b>2o</b>) are not beneficial, but small steric hydrophobic substituents can maintain, even improve, the potency (<b>2k</b> vs <b>16</b>).</div><div class="NLM_p">Analysis of IC<sub>50</sub> data has provided some interesting SARs. Considering the specialty of covalent inhibitors, IC<sub>50</sub> value alone may be not sufficient for SAR discussion. To validate the SAR concluded above, we introduced the second-order rate constant of target inactivation (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>) as the quantitative assessment of potency. Several representative compounds closely related to the above SAR were tested for their <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>, and the resultant values were incorporated into a rectangular coordinate (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> of <b>16</b>, <b>2k</b>, and <b>3a</b> (1.94 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, 4.17 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, and 5.14 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, respectively), which filled in quadrant III, suggested the high affinity and moderate specific reactivity. In contrast, <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> of <b>2e</b>, <b>2g</b>, <b>2h</b>, and <b>2r</b> (0.06 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, 0.07 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, 0.54 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, and 0.03 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, respectively), as located in quadrant IV, indicated weak affinity and resultant low inhibitory potencies. <b>1a</b> and <b>1m</b> (<i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> = 1.53 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup> and 3.93 × 10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>, respectively) were located in quadrant I, and their high activities likely stemmed from the strong specific reactivity whereas the affinity was responsible for the SAR. These results were overall in agreement with IC<sub>50</sub> data indicated activities (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) and the corresponding SAR. Moreover, the two isomers (<b>2k</b> and <b>2s</b>) did not show difference in both IC<sub>50</sub> and <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> values (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), indicating that the chirality of compounds had no influence on the enzymatic activities.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> Values for Representative Analogues<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>inact</sub> (10<sup>–4</sup>vs<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> (10<sup>3</sup> M<sup>–1</sup>s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">56.47 ± 3.47</td><td class="colsep0 rowsep0" align="char" char="±">37.31 ± 3.30</td><td class="colsep0 rowsep0" align="char" char="±">1.53 ± 0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1m</b></td><td class="colsep0 rowsep0" align="char" char="±">69.88 ± 5.46</td><td class="colsep0 rowsep0" align="char" char="±">18.03 ± 1.65</td><td class="colsep0 rowsep0" align="char" char="±">3.93 ± 0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="char" char="±">2.10 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">33.45 ± 1.15</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="char" char="±">4.74 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">8.72 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="char" char="±">3.24 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="±">40.28 ± 6.94</td><td class="colsep0 rowsep0" align="char" char="±">0.07 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="char" char="±">4.43 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">1.10 ± 0.20</td><td class="colsep0 rowsep0" align="char" char="±">4.17 ± 0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2r</b></td><td class="colsep0 rowsep0" align="char" char="±">6.90 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">225.73 ± 25.04</td><td class="colsep0 rowsep0" align="char" char="±">0.03 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2s</b></td><td class="colsep0 rowsep0" align="char" char="±">4.95 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">4.06 ± 0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char="±">5.47 ± 0.41</td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">5.14 ± 0.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="±">8.75 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">4.62 ± 0.50</td><td class="colsep0 rowsep0" align="char" char="±">1.94 ± 0.27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The experiments were carried out in triplicate. The values are reported as the average ± SD.</p></div></div></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative inhibitors characterization based on kinetic properties with PDK1: quadrant I, low affinity and high reactivity; quadrant II, high affinity and high reactivity; quandrant III, high affinity and moderate reactivity; quadrant IV, weak affinity and moderate to low reactivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taken together, the SARs are obviously regular. A subtle interplay between <i>N</i>,<i>O</i>-containing aliphatic rings and small steric hydrophobic substituents is critical for potent PDK1 inhibitory activity. In our limited analogues, <b>2k</b> and <b>3a</b> represent the best combination of these factors, leading to ∼2-fold potency improvement compared to the lead compound <b>16</b>.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Activity of Representative Analogues</h3><div class="NLM_p">Our chemical efforts based on <b>16</b> led to the discovery of two types of novel disulfide-based PDK1 inhibitors. Encouraged by the favorable PDK1 inhibitory activity in the biochemical kinase activity assay, we assessed the cellular activity using immunoblotting analysis, which examined the impact on PDHE1 phosphorylation downstream from PDK1. All analogues were subgrouped at a cutoff IC<sub>50</sub> value of 0.3 μM, and the 22 best analogues (<b>1c</b>–<b>d</b>, <b>1f</b>–<b>m</b>, <b>2a</b>–<b>d</b>, <b>2f</b>, <b>2i</b>–<b>k</b>, <b>2m</b>–<b>n</b>, <b>2p</b>, and <b>3a</b>) were selected and tested against A549 lung cancer cell lines. First, we performed the immunoblotting analysis of the 22 analogues at 10 μM. DCA and <b>16</b> were used as positive controls. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, among these samples, analogues <b>2a</b>–<b>b</b>, <b>2d</b>, <b>2i</b>–<b>k</b>, <b>2m</b>–<b>n</b>, and <b>3a</b> displayed the strongest cellular potency. These nine analogues almost abolished PDHE phosphorylation at both S293 and S232, while the others showed marginal cellular activity or were only effective at one site (analogues <b>2f</b> and <b>2p</b>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cellular potencies of representative analogues on PDK1 inhibition evaluated by downstream PDHE1 phosphorylation in A549 cells. (A) Screening of analogues at 10 μM. (B) Screening of analogues at 1 and 0.3 μM. (C) Analogues <b>2k</b>, <b>3a</b>, and <b>16</b> inhibited PDHE1 phosphorylation in a dose-dependent manner, and the comparison was determined by semiquantitative analysis of the Gray-Scale. All cells treated for 24 h with the analogues at the indicated concentrations were lysed and subjected to immunoblotting analysis. Error bars represent the average ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For further screening, these nine potent analogues were investigated at much lower concentrations. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B, when the concentration was 1 μM, all the analogues, except for <b>2i</b>, maintained similar strong inhibition of phosphorylation at both sites. We then adjusted the concentration to 0.3 μM, and the different cellular potency of the analogues could be easily distinguished. Among the nine analogues, only <b>2k</b> and <b>3a</b> maintained obvious activity comparable to that of <b>16</b>. Considering the good performance in cell-based assays, together with <b>16</b>, analogues <b>2k</b> and <b>3a</b> were selected for the next phase of investigation. For a more accurate comparison of the three analogues in the cell lines, we performed a concentration gradient assay (0.1, 0.3, and 1 μM), and the semiquantitative analysis was performed by Gray-Scale. As illustrated in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C, the cellular potency increased against a concentration gradient. Analogue <b>3a</b> exhibited the best inhibition at each concentration at both sites. Although analogue <b>2k</b> was slightly weaker than <b>3a</b>, it exhibited stronger inhibition at S293 than that of <b>16</b>.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>2k</b> and <b>3a</b> Inhibit PDK1 by Covalent Interaction</h3><div class="NLM_p">Taking the similar chemical structures and comparable cellular activities into consideration, we believed that analogues <b>2k</b> and <b>3a</b> inhibited PDK1 through the same mechanism as <b>16</b>, i.e., covalently binding to a conserved cysteine residue (C240).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> To confirm this hypothesis, we introduced the reducing thiol group to interrupt the inferential formation of disulfide bonds between PDK1 and the analogues by adding glutathione (GSH) to the system. As with <b>16</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> an increasing loss of activity was observed as the GSH concentration increased in the experiments with analogues <b>2k</b> and <b>3a</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), while DCA was not affected.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This result was consistent with our previous findings<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and suggested that <b>2k</b> and <b>3a</b> exerted strong inhibitions on the PDK1 activity through covalent interactions.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition curves of analogues <b>2k</b> (A) and <b>3a</b> (B) toward PDK1 at different concentrations of GSH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <b>2k</b> and <b>3a</b> Are Subtype-Selective and Potent PDK1 Inhibitors</h3><div class="NLM_p">Because of the most significant role of PDK1 among the PDK subtypes in cancer therapy, we measured the <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value of <b>16</b>, <b>2k</b>, and <b>3a</b> against all PDK isoforms using a biochemical enzymatic assay. As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, all three compounds exhibited more or less selectivity toward PDK1 over other PDK subtypes. Compounds <b>2k</b> and <b>3a</b> displayed better subtypevselectivity than <b>16</b>. Among them, <b>3a</b> exhibited ∼40-fold selectivity toward PDK1 over PDK2 and 3, better than <b>2k</b> and even 10-fold improvement than that of <b>16</b>. All three compounds did not inhibit PDK4 at a concentration up to 10 μM. The control DCA had no subtype-selectivity for PDK1–4. To the best of our knowledge, these two analogues (<b>2k</b> and <b>3a</b>) are the first generation of subtype-selective and potent PDK1 inhibitors.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PDK1–4 Inhibitory Activities of Analogues <b>2k</b>, <b>3a</b>, <b>16</b>, and DCA<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">PDK1</th><th class="rowsep1 colsep0" colspan="2" align="center">PDK2</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">PDK3</th><th class="rowsep1 colsep0" colspan="3" align="center">PDK4</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub> (10<sup>–4</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub><b>i</b></sub> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> (10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub> (10<sup>–4</sup> s<sup><b>–1</b></sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> (10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub> (10<sup>–4</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub><b>i</b></sub> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> (10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub> (10<sup>–4</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (10<sup>–7</sup> M)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> (10<sup>3</sup> M<sup>–1</sup> s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="center">4.43 ± 0.23</td><td class="colsep0 rowsep0" align="center">1.10 ± 0.20</td><td class="colsep0 rowsep0" align="center">4.17 ± 0.94</td><td class="colsep0 rowsep0" align="center">2.07 ± 0.7</td><td class="colsep0 rowsep0" align="center">7.02 ± 0.05</td><td class="colsep0 rowsep0" align="center">0.30 ± 0.01</td><td class="colsep0 rowsep0" align="center">17.64 ± 1.26</td><td class="colsep0 rowsep0" align="center">29.87 ± 0.93</td><td class="colsep0 rowsep0" align="center">0.59 ± 0.03</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="center">5.47 ± 0.41</td><td class="colsep0 rowsep0" align="center">1.09 ± 0.11</td><td class="colsep0 rowsep0" align="center">5.14 ± 0.68</td><td class="colsep0 rowsep0" align="center">1.56 ± 0.06</td><td class="colsep0 rowsep0" align="center">12.78 ± 2.06</td><td class="colsep0 rowsep0" align="center">0.12 ± 0.02</td><td class="colsep0 rowsep0" align="center">8.58 ± 0.58</td><td class="colsep0 rowsep0" align="center">77.62 ± 3.50</td><td class="colsep0 rowsep0" align="center">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">8.75 ± 0.21</td><td class="colsep0 rowsep0" align="center">4.62 ± 0.50</td><td class="colsep0 rowsep0" align="center">1.94 ± 0.27</td><td class="colsep0 rowsep0" align="center">0.99 ± 0.14</td><td class="colsep0 rowsep0" align="center">1.76 ± 0.02</td><td class="colsep0 rowsep0" align="center">0.56 ± 0.07</td><td class="colsep0 rowsep0" align="center">12.80 ± 1.12</td><td class="colsep0 rowsep0" align="center">28.51 ± 1.61</td><td class="colsep0 rowsep0" align="center">0.45 ± 0.06</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td><td class="colsep0 rowsep0" align="center">no inhibition at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DCA</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 1025 ± 19 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 1025 ± 19 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 1025 ± 19 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 504 ± 205 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 504 ± 205 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 504 ± 205 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 5560 ± 540 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 5560 ± 540 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 5560 ± 540 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 727 ± 251 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 727 ± 251 μM</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 727 ± 251 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The data was calculated from two independent experimental measurements. The values are reported as the average ± SD.</p></div></div></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Molecular Docking of <b>16</b>, <b>2k</b>, and <b>3a</b> with PDK1–4</h3><div class="NLM_p">To better understand the binding mode of <b>16</b> analogues with PDKs, we carried out molecular docking of <b>16</b>, <b>2k</b>, and <b>3a</b> with PDK1–4, respectively. First, <b>16</b>, <b>2k</b>, and <b>3a</b> all suited well in the binding pocket near C240 of PDK1 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A), which provided a good model to explain the improved activities of <b>2k</b> and <b>3a</b> toward PDK1. Apparently, the substituted morpholinyl of <b>2k</b> and homomorpholinyl ring of <b>3a</b> allowed stronger hydrophobic interactions with C240 surrounding residues, with more residues (A236, L239, N246, K282, M285, P351, L352, and A293) participating in <b>2k</b> and <b>3a</b> interactions compared with the <b>16</b>–PDK1 binding model. In the meanwhile, distance between the thiol of C240 and the thiocarbonyl of <b>2k</b> (3.2 Å) and <b>3a</b> (3.0 Å) was smaller than that of <b>16</b> (3.8 Å), suggesting a higher possibility to form a disulfide bond (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Second, the docking models may also explain the subtype selectivity of <b>16</b> analogues for PDK1. The binding pockets of <b>16</b>/<b>2k</b>/<b>3a</b> in PDK2 and PDK3 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B–C) appeared less suitable (i.e., narrow) for compounds entry. For example, the binding pockets of <b>16</b>/<b>2k</b>/<b>3a</b> in PDK3 showed rather small hole shapes, indicating that the compound need to overcome the solvent repulsion before binding and fitting into the enzyme pockets (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). These findings were consistent with the measured <i>K</i><sub>i</sub> values of <b>16</b>/<b>2k</b>/<b>3a</b> toward PDK2 and PDK3 versus PDK1 (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In the case of the irreversible binding, the <i>k</i><sub>inact</sub> value reflects the reaction rate. In addition to the distances, many different factors contributed to <i>k</i><sub>inact</sub>, including intrinsic chemical reactivity, reactant alignment, enforced local concentration, etc.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As shown in <a class="ref internalNav" href="#fig6" aria-label="Figures 6">Figures 6</a>A–B, the distances between the thiocarbonyl of these compounds and the thiol of C148 in PDK2 were much bigger than that of C240 in PDK1, consistent with the lower <i>k</i><sub>inact</sub> of <b>16</b>/<b>2k</b>/<b>3a</b> toward PDK2. Similarly, the distances of <b>16</b> and <b>2k</b> to the cysteine in PDK1 and PDK3 were 3.8/3.5 Å and 3.2/3.1 Å, respectively, which were consistent with the higher <i>k</i><sub>inact</sub> of <b>16</b>/<b>2k</b> toward PDK3 over PDK1 (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). One exception was <b>3a</b>, whose distance to the cysteine in PDK1 was closer than that of PDK3 (3.0/3.2 Å, respectively), but the <i>k</i><sub>inact</sub> value toward PDK3 was obvious higher. We speculated that the binding pose of <b>3a</b> in PDK3 may offer an advantageous trajectory of the thiocarbonyl to the cysteine. Altogether, these results suggested the lower <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value of <b>16</b> analogues toward PDK2/3. Likewise, there were no obvious binding pockets for <b>16</b>/<b>2k</b>/<b>3a</b> in PDK4 and appeared quite low possibility to form the disulfide bonds (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D), explaining the lack of activity against PDK4.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular docking of <b>16</b>, <b>2k</b>, and <b>3a</b> with PDK1–4. (A–C) The binding pocket of <b>3a</b> (white sticks) in PDK1–3 (green surface) and the detailed interactions between inhibitors and their surrounding residues (green sticks) in PDK1–3. (D) No obvious binding pockets for <b>16</b>, <b>2k</b>, and <b>3a</b> in PDK4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <b>2k</b> and <b>3a</b> Alter Glucose Metabolic Pathways</h3><div class="NLM_p">Inhibition of PDK1 in cancer cells leads to the recovery of the impaired mitochondrial function, which switches the metabolism of pyruvate from cytoplasm-based lactate production to mitochondria-based oxidative phosphorylation. This metabolic pathway change is characterized by a decrease in ECAR and an increase in ROS. We tested the influence of <b>2k</b> and <b>3a</b> on the two indicators of metabolic pathway change and used <b>16</b> as the reference substance. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, ECAR was significantly decreased by analogues <b>2k</b> and <b>3a</b> in a dose-dependent manner, which was consistent with the expected reduction of lactate production in A549 cells. In line with the accelerated oxidative phosphorylation, ROS was increased by analogues <b>2k</b> and <b>3a</b> with increasing concentration. The regulative results of analogues <b>2k</b> and <b>3a</b> for ECAR and ROS were largely the same as lead compound <b>16</b>. These data suggested that analogues <b>2k</b> and <b>3a</b> affected cell metabolism in the same way as <b>16</b>.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Metabolic alteration caused by <b>2k</b>, <b>3a</b>, and <b>16</b> on A549 cells. (A) Effect on the extracellular acidification rate (ECAR) in a dose-dependent manner. (B) Effect on the reactive oxygen species (ROS) in a dose-dependent manner. Cells were treated with compounds at the indicated concentrations for 24 h. Error bars represent the average ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <b>2k</b> and <b>3a</b> Exhibit Antiproliferative Effects in Cancer Cells but Not in Normal Cells</h3><div class="NLM_p">Encouraged by the above observations, we tested the antiproliferative effects of analogues <b>2k</b> and <b>3a</b> by the CCK8 assay. Two cancer cells, A549 (human lung cancer cells) and Kelly (human neural cancer cells), and two normal cells, GM00637 (human skin fibroblast cells) and LO2 (human normal liver cells), were employed. DCA was used as the positive control. All three compounds dose-dependently inhibited the proliferation of cancer cells and had no obvious influence on normal cells (IC<sub>50</sub> > 10 μM, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). As the best analogue in the immunoblotting analysis (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), analogue <b>3a</b> sustained its advantage and inhibited Kelly cell proliferation with a promising IC<sub>50</sub> of 0.057 μM (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), leading to ∼5-fold potency improvement compared to the lead compound <b>16</b>, whereas analogue <b>2k</b> possessed less than satisfactory potency (IC<sub>50</sub> = 1.426 μM). In addition to Kelly cells, analogue <b>3a</b> effectively inhibited A549 cell proliferation (IC<sub>50</sub> = 0.225 μM, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), to a greater extent than both <b>16</b> (IC<sub>50</sub> = 0.480 μM) and analogue <b>2k</b> (IC<sub>50</sub> = 0.957 μM). Of note, compounds <b>2k</b> and <b>3a</b> barely inhibited the growth of two normal cell lines.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Antiproliferative Effects of Analogues <b>2k</b>, <b>3a</b>, and <b>16</b> on Different Cell Lines<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell</th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>2k</b></th><th class="colsep0 rowsep0" align="center"><b>3a</b></th><th class="colsep0 rowsep0" align="center">DCA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="center">0.480 ± 0.014</td><td class="colsep0 rowsep0" align="center">0.957 ± 0.009</td><td class="colsep0 rowsep0" align="center">0.225 ± 0.045</td><td class="colsep0 rowsep0" align="center">14827 ± 5333</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Kelly</td><td class="colsep0 rowsep0" align="center">0.289 ± 0.017</td><td class="colsep0 rowsep0" align="center">1.426 ± 0.010</td><td class="colsep0 rowsep0" align="center">0.057 ± 0.002</td><td class="colsep0 rowsep0" align="center">11095 ± 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GM00637</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">13812 ± 4587</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LO2</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>15000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The experiments were carried out in triplicate by CCK8 assay after incubation for 72 h. The IC<sub>50</sub> values are reported as the average ± SD.</p></div></div></div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Compounds <b>2k</b> and <b>3a</b> Attenuates Tumor Growth in A549 Xenograft Models</h3><div class="NLM_p">To further prove the therapeutic potential of compound <b>3a</b>, we compared antitumor efficacy of <b>16</b>, <b>2k</b>, and <b>3a</b> in A549 subcutaneous xenograft mice models (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Tumor-bearing mice were randomly subgrouped and intraperitoneally received vehicle control or <b>16</b> analogues at 40 and 80 mg/kg per day, respectively. A 21-day continuous treatment of <b>16</b> and <b>3a</b> considerably reduced tumor volume at both dosages compared with the vehicle control (<b>16</b>, TGI = 27.7% at 40 mg/kg, TGI = 50.4% at 80 mg/kg; <b>3a</b>, TGI = 26.2% at 40 mg/kg, TGI = 47.8% at 80 mg/kg; <a class="ref internalNav" href="#fig8" aria-label="Figures 8">Figures 8</a>A,C), but the effect of <b>2k</b> was marginal (TGI = 11.0% at 40 mg/kg, TGI = 20.0% at 80 mg/kg; <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). Likewise, end point tumor weights in the <b>16</b> and <b>3a</b> treated group were significantly less than those treated with vehicle control (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>D). In this experiment, compound <b>3a</b> showed similar antitumor efficacy as <b>16</b>. The 2-fold improvement in the enzymatic activity of <b>3a</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) was not translated to in vivo efficacy in inhibiting tumor growth (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>E). None of the results resulted in mice bodyweight loss even at higher dosage.</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>2k</b>, <b>3a</b>, and <b>16</b> inhibit tumor growth in vivo. A549 xenograft mouse models were treated with inhibitors or vehicle control daily at indicated dosages for 21 consecutive days. (A–C) The tumor growth inhibition values (TGI) were measured on the final day of the study. (D) Tumor weight after last dosing. (E) Body weight change of <b>16</b> and <b>3a</b>. One-way ANOVA analysis, *, <i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have discovered two novel types of PDK1 inhibitors, i.e., bis(thiazolyl)disulfides (<b>1a</b>–<b>m</b>) and bis(thiocarbonyl)disulfides (<b>2a</b>–<b>s</b>, <b>3a</b>–<b>j</b>). On the basis of the structure of the lead compound <b>16</b>, 31 completely novel disulfide-based analogues have been synthesized and tested by a PDK1 enzymatic inhibitory assay. Twenty-two analogues (<b>1c</b>–<b>d</b>, <b>1f</b>–<b>m</b>, <b>2a</b>–<b>d</b>, <b>2f</b>, <b>2i</b>, <b>2j</b>–<b>k</b>, <b>2m</b>–<b>n</b>, <b>2p</b>, and <b>3a</b>) showed potent PDK1 inhibitory activity (IC<sub>50</sub> < 0.3 μM). Preliminary SARs were obtained base on IC<sub>50</sub> data and were further validated by <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>, showing that the disulfide bond and bulky <i>N</i>,<i>O</i>-containing aliphatic rings of <b>16</b> are indispensable for PDK1 inhibitory activity, and terminal small steric hydrophobic substituents can substantially improve the potency.</div><div class="NLM_p">The PDK1 inhibition assays at the cellular level further confirmed that nine analogues (<b>2a</b>–<b>b</b>, <b>2d</b>, <b>2i</b>–<b>k</b>, <b>2m</b>–<b>n</b>, and <b>3a</b>) were potent PDK inhibitors and effectively abolished PDHE phosphorylation at both S293 and S232. Among the nine analogues, analogue <b>3a</b> exhibited the best inhibition (down to 0.1 μM) at both S293 and S232 and the PDK-selective profile of <b>3a</b> was observed. <b>3a</b> was also identified to inhibit PDK1 by covalently binding to a conserved cysteine residue. Compound <b>3a</b> demonstrated approximately 2 times higher potency in inhibiting PDK1 than that of <b>16</b> according to the <i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub> value. In the meanwhile, <b>3a</b> had a ∼40-fold selectivity for PDK1 over PDK2 and 3 and showed no inhibition of PDK4 at a concentration up to 10 μM. Subtype selectivity of <b>3a</b> was 10 times higher than that of <b>16</b>. Further detailed analysis of molecular docking of <b>16</b>, <b>2k</b>, and <b>3a</b> with PDK1–4 gained a better understanding of the subtype-selectivity for PDK1–4 of these compounds.</div><div class="NLM_p last">Compound <b>3a</b> significantly altered glucose metabolic profile in a dose-dependent manner in A549 cells by decreasing ECAR and increasing ROS. Moreover, the in vitro antiproliferative assays showed that <b>3a</b> had more potent inhibitory effects than that of <b>16</b> on the proliferation of two human cancer cell lines (A549, IC<sub>50</sub> = 0.225 μM; and Kelly, IC<sub>50</sub> = 0.057 μM), without inhibition activity against normal cell lines GM00637 and LO2 (IC<sub>50</sub> > 10 μM). Together with <b>16</b>, compound <b>3a</b> also showed significant antitumor activity in the in vivo A549 xenograft models which was better than that of <b>2k</b>. Altogether, these data demonstrate that <b>3a</b> may be a promising starting point for the discovery of potential therapeutic drugs to specifically inhibit PDK1. Considering the small number of PDK1 inhibitors reported thus far, <b>3a</b> could be regarded as the first generation of subtype-selective and covalent PDK1 inhibitors. Further characterization of <b>3a</b> as a potential cancer therapeutic drug will be performed in the future.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Chemistry</h4><div class="NLM_p last">The synthetic starting materials, reagents, and solvents were purchased from Alfa Aesar, Acros, Adamas-beta, Energy Chemical, J&K, Shanghai Chemical Reagent Co., and TCI at the highest commercial quality and were used without further purification. Analytical thin-layer chromatography (TLC) was performed on HSGF 254 (150–200 μm thickness; Yantai Huiyou Co., China), and the components were visualized by observation under UV light (254 and 365 nm). Melting points were determined on an SGW X-4 melting point apparatus without correction. Optical rotation of the chiral compounds was measured using a RUDOLPH (AUTOPOL V) automatic polarimeter. The products were purified by recrystallization or column chromatography on silica gel (200–300 mesh). The reaction yields were not optimized. Nuclear magnetic resonance (NMR) spectroscopy was performed on a Bruker AMX-400 NMR using deuterated chloroform (CDCl<sub>3</sub>), deuterated methanol (CD<sub>3</sub>OD), or deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) as the solvent. The chemical shifts were reported in parts per million (ppm, δ) downfield from tetramethylsilane. The proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). Low- and high-resolution mass spectra (LRMS and HRMS) were performed with electric and electrospray ionization (EI and ESI) with a Finnigan MAT-95 and an LCQ-DECA spectrometer. HPLC analysis of compounds <b>1a</b>–<b>m</b>, <b>2a</b>–<b>s</b>, and <b>3a</b>–<b>j</b> was performed on an Agilent 1100 with a quaternary pump and a diode-array detector (DAD). The peak purity was checked by UV spectra. All analogues were confirmed to be ≥95% purity.</div></div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Bis(thiazol-2-yl)disulfide (<b>1a</b>)</h4><div class="NLM_p last">This analogue is commercially available from J&K Scientific Ltd.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Bis(benzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1b</b>)</h4><div class="NLM_p last">An aqueous solution of ammonium persulfate (342 mg, 1.5 mmol in 5 mL water) was added dropwise at room temperature to a stirred solution of benzo[<i>d</i>]thiazole-2-thiol (<b>4a</b>, 167 mg, 1 mmol) in THF (10 mL), and the reaction was monitored by TLC. After 0.5 h, the mixture was separated between EtOAc (50 mL) and water (50 mL). The organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>1b</b> as a white solid (150 mg). Yield: 90%; mp 179–181 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.94 (d, <i>J</i> = 8.2 Hz, 2H), 7.77 (d, <i>J</i> = 8.0 Hz, 2H), 7.49–7.45 (m, 2H), 7.38–7.34 (m, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>8</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 331.9570, found 331.9576.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Bis(6-nitrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1c</b>)</h4><div class="NLM_p last">Fuming nitric acid (0.016 mL, 0.35 mmol) was added to a stirred solution of <b>1b</b> (100 mg, 0.3 mmol) in concentrated sulfuric acid (5 mL) maintained at 0 °C. The solution was stirred at room temperature for 1 h and was then added to ice–water (50 mL). The precipitated product was collected and crystallized from EtOAc to give analogue <b>1c</b> as a yellow solid (90 mg). Yield: 71%; mp 218–220 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.13 (d, <i>J</i> = 2.3 Hz, 2H), 8.35 (dd, <i>J</i> = 9.0, 2.3 Hz, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>6</sub>N<sub>4</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 421.9272, found 421.9277.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Bis(6-ethoxybenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1d</b>)</h4><div class="NLM_p last"><b>1d</b> was obtained in the same manner as described in the preparation of <b>1b</b> from 6-ethoxybenzo[<i>d</i>]thiazole-2-thiol (<b>4b</b>) as a white solid. Yield: 85%; mp 132–135 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83 (d, <i>J</i> = 9.0 Hz, 2H), 7.65 (d, <i>J</i> = 2.2 Hz, 2H), 7.10 (dd, <i>J</i> = 9.0, 2.4 Hz, 2H), 4.06 (q, <i>J</i> = 6.9 Hz, 4H), 1.34 (t, <i>J</i> = 6.9 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 420.0095, found 420.0096.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Bis(thiazolo[5,4-<i>b</i>]pyridin-2-yl)disulfide (<b>1e</b>)</h4><div class="NLM_p last"><b>1e</b> was obtained in the same manner as described in the preparation of <b>1b</b> from thiazolo[5,4-<i>b</i>]pyridine-2-thiol (<b>4c</b>) as a white solid. Yield: 60%; mp 147–148 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.61 (d, <i>J</i> = 4.6 Hz, 2H), 8.39 (d, <i>J</i> = 8.3 Hz, 2H), 7.65–7.58 (m, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>6</sub>N<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 333.9475, found 333.9476.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Bis(6,7-dihydro-4<i>H</i>-pyrano[4,3-<i>d</i>]thiazol-2-yl)disulfide (<b>1f</b>)</h4><div class="NLM_p last">Ammonium dithiocarbamate (110 mg, 1 mmol) was added to a solution of 3-bromooxan-4-one (<b>5a</b>, 179 mg, 1 mmol) in EtOH (20 mL), and the mixture was heated to reflux for 1 h and concentrated under reduced pressure. The residue was separated between EtOAc (50 mL) and water (50 mL), the organic layer was washed with brine and dried over anhydrous sodium sulfate, and the solvent was removed to give the crude product 6,7-dihydro-4<i>H</i>-pyrano[4,3-<i>d</i>]thiazole-2-thiol (<b>4d</b>, 180 mg), which was used in the next step without further purification. Analogue <b>1f</b> was obtained in the same manner as described in the preparation of <b>1b</b> from the crude product <b>4d</b> as a white solid. Yield: 52% over two steps; mp 125–127 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.75 (s, 4H), 3.96–3.88 (m, 4H), 2.83–2.75 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 343.9782, found 343.9781.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Bis(5,6-dihydro-4<i>H</i>-cyclopenta[<i>d</i>]thiazol-2-yl)disulfide (<b>1g</b>)</h4><div class="NLM_p last"><b>1g</b> was obtained in the same manner as described in the preparation of <b>1f</b> from 2-bromocyclopentanone (<b>5b</b>) as a white solid. Yield: 70% over two steps; mp 115–118 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.91 (t, <i>J</i> = 7.2 Hz, 4H), 2.77 (t, <i>J</i> = 7.4 Hz, 4H), 2.46–2.37 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 311.9883, found 311.9884.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Bis(4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1h</b>)</h4><div class="NLM_p last"><b>1h</b> was obtained in the same manner as described in the preparation of <b>1f</b> from 2-bromocyclohexanone (<b>5c</b>) as a white solid. Yield: 85% over two steps; mp 102–105 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 2.78–2.71 (m, 4H), 2.71–2.63 (m, 4H), 1.84–1.72 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 340.0196, found 340.0197.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Bis(6-methyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1i</b>)</h4><div class="NLM_p last"><b>1i</b> was obtained in the same manner as described in the preparation of <b>1f</b> from 2-bromo-4-methylcyclohexanone (<b>5d</b>) as a light-yellow solid. Yield: 80% over two steps; mp 110–112 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.93–2.79 (m, 4H), 2.79–2.68 (m, 2H), 2.40–2.29 (m, 2H), 1.94–1.79 (m, 4H), 1.56–1.43 (m, 2H), 1.10 (s, 3H), 1.08 (s, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 368.0509, found 368.0508.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Bis(6,6-dimethyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1j</b>)</h4><div class="NLM_p last"><b>1j</b> was obtained in the same manner as described in the preparation of <b>1f</b> from 2-bromo-4,4-dimethylcyclohexanone (<b>5e</b>) as a light-yellow solid. Yield: 77% over two steps; mp 110–111 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.83–2.75 (m, 4H), 2.53 (s, 4H), 1.67–1.58 (m, 4H), 1.03 (s, 12H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>24</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 396.0822, found 396.0829.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Bis(6-ethoxycarbonyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1k</b>)</h4><div class="NLM_p last"><b>1k</b> was obtained in the same manner as described in the preparation of <b>1f</b> from ethyl 3-bromo-4-oxocyclohexanecarboxylate (<b>5f</b>) as a white solid. Yield: 67% over two steps; mp 129–131 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.18 (q, <i>J</i> = 7.0 Hz, 4H), 3.08–2.99 (m, 4H), 2.99–2.87 (m, 2H), 2.87–2.74 (m, 4H), 2.32–2.21 (m, 2H), 2.07–1.90 (m, 2H), 1.28 (t, <i>J</i> = 7.1 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>20</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> [M + H]<sup>+</sup> 485.0697, found 485.0700.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Bis(6-carboxyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazol-2-yl)disulfide (<b>1l</b>)</h4><div class="NLM_p last">A mixture of ethyl 2-mercapto-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-6-carboxylate (243 mg, 1 mmol) and LiOH (100 mg, 4 mmol) was combined in 4 mL of THF and H<sub>2</sub>O solvent (<i>V</i><sub>THF</sub>:<i>V</i><sub>H2O</sub> = 3:1) at room temperature for 0.5 h and was acidified to pH 5.5. Then, the precipitate was collected, washed with H<sub>2</sub>O, and dried to afford 2-mercapto-4,5,6,7-tetrahydrobenzo[<i>d</i>]thiazole-6-carboxylic acid (<b>4j</b>, 200 mg, 93%) as a white solid. <b>1l</b> was obtained in the same manner as described in the preparation of <b>1f</b> from <b>4j</b> as a white solid. Yield: 95%; mp 222–223 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 12.48 (brs, 2H), 3.07–2.97 (m, 2H), 2.95–2.83 (m, 2H), 2.83–2.68 (m, 6H), 2.19–2.06 (m, 2H), 1.93–1.79 (m, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 427.9993, found 427.9991.</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Bis(5,6,7,8-tetrahydro-4<i>H</i>-cyclohepta[<i>d</i>]thiazol-2-yl)disulfide (<b>1m</b>)</h4><div class="NLM_p last"><b>1m</b> was obtained in the same manner described in the preparation of <b>1f</b> from 2-bromocycloheptanone (<b>5g</b>) as a white solid. Yield: 60% over two steps; mp 87–88 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.98–2.89 (m, 4H), 2.83–2.75 (m, 4H), 1.89–1.81 (m, 4H), 1.77–1.64 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 368.0509, found 368.0510.</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Bis(2-methylmorpholin-4-yl-thiocarbonyl)disulfide (<b>2a</b>)</h4><div class="NLM_p last">A mixture of 2-methylmorpholine (<b>6a</b>, 505 mg, 5 mmol), carbon disulfide (0.6 mL, 10 mmol), potassium hydroxide (616 mg, 11 mmol), and water (50 mL) was stirred at 50 °C overnight. After cooling to room temperature, the solution was mixed with sodium nitrite (345 mg, 5 mmol) and MeOH (0.3 mL), and concentrated HCl (1 mL) was added dropwise at 0 °C under vigorous stirring. After 0.5 h, the system was separated between EtOAc (200 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2a</b> as a colorless oil (818 mg). Yield: 93%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.63–4.65 (m, 4H), 4.10–3.92 (m, 2H), 3.88–3.65 (m, 4H), 3.62–3.36 (m, 2H), 3.32–2.94 (m, 2H), 1.27 (s, 3H), 1.26 (s, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 352.0408, found 352.0405.</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Bis((2<i>R</i>,6<i>S</i>)-2,6-dimethylmorpholin-4-yl-thiocarbonyl)disulfide (<b>2b</b>)</h4><div class="NLM_p last"><b>2b</b> was obtained in the same manner as described in the preparation of <b>2a</b> from (2<i>S</i>,6<i>R</i>)-2,6-dimethylmorpholine (<b>6b</b>) as a white solid. Yield: 90%; mp 124–125 °C. [α]<sub>D</sub><sup>25</sup> = −0.010 (<i>c</i> 1, methanol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.30 (br s, 2H), 4.82 (br s, 2H), 3.77 (br s, 4H), 3.09 (br s, 2H), 294 (br s, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 380.0721, found 380.0723.</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Bis(2-carboxyl-morpholin-4-yl-thiocarbonyl)disulfide (<b>2c</b>)</h4><div class="NLM_p last"><b>2c</b> was obtained in the same manner as described in the preparation of <b>2a</b> from morpholine-2-carboxylic acid (<b>6c</b>) as a white solid. Yield: 90%; mp 112–113 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.30 (brs, 2H), 5.14–4.90 (m, 1H), 4.79–4.17 (m, 5H), 4.16–3.73 (m, 6H), 3.73–3.63 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>O<sub>6</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 434.9789, found 434.9784.</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Bis(2-methoxycarbonylmorpholin-4-yl-thiocarbonyl)disulfide (<b>2d</b>)</h4><div class="NLM_p last">Concentrated sulfuric acid (0.05 mL) was added to a stirred solution of <b>2c</b> (412 mg, 1 mmol) in MeOH (50 mL), and the solution was stirred at room temperature for 10 h. The system was separated between EtOAc (200 mL) and water (100 mL), and the organic layer was washed with water and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2d</b> as a white solid (380 mg). Yield: 86%; mp 150–152 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.50–5.00 (m, 2H), 4.96–4.72 (m, 2H), 4.34 (dd, <i>J</i> = 9.4, 2.9 Hz, 2H), 4.23–4.11 (m, 2H), 3.93–3.72 (m, 12H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 440.0204, found 440.0205.</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Bis(3,4-dihydro-2<i>H</i>-benzo[<i>b</i>]morpholin-4-yl-thiocarbonyl)disulfide (<b>2e</b>)</h4><div class="NLM_p last"><b>2e</b> was obtained in the same manner as described in the preparation of <b>2a</b> from 3,4-dihydro-2<i>H</i>-benzo[<i>b</i>]morpholine (<b>6d</b>) as a colorless oil. Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (t, <i>J</i> = 8.0 Hz, 2H), 7.16–7.04 (m, 4H), 4.28 (t, <i>J</i> = 4.8 Hz, 2H), 4.03 (t, <i>J</i> = 4.8 Hz, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 420.0095, found 420.0093.</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Bis(<i>trans</i>-octahydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazin-4-yl-thiocarbonyl)disulfide (<b>2f</b>)</h4><div class="NLM_p last"><b>2f</b> was obtained in the same manner as described in the preparation of <b>2a</b> from <i>trans</i>-octahydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine (<b>6e</b>) as a light-yellow solid. Yield: 70%; mp 55–56 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.27–5.16 (m, 2H), 4.36–4.24 (m, 2H), 4.23–4.15 (m, 2H), 4.10–4.06 (m, 2H), 4.00–3.89 (m, 2H), 3.86–3.76 (m, 2H), 2.88–2.72 (m, 2H), 2.04–1.98 (m, 2H), 1.88–1.78 (m, 4H), 1.27–1.25 (m, 8H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 432.1034, found 432.1036.</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Bis(3-hydroxyazetidin-1-yl-thiocarbonyl)disulfide (<b>2g</b>)</h4><div class="NLM_p last">Carbon disulfide (0.6 mL, 10 mmol) was added to a solution of azetidin-3-ol (<b>6f</b>, 730 mg, 10 mmol) in THF (50 mL), and the mixture was stirred at room temperature for 1 h before an aqueous solution of ammonium persulfate (2280 mg, 10 mmol in 10 mL water) was added. After 0.5 h, the mixture was separated between EtOAc (200 mL) and water (100 mL). The organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2g</b> as a colorless oil (800 mg). Yield: 54%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.86–4.80 (m, 2H), 4.79–4.71 (m, 2H), 4.64–4.56 (m, 2H), 4.39–4.31 (m, 2H), 4.25–4.18 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>8</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 318.9679, found 318.9678.</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Bis((<i>R</i>)-3-hydroxymethylmorpholin-4-yl-thiocarbonyl)disulfide (<b>2h</b>)</h4><div class="NLM_p last">(<i>R</i>)-(4-Benzylmorpholin-3-yl)methanol (<b>8a</b>, 207 mg, 1 mmol) was dissolved in MeOH (50 mL) in a hydrogenation reactor. Then, 10% Pd/C (50 mg) was added, the reactor was filled with hydrogen gas to a pressure of 1 atm, and the reaction mixture was stirred overnight. The spent catalyst was filtered through Celite, and the filtrate was evaporated to dryness. The residue was stirred with CS<sub>2</sub> (114 mg, 1.5 mmol) in THF (10 mL) for 1 h before an aqueous solution of ammonium persulfate (228 mg, 1 mmol in 1 mL water) was added. After 0.5 h, the mixture was separated between EtOAc (100 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2h</b> as a colorless oil (158 mg). Yield: 80% over two steps. [α]<sub>D</sub><sup>25</sup> = −0.201 (<i>c</i> 1, methanol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.69–4.62 (m, 4H), 4.11–3.93 (m, 10H), 3.80–3.56 (m, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 407.0204, found 407.0197.</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Bis(2-methanolylmorpholin-4-yl-thiocarbonyl)disulfide (<b>2i</b>)</h4><div class="NLM_p last">4-Benzyl-2-chloromethylmorpholine (<b>10</b>, 2.25 g, 10 mmol), 10 mL of water, and 50 mL of formamide were placed in a 250 mL round-bottomed flask with a condenser. The mixture was heated at 190 °C overnight. After returning to room temperature, the medium was poured into 100 mL of ice-cold water, and the resulting mixture was basified with 10 M sodium hydroxide to pH = 12. Extraction was conducted with 400 mL of EtOAc, and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford 4-benzyl-2-(hydroxymethyl)morpholine (<b>11e</b>) as an amber oil (1.8 g). Yield: 87%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.57–7.22 (m, 5H), 3.94–3.86 (m, 1H), 3.78–3.65 (m, 2H), 3.64–3.46 (m, 4H), 2.76–2.63 (m, 2H), 2.21 (td, <i>J</i> = 11.4, 3.3 Hz, 1H), 2.03 (t, <i>J</i> = 10.8 Hz, 1H). <b>11e</b> (207 mg, 1 mmol) was dissolved in MeOH (50 mL) in a hydrogenation reactor. Then, 10% Pd/C (50 mg) was added, the reactor was filled with hydrogen gas to a pressure of 1 atm, and the reaction mixture was stirred overnight. The spent catalyst was filtered through Celite, and the filtrate was evaporated to dryness. The residue was stirred with carbon disulfide (0.06 mL, 1 mmol) and potassium hydroxide (61.6 mg, 1.1 mmol) in 10 mL of water at 50 °C overnight. After cooling to room temperature, the solution was mixed with sodium nitrite (34.5 mg, 0.5 mmol) and MeOH (0.1 mL) before concentrated HCl (0.1 mL) was added dropwise at 0 °C under vigorous stirring. After 0.5 h, the mixture was separated between EtOAc (100 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2i</b> as a colorless oil (140 mg). Yield: 73% over two steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.67–4.42 (m, 4H), 4.10–4.00 (m, 2H), 3.84–3.62 (m, 8H), 3.61–3.30 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 407.0204, found 407.0205.</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Bis((<i>R</i>)-3-(ethoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2j</b>)</h4><div class="NLM_p last"><b>2j</b> was obtained in the same manner as described in the preparation of <b>2h</b> from (<i>R</i>)-4-benzyl-3-(ethoxymethyl)morpholine (<b>8b</b>) as a light-yellow oil. Yield: 75%. [α]<sub>D</sub><sup>25</sup> = −0.185 (<i>c</i> 1, methanol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.74–4.50 (m, 4H), 4.15–4.09 (m, 2H), 4.04–3.94 (m, 2H), 3.93–3.31 (m, 14H), 1.21 (t, <i>J</i> = 6.8 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 440.0932, found 440.0931.</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Bis((<i>R</i>)-3-(methoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2k</b>)</h4><div class="NLM_p last"><b>2k</b> was obtained in the same manner as described in the preparation of <b>2h</b> from (<i>R</i>)-4-benzyl-3-(methoxymethyl)morpholine (<b>8c</b>) as a light-yellow solid. Yield: 75%; mp 100–102 °C. [α]<sub>D</sub><sup>25</sup> = −0.094 (<i>c</i> 1, methanol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.74–4.50 (m, 4H), 4.17–4.06 (m, 2H), 4.02–4.01 (m, 2H), 3.89–3.52 (m, 10H), 3.43 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 412.0619, found 412.0621.</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Bis(2-(ethoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2l</b>)</h4><div class="NLM_p last">Sodium hydride (60%, 120 mg, 3 mmol) was added slowly to a stirred solution of (4-benzylmorpholin-2-yl)methanol (<b>11e</b>, 207 mg, 1 mmol) in DMF (10 mL). The resulting mixture was stirred for 20 min at room temperature. Subsequently, iodoethane (300 mg, 2 mmol) was added to the resulting suspension, followed by stirring at 80 °C overnight. The mixture was separated between EtOAc (100 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford 4-benzyl-2-(ethoxymethyl)morpholine (<b>11f</b>) as a yellow oil (141 mg). Yield: 60%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.40–7.29 (m, 5H), 3.92–3.84 (m, 1H), 3.83–3.66 (m, 2H), 3.58–3.35 (m, 6H), 2.82–2.63 (m, 2H), 2.28–2.15 (m, 1H), 2.08–1.93 (m, 1H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H). <b>2l</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>11f</b> as a light-yellow oil. Yield: 74%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.45–4.66 (m, 4H), 4.09–4.00 (m, 2H), 3.85–3.71 (m, 4H), 3.66–3.25 (m, 12H), 1.23 (t, <i>J</i> = 6.8 Hz, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 440.0932, found 440.0936.</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Bis(2-(methoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2m</b>)</h4><div class="NLM_p last">4-Benzyl-2-(methoxymethyl)morpholine (<b>11a</b>) was obtained in the same manner as described in the preparation of <b>8c</b> from 4-benzyl-2-(chloromethyl)morpholine (<b>10</b>). <b>2m</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>11a</b> as a light-yellow oil. Yield: 68%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.61–4.50 (m, 4H), 4.12–4.01 (m, 2H), 3.85–3.67 (m, 4H), 3.60–3.44 (m, 6H), 3.41 (s, 6H), 3.39–3.14 (m, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 412.0619, found 412.0618.</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Bis(2-(acetoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2n</b>)</h4><div class="NLM_p last">TEA (300 mg, 3 mmol) was added to a stirred solution of (4-benzylmorpholin-2-yl)methanol (<b>11e</b>, 207 mg, 1 mmol) in DCM (10 mL). Subsequently, acetyl chloride (156 mg, 2 mmol) was added to the solution, and the solution was stirred at room temperature overnight. The mixture was separated between EtOAc (50 mL) and cold water (50 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford 4-benzyl-2-(acetoxymethyl)morpholine (<b>11g</b>) as a yellow oil (181 mg). Yield: 73%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37–7.22 (m, 5H), 4.09–4.05 (m, 2H), 3.94–3.86 (m, 1H), 3.85–3.65 (m, 2H), 3.53 (s, 2H), 2.78–2.62 (m, 2H), 2.28–2.16 (m, 1H), 2.08 (s, 3H), 2.03–1.93 (m, 1H). <b>2n</b> was obtained in the same manner as described in the preparation of <b>2h</b> from <b>11g</b> as a yellow oil. Yield: 85%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 3.53–4.79 (m, 4H), 4.15–4.16 (m, 4H), 4.10–4.03 (m, 2H), 3.91–3.83 (m, 2H), 3.82–3.74 (m, 2H), 3.64–3.48 (m, 2H), 3.45–3.25 (m, 2H), 2.12 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub>S<sub>4</sub> (M<sup>+</sup>) 468.0517, found 468.0519.</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Bis(2-((dimethylcarbamoyloxy)methyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2o</b>)</h4><div class="NLM_p"><b>11e</b> (207 mg, 1 mmol) was dissolved in MeOH (50 mL) in a hydrogenation reactor. Then, 10% Pd/C (50 mg) was added, the reactor was filled with hydrogen gas to a pressure of 1 atm, and the reaction mixture was stirred overnight. The spent catalyst was filtered through Celite, and the filtrate was evaporated to dryness. The residue was stirred with di-<i>tert</i>-butyl dicarbonate (240 mg, 1.1 mmol), sodium bicarbonate (250 mg, 3 mmol) in 20 mL of THF, and 5 mL of water at room temperature overnight. The mixture was separated between EtOAc (100 mL) and water (50 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford <i>tert</i>-butyl 2-(hydroxymethyl)morpholine-4-carboxylate (<b>12</b>) as a colorless oil (173 mg). Yield: 80% over two steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.02–3.78 (m, 3H), 3.70–3.66 (m, 1H), 3.61–3.49 (m, 3H), 3.02–2.86 (m, 1H), 2.84–2.68 (m, 1H), 1.47 (s, 9H).</div><div class="NLM_p">TEA (300 mg, 3 mmol) was added to a stirred solution of <b>12</b> (217 mg, 1 mmol) in DCM (10 mL). Subsequently, dimethylcarbamic chloride (214 mg, 2 mmol) was added to the solution, and the solution was stirred at room temperature overnight. The mixture was separated between EtOAc (50 mL) and cold water (50 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford <i>tert</i>-butyl 2-((dimethylcarbamoyloxy)methyl)morpholin-4-carboxylate (<b>11h</b>) as a white solid (175 mg). Yield: 61%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.19–4.03 (m, 2H), 4.00–3.75 (m, 3H), 3.68–3.47 (m, 2H), 3.04–2.97 (m, 1H), 2.92 (s, 6H), 2.79–2.63 (m, 1H), 1.47 (s, 9H).</div><div class="NLM_p last"><b>11h</b> (288 mg, 1 mmol) was treated with HCl in dioxane (10 mL, 4 mol/L) for 1 h at room temperature and was then evaporated to dryness. The residue was stirred with CS<sub>2</sub> (114 mg, 1.5 mmol) in THF (10 mL) for 1 h before an aqueous solution of ammonium persulfate (228 mg, 1 mmol in 1 mL water) was added. After 0.5 h, the mixture was separated between EtOAc (100 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford analogue <b>2o</b> as a colorless oil (118 mg). Yield: 45% over two steps. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.64–4.60 (m, 4H), 4.26–4.02 (m, 6H), 3.92–3.82 (m, 2H), 3.79–3.73 (m, 2H), 3.63–3.15 (m, 4H), 2.94 (s, 12H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 549.0946, found 549.0943.</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Bis(2-(phenoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2p</b>)</h4><div class="NLM_p last">Sodium hydride (60%, 120 mg, 3 mmol) was added slowly to a stirred solution of phenol (188 mg, 2 mmol) in DMF (10 mL). The resulting mixture was stirred for 20 min at room temperature. Subsequently, <b>10</b> (225 mg, 1 mmol) was added to the resulting suspension, followed by stirring at 120 °C overnight. The mixture was separated between EtOAc (100 mL) and water (100 mL), and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel to afford 4-benzyl-2-(phenoxymethyl)morpholine (<b>11b</b>) as a white solid (136 mg). Yield: 48%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.40–7.28 (m, 7H), 6.97–6.86 (m, 3H), 4.05–3.87 (m, 4H), 3.84–3.69 (m, 1H), 3.58 (s, 2H), 2.98–2.66 (m, 2H), 2.34–2.09 (m, 2H). <b>2p</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>11b</b> as a light-yellow oil. Yield: 76%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.34–7.26 (m, 5H), 7.00–6.89 (m, 5H), 5.92–4.57 (m, 4H), 4.33–3.22 (m, 14H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>24</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 559.0830, found 559.0823.</div></div><div id="sec5_1_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Bis(2-((<i>p</i>-tolyloxy)methyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2q</b>)</h4><div class="NLM_p last"><b>2q</b> was obtained in the same manner as described in the preparation of <b>2p</b> from 4-benzyl-2-((<i>p</i>-tolyloxy)methyl)morpholine (<b>11c</b>) as a light-yellow oil. Yield: 70%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.09–7.07 (m, 4H), 6.84–6.82 (m, 4H), 5.63–4.60 (m, 4H), 4.09–3.92 (m, 8H), 3.87–3.74 (m, 2H), 3.67–3.36 (m, 4H), 3.29 (s, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>26</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 587.1143, found 587.1147.</div></div><div id="sec5_1_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Bis(2-((naphth-1-yloxy)methyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2r</b>)</h4><div class="NLM_p last"><b>2r</b> was obtained in the same manner as described in the preparation of <b>2p</b> from 4-benzyl-2-((naphth-1-yloxy)methyl)morpholine (<b>11d</b>) as a light-yellow solid. Yield: 70%; mp 69–70 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33–8.18 (m, 2H), 7.85–7.75 (m, 2H), 7.57–7.42 (m, 6H), 7.41–7.32 (m, 2H), 6.89–6.68 (m, 2H), 5.88–4.42 (m, 4H), 4.37–4.11 (m, 8H), 3.89–3.39 (m, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>32</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 659.1143, found 659.1141.</div></div><div id="sec5_1_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Bis((<i>S</i>)-3-(methoxymethyl)morpholin-4-yl-thiocarbonyl)disulfide (<b>2s</b>)</h4><div class="NLM_p last"><b>2s</b> was obtained in the same manner as described in the preparation of <b>2h</b> from (<i>S</i>)-4-benzyl-3-(methoxymethyl)morpholine (<b>8c</b>) as a white solid. Yield: 80%; mp 100–102 °C. [α]<sub>D</sub><sup>25</sup> = +0.117 (<i>c</i> 1, methanol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.74–4.50 (m, 4H), 4.17–4.06 (m, 2H), 4.02–4.01 (m, 2H), 3.89–3.52 (m, 10H), 3.43 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 412.0619, found 412.0621.</div></div><div id="sec5_1_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Bis(1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3a</b>)</h4><div class="NLM_p last"><b>3a</b> was obtained in the same manner as described in the preparation of <b>2a</b> from 1,4-oxazepane (<b>7</b>) as a white solid. Yield: 87%; mp 100–102 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.42–4.26 (m, 7H), 4.15–3.96 (m, 2H), 3.92–3.70 (m, 7H), 2.31–2.21 (m, 2H), 2.18–2.06 (m, 2H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>12</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub>S<sub>4</sub> (M<sup>+</sup>) 352.0408, found 352.0405.</div></div><div id="sec5_1_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Bis(2-hydroxymethyl-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3b</b>)</h4><div class="NLM_p last">(4-Benzyl-1,4-oxazepan-2-yl)methanol (<b>14d</b>) was obtained in the same manner as described in the preparation of <b>11e</b> from 1-benzyl-3-(chloromethyl)azepane (<b>13</b>). <b>3b</b> was obtained in the same manner as described in the preparation of <b>2h</b> from <b>14d</b> as a light-yellow oil. Yield: 65%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.08–4.97 (m, 1H), 4.87–4.60 (m, 2H), 4.25–4.12 (m, 3H), 4.07–3.41 (m, 12H), 2.50–1.90 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>14</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 435.0517, found 435.0518.</div></div><div id="sec5_1_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Bis(2-methoxymethyl-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3c</b>)</h4><div class="NLM_p last">4-Benzyl-2-(methoxymethyl)-1,4-oxazepane (<b>14a</b>) was obtained in the same manner as described in the preparation of <b>8c</b> from <b>13</b>. <b>3c</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>14a</b> as a light-yellow oil. Yield: 84%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.21–5.10 (m, 1H), 4.92–4.68 (m, 2H), 4.27–4.08 (m, 3H), 3.99–3.45 (m, 12H), 3.42 (s, 3H), 3.39 (s, 3H), 2.51–1.98 (m, 4H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>16</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 440.0932, found 440.0930.</div></div><div id="sec5_1_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Bis(2-ethoxymethyl-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3d</b>)</h4><div class="NLM_p last"><b>3d</b> was obtained in the same manner as described in the preparation of <b>2j</b> from <b>14e</b> as a light-yellow oil. Yield: 83%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.21–5.11 (m, 1H), 4.91–4.67 (m, 2H), 4.27–4.10 (m, 3H), 3.99–3.45 (m, 16H), 2.51–2.03 (m, 4H), 1.26–1.17 (m, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> (M<sup>+</sup>) 468.1245, found 468.1246.</div></div><div id="sec5_1_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Bis(2-(<i>n</i>-butoxymethyl)-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3e</b>)</h4><div class="NLM_p last"><b>3e</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>14f</b> as a light-yellow oil. Yield: 83%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.21–5.11 (m, 1H), 4.91–4.68 (m, 2H), 4.27–4.05 (m, 3H), 4.00–3.74 (m, 3H), 3.66–3.40 (m, 12H), 2.51–1.96 (m, 4H), 1.63–1.56 (m, 4H), 1.42–1.32 (m, 4H), 0.97–0.87 (m, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>22</sub>H<sub>40</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub> Na [M + Na]<sup>+</sup> 547.1769, found 547.1774.</div></div><div id="sec5_1_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Bis(2-decyloxymethyl-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3f</b>)</h4><div class="NLM_p last"><b>3f</b> was obtained in the same manner as described in the preparation of <b>2i</b> from <b>14g</b> as a light-yellow oil. Yield: 90%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.21–5.11 (m, 1H), 4.91–4.68 (m, 2H), 4.29–4.03 (m, 3H), 4.02–3.74 (m, 4H), 3.73–3.37 (m, 12H), 2.50–1.96 (m, 4H), 1.65–1.51 (m, 4H), 1.41–1.19 (m, 28H), 0.88 (t, <i>J</i> = 6.5 Hz, 6H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>34</sub>H<sub>64</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 715.3647, found 715.3645.</div></div><div id="sec5_1_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Bis(2-phenoxymethyl-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3g</b>)</h4><div class="NLM_p last"><b>3g</b> was obtained in the same manner as described in the preparation of <b>2p</b> from <b>14b</b> as a yellow solid. Yield: 55%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33–7.21 (m, 4H), 7.04–6.86 (m, 6H), 5.32–5.21 (m, 1H), 5.06–4.70 (m, 2H), 4.40–4.14 (m, 5H), 4.14–4.12 (m, 4H), 4.02–3.83 (m, 3H), 3.77–3.54 (m, 3H), 2.54–2.03 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>26</sub>H<sub>32</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 587.1143, found 587.1135.</div></div><div id="sec5_1_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Bis(2-(<i>p</i>-tolyloxymethyl)-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3h</b>)</h4><div class="NLM_p last"><b>3h</b> was obtained in the same manner as described in the preparation of <b>2q</b> from <b>14c</b> as a light-yellow oil. Yield: 61%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.15–7.01 (m, 4H), 6.90–6.77 (m, 4H), 5.29–5.20 (m, 1H), 5.05–4.68 (m, 2H), 4.38–4.11 (m, 5H), 4.11–3.90 (m, 5H), 3.90–3.50 (m, 5H), 2.53–2.00 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>28</sub>H<sub>36</sub>N<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 615.1456, found 615.1456.</div></div><div id="sec5_1_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Bis(2-((dimethylcarbamoyloxy)methyl)-1,4-oxazepan-4-yl-thiocarbonyl)disulfide (<b>3i</b>)</h4><div class="NLM_p last"><b>3i</b> was obtained in the same manner as described in the preparation of <b>2o</b> from <b>13</b> as a light-yellow oil. Yield: 66%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.26–5.18 (m, 1H), 4.93–4.65 (m, 2H), 4.34–4.00 (m, 8H), 4.00–3.71 (m, 3H), 3.69–3.39 (m, 4H), 3.01–2.85 (m, 12H), 2.49–1.98 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>20</sub>H<sub>34</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 577.1259, found 577.1262.</div></div><div id="sec5_1_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Bis(2-((2-hydroxyethoxy)methyl)-1,4-oxazepane-4-yl-thiocarbonyl)disulfide (<b>3j</b>)</h4><div class="NLM_p last"><b>3j</b> was obtained in the same manner as described in the preparation of <b>2h</b> from <b>14h</b> as a light-yellow oil. Yield: 78%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 5.22–5.11 (m, 1H), 4.90–4.65 (m, 2H), 4.26–4.08 (m, 3H), 4.01–3.40 (m, 22H), 2.51–2.00 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd C<sub>18</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>S<sub>4</sub>Na [M + Na]<sup>+</sup> 523.1041, found 523.1041.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Biological Procedures</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Chemicals and Antibodies</h4><div class="NLM_p last">DCA was purchased from Sigma-Aldrich. The following antibodies were used: pyruvate dehydrogenase E1-alpha subunit [pSer293] antibody (Novus Biologicals), PhosphoDetect anti-PDH-E1α (pSer<sup>232</sup>) rabbit pAb (Calbiochem), GAPDH (Cell Signaling), horseradish peroxidase-conjugated antimouse and antirabbit secondary antibodies (Kang Chen Biotech, China).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Cell Lines</h4><div class="NLM_p last">A549 cells were obtained from American Type Culture Collection (ATCC). Kelly cells were purchased from Deutsche Sammlung von Mikroorganismen and Zellkulturen (DSMZ). GM00637 cells were gifted by Dr. Yves Pommier (NCI, Bethesda, MD). LO2 cells were obtained from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). The cells were authenticated by analyzing the DNA profile of eight short tandem repeat (STR) loci plus amelogenin (Genesky Biotechnologies Inc.). The cells were maintained in appropriate culture media suggested by the supplier.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> ELISA-Based Kinase Activity Assay</h4><div class="NLM_p last">The 6xHis-tagged full-length coding sequences of PDK1 and PDHA1 were expressed in <i>Escherichia coli</i> and purified with Ni-NTA column following the manufacturer’s instructions (Qiagen). The enzymatic reaction was performed with enzyme PDK1 (0.25 μg/well), substrate PDHA1 (0.5 μg/well), and preincubated with compound or with GSH (2, 10, 50 μM) for 30 min in 50 μL of reaction buffer (50 mM HEPES, 10 mM MgCl<sub>2</sub>, and 1 mM EGTA), then adding 50 μL of reaction buffer containing 10 μM of ATP to initiate the reaction and placed in a 37 °C incubator for 1 h. After the reaction, the plate was washed with Tween-PBS, followed by incubation with primary antibody (p-PDHE1, S293; Abgent) for 1 h and horseradish peroxidase-conjugated secondary antibody (Calbiochem) for 1 h. The plate was washed and visualized with citrate buffer containing 0.1% H<sub>2</sub>O<sub>2</sub> and 2 mg/mL <i>o</i>-phenylenediamine. The absorbance was measured at 490 nm after termination by H<sub>2</sub>SO<sub>4</sub> (2 M; 50 μL/well). For enzymatic assay of other PDK isoforms, the procedure was similar to PDK1 except using of different amount of enzymes, as PDK2 (0.5 μg), PDK3 (0.2 μg), and PDK4 (0.3 μg).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>k</i><sub>inact</sub> and <i>K</i><sub>i</sub> Assay</h4><div class="NLM_p last">The method for measuring <i>k</i><sub>inact</sub> and <i>K</i><sub>i</sub> is according to the classical enzymatic assay described by Singh et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The procedure is similar to the PDKs enzymatic activity assay as described above except using various preincubation time points (45, 35, 25, 15, 5, 0 min) at each concentration of compounds, then adding ATP to initiate the reaction and placed in 37 °C incubator for 15 min. After the reaction, the plate was washed with Tween-PBS, followed by incubation with primary antibody (p-PDHE1, S293; Abgent) for 1 h and horseradish peroxidase-conjugated secondary antibody (Calbiochem) for 1 h. The plate was washed and visualized with citrate buffer containing 0.1% H<sub>2</sub>O<sub>2</sub> and 2 mg/mL <i>o</i>-phenylenediamine. The absorbance was measured at 490 nm after termination by H<sub>2</sub>SO<sub>4</sub> (2 M; 50 μL/well). Following least-squares regression analysis to determine the negative slope of the logarithm of the % remaining activity (corrected for negative control) versus preincubation time at each concentration of compound, nonlinear regression analysis of the negative slopes against compound concentration enables <i>k</i><sub>inact</sub> and <i>K</i><sub>i</sub> to be calculated.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Immunoblotting Analysis</h4><div class="NLM_p last">Cells were lysed using preheated 2% SDS by vortexing vigorously for 2–3 s followed by boiling for 30 min. The protein content was measured using a BCA protein assay kit (Beyotime). Blocking was performed for 1 h with 5% nonfat milk in Tris-buffered saline Tween 20 (TBST) (25 mM Tris, 150 mM NaCl, 2 mM KCl, pH 7.4, supplemented with 0.1% Tween 20), and blotting was performed with primary antibodies (1:2000) at 4 °C overnight. After washing the membranes with TBST three times for 10 min, horseradish peroxidase-conjugated antirabbit IgG (1:2000) or antimouse IgG (1:2000) antibodies were incubated at room temperature for 1 h. The membranes were washed for 10 min with TBST for three times before visualization using an enhanced chemiluminescence assay (Thermo Scientific) or femtochemiluminescence assay (Thermo Scientific).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Extracellular Acidification Rate (ECAR) Analysis</h4><div class="NLM_p last">A Seahorse XF96 extracellular flux analyzer (Seahorse Bioscience, North Billerica, MA) was used to assess the extracellular acidification rate (ECAR). Cells were plated, and each XF96 assay well was equipped with a disposable sensor cartridge and embedded with 96 pairs of fluorescent biosensors (pH) coupled to fiber-optic waveguides. The ECAR measurement was expressed in mpH/min.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Reactive Oxygen Species (ROS) Measurement</h4><div class="NLM_p last">After treatment for 24 h, cells were harvested and washed with 1× PBS, followed by incubation with 3 mM dihydroethidium (Invitrogen) in the dark for at 37 °C for 20 min. The cells were then washed in 1× PBS and resuspended in regular DMEM. Intracellular ROS was measured by FACS analysis (FACSCalibur flow cytometer; BD Biosciences).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Cell Proliferation Assay</h4><div class="NLM_p last">Cells were seeded into 96-well plates, and cell proliferation was assessed using the CCK8 assay (Life Technologies) after incubation for 72 h. The absorbance (optical density, OD) was read at 450 nm on an ELISA plate reader. The IC<sub>50</sub> values were calculated by concentration–response curve fitting using the four-parameter method.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Animal Studies</h4><div class="NLM_p last">All procedures were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and European Union directives, and guidelines and were approved by the local ethics committees. Four–six week old female BALB/c-nude mice were inoculated subcutaneously with 5 × 10<sup>6</sup> A549 cells which were mixed with equal volumes of Matrigel Matrix (catalogue no. 356237, Corning) in the right forearm, and treatment was started when tumor volume reached around 100 mm<sup>3</sup>. Mice grouped into six mice per group were intraperitoneally treated with saline or <b>16</b>, <b>2k</b>, and <b>3a</b> at a dose of 80 or 40 mg/kg daily for 21 days. Tumor growth was monitored by measurement of tumor size slide caliper twice a week. Mice were sacrificed and analyzed after last dosing. Percent tumor growth inhibition (% TGI) was calculated based on the ratio of the change in average tumor volumes for inhibitors vs vehicle treatment: TGI = 100(1 – [{<i>V</i><sub>day21</sub> – <i>V</i><sub>day0</sub>}<sub>dose</sub>/{<i>V</i><sub>day21</sub> – <i>V</i><sub>day0</sub>}<sub>vehicle</sub>]).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Molecular Docking</h4><div class="NLM_p last">Missing residues of PDK1 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8F">2Q8F</a>,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> residue 68–71, 168–169, 204–214, 415–416), PDK2 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTZ">2BTZ</a>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> residue 165–172, 300–313), PDK3 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8N">1Y8N</a>,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> residue 317–319, 322–323), and PDK4 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A">2E0A</a>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> residue 46–48, 318–323) were complemented using “Build Homology Models” module of Discovery Studio 2.5 (Accelrys Software Inc., San Diego, CA). Then Autodock 4.0 software was used for molecular docking. The binding sites were defined as a sphere with a radius of 10 Å around the sulfur atom of PDK1 Cys240, PDK2 Cys148, PDK3 Cys208, and PDK4 Cys215, respectively. The grid parameter files (gpf) and the docking parameter files (dpf) were generated by AutoDock Tools (ADT). The Lamarckian genetic algorithm (LGA) was employed to explore the optimal chemical space in the binding site.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Docking parameters were kept the default values.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01245">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01245" class="ext-link">10.1021/acs.jmedchem.6b01245</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">The HPLC reports for the purity check of analogues <b>1a</b>–<b>m</b>, <b>2a</b>–<b>s</b>, and <b>3a</b>–<b>j</b>, and the source and chemical data of intermediates <b>4a</b>–<b>k</b>, <b>5a</b>–<b>g</b>, <b>6a</b>–<b>f</b>, <b>7</b>, <b>8a</b>–<b>c</b>, <b>9</b>–<b>10</b>, <b>11a</b>, <b>11c</b>–<b>d</b>, <b>13</b>, <b>14a</b>–<b>i</b>, and <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf">jm6b01245_si_001.pdf (87.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_002.csv">jm6b01245_si_002.csv (3.32 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01245" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Huang</span> - <span class="hlFld-Affiliation affiliation">Division of Antitumor Pharmacology, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1c7174697d727b5c6f757171327d7f327f72"><span class="__cf_email__" data-cfemail="95f8fde0f4fbf2d5e6fcf8f8bbf4f6bbf6fb">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e34373f3032371e3b3d2b2d2a703b3a2b703d30"><span class="__cf_email__" data-cfemail="254f4c444b494c6540465056510b4041500b464b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yifu Liu</span> - <span class="hlFld-Affiliation affiliation">Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zuoquan Xie</span> - <span class="hlFld-Affiliation affiliation">Division of Antitumor Pharmacology, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Zhao</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery and Design Center, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Zhu</span> - <span class="hlFld-Affiliation affiliation">Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Mao</span> - <span class="hlFld-Affiliation affiliation">Shanghai Key Laboratory
of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuai Tang</span> - <span class="hlFld-Affiliation affiliation">Division of Antitumor Pharmacology, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Xu</span> - <span class="hlFld-Affiliation affiliation">Division of Antitumor Pharmacology, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Luo</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery and Design Center, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meiyu Geng</span> - <span class="hlFld-Affiliation affiliation">Division of Antitumor Pharmacology, State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.L. and Z.X. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6331-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support of this research provided by the National Natural Science Foundation of China (grants 21672064, 21372001, 81573464), the “Shu Guang” project supported by the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation (grant 14SG28), and the Fundamental Research Funds for the Central Universities is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> Abbreviations Used</h2><tr><td class="NLM_term">PDC</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase complex</p></td></tr><tr><td class="NLM_term">PDK</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor-1α</p></td></tr><tr><td class="NLM_term">DCA</td><td class="NLM_def"><p class="first last">dichloroacetate</p></td></tr><tr><td class="NLM_term">GHKL</td><td class="NLM_def"><p class="first last">gyrase</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">histidine kinase, MutL</p></td></tr><tr><td class="NLM_term">ECAR</td><td class="NLM_def"><p class="first last">extracellular acidification rate</p></td></tr><tr><td class="NLM_term">OCR</td><td class="NLM_def"><p class="first last">oxygen consumption rate</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">A549</td><td class="NLM_def"><p class="first last">human lung cancer cells</p></td></tr><tr><td class="NLM_term">Kelly</td><td class="NLM_def"><p class="first last">human neural cancer cells</p></td></tr><tr><td class="NLM_term">GM00637</td><td class="NLM_def"><p class="first last">human skin fibroblast cells</p></td></tr><tr><td class="NLM_term">LO2</td><td class="NLM_def"><p class="first last">human normal live cells</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0li3GPwtTi8JqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span> </span><span class="NLM_article-title">Targeting cancer metabolism: a therapeutic window opens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1038/nrd3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnrd3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21878982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=671-684&author=M.+G.+Vander+Heiden&title=Targeting+cancer+metabolism%3A+a+therapeutic+window+opens&doi=10.1038%2Fnrd3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer metabolism: a therapeutic window opens</span></div><div class="casAuthors">Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-684</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic events in cancer activate signalling pathways that alter cell metab.  Clin. evidence has linked cell metab. with cancer outcomes.  Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells.  However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today.  Research into how changes in cell metab. promote tumor growth has accelerated in recent years.  This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwef_xmbtRrVg90H21EOLACvtfcHk0li3GPwtTi8JqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J&md5=5051a52f70ba7dd0cd99cf6ffce7f4c6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3504%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520cancer%2520metabolism%253A%2520a%2520therapeutic%2520window%2520opens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D671%26epage%3D684%26doi%3D10.1038%2Fnrd3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wieland, O. H.</span><span> </span><span class="NLM_article-title">The mammalian pyruvate dehydrogenase complex: structure and regulation</span> <span class="citation_source-journal">Rev. Physiol., Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1007/BFb0031008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1007%2FBFb0031008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=6338572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaL3sXmslGltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1983&pages=123-170&author=O.+H.+Wieland&title=The+mammalian+pyruvate+dehydrogenase+complex%3A+structure+and+regulation&doi=10.1007%2FBFb0031008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The mammalian pyruvate dehydrogenase complex:  structure and regulation</span></div><div class="casAuthors">Wieland, Otto H.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-70</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    </div><div class="casAbstract">A review with 246 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSVMTkdjEobVg90H21EOLACvtfcHk0lhWWU9LkUvGOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmslGltg%253D%253D&md5=1bd06610b823cbd0a7fb058d5cc11c9c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBFb0031008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBFb0031008%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DO.%2BH.%26atitle%3DThe%2520mammalian%2520pyruvate%2520dehydrogenase%2520complex%253A%2520structure%2520and%2520regulation%26jtitle%3DRev.%2520Physiol.%252C%2520Biochem.%2520Pharmacol.%26date%3D1983%26volume%3D96%26spage%3D123%26epage%3D170%26doi%3D10.1007%2FBFb0031008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Saunier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoli, S.</span><span> </span><span class="NLM_article-title">The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">817</span><span class="refDoi"> DOI: 10.1002/ijc.29564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1002%2Fijc.29564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=25868605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=809-817&author=E.+Saunierauthor=C.+Benelliauthor=S.+Bortoli&title=The+pyruvate+dehydrogenase+complex+in+cancer%3A+an+old+metabolic+gatekeeper+regulated+by+new+pathways+and+pharmacological+agents&doi=10.1002%2Fijc.29564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents</span></div><div class="casAuthors">Saunier, Elise; Benelli, Chantal; Bortoli, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cancer cells exhibit an altered metab. which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidn. of pyruvate.  This provides anabolic support and selective growth advantage for cancer cells.  Recently, a new concept has arisen suggesting that these metabolic changes may be due, in part, to an attenuated mitochondrial function which results from the inhibition of the pyruvate dehydrogenase complex (PDC).  This mitochondrial complex links glycolysis to the Krebs cycle and the current understanding of its regulation involves the cyclic phosphorylation and dephosphorylation by specific pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoUftek7vjrVg90H21EOLACvtfcHk0lhWWU9LkUvGOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D&md5=5ed6990e7c6e5d4619149746338f5582</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.29564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29564%26sid%3Dliteratum%253Aachs%26aulast%3DSaunier%26aufirst%3DE.%26aulast%3DBenelli%26aufirst%3DC.%26aulast%3DBortoli%26aufirst%3DS.%26atitle%3DThe%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520cancer%253A%2520an%2520old%2520metabolic%2520gatekeeper%2520regulated%2520by%2520new%2520pathways%2520and%2520pharmacological%2520agents%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D809%26epage%3D817%26doi%3D10.1002%2Fijc.29564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span> </span><span class="NLM_article-title">Mitochondrial alpha-ketoacid dehydrogenase kinases: a new family of protein kinases</span> <span class="citation_source-journal">Adv. Second Messenger Phosphoprotein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/S1040-7952(97)80012-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2FS1040-7952%2897%2980012-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=9344245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A280%3ADyaK1c%252Fgt12gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=105-111&author=K.+M.+Popovauthor=J.+W.+Hawesauthor=R.+A.+Harris&title=Mitochondrial+alpha-ketoacid+dehydrogenase+kinases%3A+a+new+family+of+protein+kinases&doi=10.1016%2FS1040-7952%2897%2980012-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial alpha-ketoacid dehydrogenase kinases: a new family of protein kinases</span></div><div class="casAuthors">Popov K M; Hawes J W; Harris R A</div><div class="citationInfo"><span class="NLM_cas:title">Advances in second messenger and phosphoprotein research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-11</span>
        ISSN:<span class="NLM_cas:issn">1040-7952</span>.
    </div><div class="casAbstract">Four mitochondrial protein kinases have been cloned.  These proteins represent a new family of protein kinases, related by sequence to the bacterial protein kinases but by function to the eukaryotic serine protein kinases.  Arg288 is required for recognition by BCKDK of the phosphorylation site on the E1alpha subunit of the BCKDH complex.  BCKDK inhibits the dehydrogenase activity of the BCKDH complex by introducing a negative charge into the active-site pocket of the E1 component.  Protein starvation of rats induces an increase in the amount of BCKDK bound to the BCKDH complex.  This causes inactivation of the BCKDH complex and conserves branched-chain amino acids for protein synthesis in the protein-starved state.  Expression of the different PDK isoenzymes is tissue specific, and the different PDK isoenzymes are unique with respect to kinetic parameters for ATP and ADP and sensitivity to allosteric effectors (NADH, NAD+, coenzyme A, acetyl-CoA, pyruvate, and dichloroacetate).  Preliminary experiments indicate that an increased amount of PDK2 protein partly explains the increase in PDK activity that occurs in rat liver in response to chemically induced diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8xuWltsjY2e-MdeMhXAHkfW6udTcc2earfOxhhOAWwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252Fgt12gsg%253D%253D&md5=aa02cbcd0a055cb467530bc2aa42fcc2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1040-7952%2897%2980012-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-7952%252897%252980012-2%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DHawes%26aufirst%3DJ.%2BW.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DMitochondrial%2520alpha-ketoacid%2520dehydrogenase%2520kinases%253A%2520a%2520new%2520family%2520of%2520protein%2520kinases%26jtitle%3DAdv.%2520Second%2520Messenger%2520Phosphoprotein%2520Res.%26date%3D1997%26volume%3D31%26spage%3D105%26epage%3D111%26doi%3D10.1016%2FS1040-7952%2897%2980012-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gudi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedishvili, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Diversity of the pyruvate dehydrogenase kinase gene family in humans</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">28989</span><span class="NLM_x">–</span> <span class="NLM_lpage">28994</span><span class="refDoi"> DOI: 10.1074/jbc.270.48.28989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.270.48.28989" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=28989-28994&author=R.+Gudiauthor=M.+Bowker-Kinleyauthor=N.+Y.+Kedishviliauthor=Y.+Zhaoauthor=K.+M.+Popov&title=Diversity+of+the+pyruvate+dehydrogenase+kinase+gene+family+in+humans&doi=10.1074%2Fjbc.270.48.28989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.48.28989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.48.28989%26sid%3Dliteratum%253Aachs%26aulast%3DGudi%26aufirst%3DR.%26aulast%3DBowker-Kinley%26aufirst%3DM.%26aulast%3DKedishvili%26aufirst%3DN.%2BY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DDiversity%2520of%2520the%2520pyruvate%2520dehydrogenase%2520kinase%2520gene%2520family%2520in%2520humans%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D28989%26epage%3D28994%26doi%3D10.1074%2Fjbc.270.48.28989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bajotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, Y.</span><span> </span><span class="NLM_article-title">Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1016/j.metabol.2005.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.metabol.2005.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16483874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=317-323&author=G.+Bajottoauthor=T.+Murakamiauthor=M.+Nagasakiauthor=B.+Qinauthor=Y.+Matsuoauthor=K.+Maedaauthor=M.+Ohashiauthor=Y.+Oshidaauthor=Y.+Satoauthor=Y.+Shimomura&title=Increased+expression+of+hepatic+pyruvate+dehydrogenase+kinases+2+and+4+in+young+and+middle-aged+Otsuka+Long-Evans+Tokushima+Fatty+rats%3A+induction+by+elevated+levels+of+free+fatty+acids&doi=10.1016%2Fj.metabol.2005.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids</span></div><div class="casAuthors">Bajotto, Gustavo; Murakami, Taro; Nagasaki, Masaru; Qin, Bolin; Matsuo, Yoshiyuki; Maeda, Ken; Ohashi, Masayo; Oshida, Yoshiharu; Sato, Yuzo; Shimomura, Yoshiharu</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The activity of the pyruvate dehydrogenase complex (PDC) is regulated by covalent modification of its E1 component, which is catalyzed by specific pyruvate dehydrogenase kinases (PDKs) and phosphatases.  In the liver, PDK2 and PDK4 are the most abundant PDK isoforms, which are responsible for inactivation of PDC when glucose availability is scarce in the body.  In the present study, regulatory mechanisms of hepatic PDC were examd. before and after the onset of type 2 diabetes mellitus in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, using Long-Evans Tokushima Otsuka (LETO) rats as controls.  Plasma glucose and insulin concns. were at normal levels in rats aged 8 wk, but were significantly higher in OLETF than in LETO rats aged 25 wk, indicating insulin resistance in OLETF rats.  Plasma free fatty acids (FFAs) were 1.6-fold concd., and the liver PDC activity was significantly lower in OLETF than in LETO rats at both ages, suggesting suppression of pyruvate oxidative decarboxylation in OLETF rats before and after the onset of diabetes.  Pyruvate dehydrogenase kinase activity and abundance of PDK2 and PDK4 proteins, as well as mRNAs, were greater in OLETF rats at both ages.  These results suggest that persistently elevated levels of circulating free fatty acid in normal and diabetic OLETF rats play an important role in stimulating PDK2 and PDK4 expression in liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pJNpKoDCJ7Vg90H21EOLACvtfcHk0lhUjAaAhklqXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOiu7o%253D&md5=1e489a7aa8f8894ecaa0e711f1675c56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2005.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2005.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DBajotto%26aufirst%3DG.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DNagasaki%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DOhashi%26aufirst%3DM.%26aulast%3DOshida%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DShimomura%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520hepatic%2520pyruvate%2520dehydrogenase%2520kinases%25202%2520and%25204%2520in%2520young%2520and%2520middle-aged%2520Otsuka%2520Long-Evans%2520Tokushima%2520Fatty%2520rats%253A%2520induction%2520by%2520elevated%2520levels%2520of%2520free%2520fatty%2520acids%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2006%26volume%3D55%26spage%3D317%26epage%3D323%26doi%3D10.1016%2Fj.metabol.2005.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kolobova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuganova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulatnikov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1042/bj3580069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1042%2Fbj3580069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=69-77&author=E.+Kolobovaauthor=A.+Tuganovaauthor=I.+Boulatnikovauthor=K.+M.+Popov&title=Regulation+of+pyruvate+dehydrogenase+activity+through+phosphorylation+at+multiple+sites&doi=10.1042%2Fbj3580069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2Fbj3580069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3580069%26sid%3Dliteratum%253Aachs%26aulast%3DKolobova%26aufirst%3DE.%26aulast%3DTuganova%26aufirst%3DA.%26aulast%3DBoulatnikov%26aufirst%3DI.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DRegulation%2520of%2520pyruvate%2520dehydrogenase%2520activity%2520through%2520phosphorylation%2520at%2520multiple%2520sites%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D358%26spage%3D69%26epage%3D77%26doi%3D10.1042%2Fbj3580069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">McFate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohyeldin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teahan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Califano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeoung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22700</span><span class="NLM_x">–</span> <span class="NLM_lpage">22708</span><span class="refDoi"> DOI: 10.1074/jbc.M801765200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.M801765200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22700-22708&author=T.+McFateauthor=A.+Mohyeldinauthor=H.+Luauthor=J.+Thakarauthor=J.+Henriquesauthor=N.+D.+Halimauthor=H.+Wuauthor=M.+J.+Schellauthor=T.+M.+Tsangauthor=O.+Teahanauthor=S.+Zhouauthor=J.+A.+Califanoauthor=N.+H.+Jeoungauthor=R.+A.+Harrisauthor=A.+Verma&title=Pyruvate+dehydrogenase+complex+activity+controls+metabolic+and+malignant+phenotype+in+cancer+cells&doi=10.1074%2Fjbc.M801765200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801765200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801765200%26sid%3Dliteratum%253Aachs%26aulast%3DMcFate%26aufirst%3DT.%26aulast%3DMohyeldin%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DThakar%26aufirst%3DJ.%26aulast%3DHenriques%26aufirst%3DJ.%26aulast%3DHalim%26aufirst%3DN.%2BD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BM.%26aulast%3DTeahan%26aufirst%3DO.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DVerma%26aufirst%3DA.%26atitle%3DPyruvate%2520dehydrogenase%2520complex%2520activity%2520controls%2520metabolic%2520and%2520malignant%2520phenotype%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22700%26epage%3D22708%26doi%3D10.1074%2Fjbc.M801765200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchernyshyov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.cmet.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16517405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=177-185&author=J.+W.+Kimauthor=I.+Tchernyshyovauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=HIF-1-mediated+expression+of+pyruvate+dehydrogenase+kinase%3A+a+metabolic+switch+required+for+cellular+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span></div><div class="casAuthors">Kim, Jung-whan; Tchernyshyov, Irina; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of glycolytic genes by HIF-1 is considered crit. for metabolic adaptation to hypoxia through increased conversion of glucose to pyruvate and subsequently to lactate.  We found that HIF-1 also actively suppresses metab. through the tricarboxylic acid cycle (TCA) by directly trans-activating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 inactivates the TCA cycle enzyme, pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA.  Forced PDK1 expression in hypoxic HIF-1α null cells increases ATP levels, attenuates hypoxic ROS generation, and rescues these cells from hypoxia-induced apoptosis.  These studies reveal a hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP prodn. and to prevent toxic ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmBOJaCXUx7Vg90H21EOLACvtfcHk0lidoISuGrLuYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D&md5=783b85071f8a48f5262ba9522d1715b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DHIF-1-mediated%2520expression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%253A%2520a%2520metabolic%2520switch%2520required%2520for%2520cellular%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.cmet.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Papandreou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denko, N. C.</span><span> </span><span class="NLM_article-title">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.cmet.2006.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16517406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=187-197&author=I.+Papandreouauthor=R.+A.+Cairnsauthor=L.+Fontanaauthor=A.+L.+Limauthor=N.+C.+Denko&title=HIF-1+mediates+adaptation+to+hypoxia+by+actively+downregulating+mitochondrial+oxygen+consumption&doi=10.1016%2Fj.cmet.2006.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span></div><div class="casAuthors">Papandreou, Ioanna; Cairns, Rob A.; Fontana, Lucrezia; Lim, Ai Lin; Denko, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF-1 transcription factor drives hypoxic gene expression changes that are thought to be adaptive for cells exposed to a reduced-oxygen environment.  For example, HIF-1 induces the expression of glycolytic genes.  It is presumed that increased glycolysis is necessary to produce energy when low oxygen will not support oxidative phosphorylation at the mitochondria.  However, we find that while HIF-1 stimulates glycolysis, it also actively represses mitochondrial function and oxygen consumption by inducing pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 phosphorylates and inhibits pyruvate dehydrogenase from using pyruvate to fuel the mitochondrial TCA cycle.  This causes a drop in mitochondrial oxygen consumption and results in a relative increase in intracellular oxygen tension.  We show by genetic means that HIF-1-dependent block to oxygen utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death in response to the hypoxic cytotoxin tirapazamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkKC5qqbwLVg90H21EOLACvtfcHk0lidoISuGrLuYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D&md5=1e6d9a6dcf39366211043e1f37cd9716</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DI.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DFontana%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DA.%2BL.%26aulast%3DDenko%26aufirst%3DN.%2BC.%26atitle%3DHIF-1%2520mediates%2520adaptation%2520to%2520hypoxia%2520by%2520actively%2520downregulating%2520mitochondrial%2520oxygen%2520consumption%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.cmet.2006.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kaplon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaneton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selivanov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdegaal, E. M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottlieb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeper, D. S.</span><span> </span><span class="NLM_article-title">A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature12154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnature12154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=109-112&author=J.+Kaplonauthor=L.+Zhengauthor=K.+Meisslauthor=B.+Chanetonauthor=V.+A.+Selivanovauthor=G.+Mackayauthor=S.+H.+van+der+Burgauthor=E.+M.+E.+Verdegaalauthor=M.+Cascanteauthor=T.+Shlomiauthor=E.+Gottliebauthor=D.+S.+Peeper&title=A+key+role+for+mitochondrial+gatekeeper+pyruvate+dehydrogenase+in+oncogene-induced+senescence&doi=10.1038%2Fnature12154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature12154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12154%26sid%3Dliteratum%253Aachs%26aulast%3DKaplon%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMeissl%26aufirst%3DK.%26aulast%3DChaneton%26aufirst%3DB.%26aulast%3DSelivanov%26aufirst%3DV.%2BA.%26aulast%3DMackay%26aufirst%3DG.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DS.%2BH.%26aulast%3DVerdegaal%26aufirst%3DE.%2BM.%2BE.%26aulast%3DCascante%26aufirst%3DM.%26aulast%3DShlomi%26aufirst%3DT.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DPeeper%26aufirst%3DD.%2BS.%26atitle%3DA%2520key%2520role%2520for%2520mitochondrial%2520gatekeeper%2520pyruvate%2520dehydrogenase%2520in%2520oncogene-induced%2520senescence%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D109%26epage%3D112%26doi%3D10.1038%2Fnature12154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Pate, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprowl-Tanio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TeSlaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoverter, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. L.</span><span> </span><span class="NLM_article-title">Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.15252/embj.201488598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.15252%2Fembj.201488598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24825347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=1454-1473&author=K.+T.+Pateauthor=C.+Stringariauthor=S.+Sprowl-Tanioauthor=K.+Wangauthor=T.+TeSlaaauthor=N.+P.+Hoverterauthor=M.+M.+McQuadeauthor=C.+Garnerauthor=M.+A.+Digmanauthor=M.+A.+Teitellauthor=R.+A.+Edwardsauthor=E.+Grattonauthor=M.+L.+Waterman&title=Wnt+signaling+directs+a+metabolic+program+of+glycolysis+and+angiogenesis+in+colon+cancer&doi=10.15252%2Fembj.201488598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer</span></div><div class="casAuthors">Pate, Kira T.; Stringari, Chiara; Sprowl-Tanio, Stephanie; Wang, Kehui; TeSlaa, Tara; Hoverter, Nate P.; McQuade, Miriam M.; Garner, Chad; Digman, Michelle A.; Teitell, Michael A.; Edwards, Robert A.; Gratton, Enrico; Waterman, Marian L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1454-1473</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Much of the mechanism by which Wnt signaling drives proliferation during oncogenesis is attributed to its regulation of the cell cycle.  Here, we show how Wnt/β-catenin signaling directs another hallmark of tumorigenesis, namely Warburg metab.  Using biochem. assays and fluorescence lifetime imaging microscopy (FLIM) to probe metab. in vitro and in living tumors, we observe that interference with Wnt signaling in colon cancer cells reduces glycolytic metab. and results in small, poorly perfused tumors.  We identify pyruvate dehydrogenase kinase 1 (PDK1) as an important direct target within a larger gene program for metab.  PDK1 inhibits pyruvate flux to mitochondrial respiration and a rescue of its expression in Wnt-inhibited cancer cells rescues glycolysis as well as vessel growth in the tumor microenvironment.  Thus, we identify an important mechanism by which Wnt-driven Warburg metab. directs the use of glucose for cancer cell proliferation and links it to vessel delivery of oxygen and nutrients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKyVhMDd5z8rVg90H21EOLACvtfcHk0lgPWjyvbFGGag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtLzF&md5=cf588b1ec7223933110102c34318bf0b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.15252%2Fembj.201488598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201488598%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BT.%26aulast%3DStringari%26aufirst%3DC.%26aulast%3DSprowl-Tanio%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DTeSlaa%26aufirst%3DT.%26aulast%3DHoverter%26aufirst%3DN.%2BP.%26aulast%3DMcQuade%26aufirst%3DM.%2BM.%26aulast%3DGarner%26aufirst%3DC.%26aulast%3DDigman%26aufirst%3DM.%2BA.%26aulast%3DTeitell%26aufirst%3DM.%2BA.%26aulast%3DEdwards%26aufirst%3DR.%2BA.%26aulast%3DGratton%26aufirst%3DE.%26aulast%3DWaterman%26aufirst%3DM.%2BL.%26atitle%3DWnt%2520signaling%2520directs%2520a%2520metabolic%2520program%2520of%2520glycolysis%2520and%2520angiogenesis%2520in%2520colon%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D1454%26epage%3D1473%26doi%3D10.15252%2Fembj.201488598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hitosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lythgoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakiewicz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/j.molcel.2011.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.molcel.2011.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=22195962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=864-877&author=T.+Hitosugiauthor=J.+Fanauthor=T.+W.+Chungauthor=K.+Lythgoeauthor=X.+Wangauthor=J.+Xieauthor=Q.+Geauthor=T.+L.+Guauthor=R.+D.+Polakiewiczauthor=J.+L.+Roeselauthor=G.+Z.+Chenauthor=T.+J.+Boggonauthor=S.+Lonialauthor=H.+Fuauthor=F.+R.+Khuriauthor=S.+Kangauthor=J.+Chen&title=Tyrosine+phosphorylation+of+mitochondrial+pyruvate+dehydrogenase+kinase+1+is+important+for+cancer+metabolism&doi=10.1016%2Fj.molcel.2011.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism</span></div><div class="casAuthors">Hitosugi, Taro; Fan, Jun; Chung, Tae-Wook; Lythgoe, Katherine; Wang, Xu; Xie, Jianxin; Ge, Qingyuan; Gu, Ting-Lei; Polakiewicz, Roberto D.; Roesel, Johannes L.; Chen, Georgia Z.; Boggon, Titus J.; Lonial, Sagar; Fu, Haian; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many tumor cells rely on aerobic glycolysis instead of oxidative phosphorylation for their continued proliferation and survival.  Myc and HIF-1 are believed to promote such a metabolic switch by, in part, upregulating gene expression of pyruvate dehydrogenase (PDH) kinase 1 (PDHK1), which phosphorylates and inactivates mitochondrial PDH and consequently pyruvate dehydrogenase complex (PDC).  Here we report that tyrosine phosphorylation enhances PDHK1 kinase activity by promoting ATP and PDC binding.  Functional PDC can form in mitochondria outside of the matrix in some cancer cells and PDHK1 is commonly tyrosine phosphorylated in human cancers by diverse oncogenic tyrosine kinases localized to different mitochondrial compartments.  Expression of phosphorylation-deficient, catalytic hypomorph PDHK1 mutants in cancer cells leads to decreased cell proliferation under hypoxia and increased oxidative phosphorylation with enhanced mitochondrial utilization of pyruvate and reduced tumor growth in xenograft nude mice.  Together, tyrosine phosphorylation activates PDHK1 to promote the Warburg effect and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt7BASuMHOGLVg90H21EOLACvtfcHk0lgPWjyvbFGGag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L&md5=d022eae26590b3fed9009260a692d67c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DHitosugi%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLythgoe%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DRoesel%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DG.%2BZ.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTyrosine%2520phosphorylation%2520of%2520mitochondrial%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520is%2520important%2520for%2520cancer%2520metabolism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D864%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2011.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kamarajugadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemboroski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span> </span><span class="NLM_article-title">Glucose oxidation modulates anoikis and tumor metastasis</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1907</span><span class="refDoi"> DOI: 10.1128/MCB.06248-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1128%2FMCB.06248-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=22431524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmsl2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1893-1907&author=S.+Kamarajugaddaauthor=L.+Stemboroskiauthor=Q.+Caiauthor=N.+E.+Simpsonauthor=S.+Nayakauthor=M.+Tanauthor=J.+Lu&title=Glucose+oxidation+modulates+anoikis+and+tumor+metastasis&doi=10.1128%2FMCB.06248-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose oxidation modulates anoikis and tumor metastasis</span></div><div class="casAuthors">Kamarajugadda, Sushama; Stemboroski, Lauren; Cai, Qingsong; Simpson, Nicholas E.; Nayak, Sushrusha; Tan, Ming; Lu, Jianrong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1893-1907</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cancer cells exhibit altered glucose metab. characterized by a preference for aerobic glycolysis or the Warburg effect, and the cells resist matrix detachment-induced apoptosis, which is called anoikis, a barrier to metastasis.  It remains largely unclear whether tumor metab. influences anoikis and metastasis.  Here we show that when detached from the matrix, untransformed mammary epithelial cells undergo metabolic reprogramming by markedly upregulating pyruvate dehydrogenase (PDH) kinase 4 (PDK4) through estrogen-related receptor γ (ERRγ), thereby inhibiting PDH and attenuating the flux of glycolytic C into mitochondrial oxidn.  To decipher the significance of this metabolic response, we found that depletion of PDK4 or activation of PDH increased mitochondrial respiration and oxidative stress in suspended cells, resulting in heightened anoikis.  Conversely, overexpression of PDKs prolonged survival of cells in suspension.  Therefore, decreased glucose oxidn. following cell detachment confers anoikis resistance.  Unlike untransformed cells, most cancer cells demonstrate reduced glucose oxidn. even under attached conditions, and thus they inherently possess a survival advantage when suspended.  Normalization of glucose metab. by stimulating PDH in cancer cells restores their susceptibility to anoikis and impairs their metastatic potential.  These results suggest that the Warburg effect, more specifically, diminished glucose oxidn., promotes anoikis resistance and metastasis and that PDKs are potential targets for antimetastasis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpFxw6qsEULrVg90H21EOLACvtfcHk0lg6Ru0NArx9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmsl2juro%253D&md5=1de2802defdabbdabe06209ccf1d61bb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.06248-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.06248-11%26sid%3Dliteratum%253Aachs%26aulast%3DKamarajugadda%26aufirst%3DS.%26aulast%3DStemboroski%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSimpson%26aufirst%3DN.%2BE.%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DGlucose%2520oxidation%2520modulates%2520anoikis%2520and%2520tumor%2520metastasis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D1893%26epage%3D1907%26doi%3D10.1128%2FMCB.06248-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9832</span><span class="NLM_x">–</span> <span class="NLM_lpage">9843</span><span class="refDoi"> DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=L.+Wyderauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Gengauthor=J.+Shen&title=Discovery+and+optimization+of+4%2C5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0lg6Ru0NArx9Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWyder%26aufirst%3DL.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C5-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span> </span><span class="NLM_article-title">JX06 selectively inhibits pyruvate dehydrogenase kinase PDK1 by a covalent cysteine modification</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">–</span> <span class="NLM_lpage">4936</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1158%2F0008-5472.CAN-15-1023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4923-4936&author=W.+Sunauthor=Z.+Xieauthor=Y.+Liuauthor=D.+Zhaoauthor=Z.+Wuauthor=D.+Zhangauthor=H.+Lvauthor=S.+Tangauthor=N.+Jinauthor=H.+Jiangauthor=M.+Tanauthor=J.+Dingauthor=C.+Luoauthor=J.+Liauthor=M.+Huangauthor=M.+Geng&title=JX06+selectively+inhibits+pyruvate+dehydrogenase+kinase+PDK1+by+a+covalent+cysteine+modification&doi=10.1158%2F0008-5472.CAN-15-1023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1023%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DJX06%2520selectively%2520inhibits%2520pyruvate%2520dehydrogenase%2520kinase%2520PDK1%2520by%2520a%2520covalent%2520cysteine%2520modification%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4923%26epage%3D4936%26doi%3D10.1158%2F0008-5472.CAN-15-1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kankotia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Dichloroacetate and cancer: new home for an orphan drug?</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1846</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2014.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.bbcan.2014.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=25157892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKntLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=617-629&author=S.+Kankotiaauthor=P.+W.+Stacpoole&title=Dichloroacetate+and+cancer%3A+new+home+for+an+orphan+drug%3F&doi=10.1016%2Fj.bbcan.2014.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate and cancer: New home for an orphan drug?</span></div><div class="casAuthors">Kankotia, Shyam; Stacpoole, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  We reviewed the anti-cancer effects of DCA, an orphan drug long used as an investigational treatment for various acquired and congenital disorders of mitochondrial intermediary metab.  Inhibition by DCA of mitochondrial pyruvate dehydrogenase kinases and subsequent reactivation of the pyruvate dehydrogenase complex and oxidative phosphorylation is the common mechanism accounting for the drug's anti-neoplastic effects.  At least two fundamental changes in tumor metab. are induced by DCA that antagonize tumor growth, metastases and survival: the first is the redirection of glucose metab. from glycolysis to oxidn. (reversal of the Warburg effect), leading to inhibition of proliferation and induction of caspase-mediated apoptosis.  These effects have been replicated in both human cancer cell lines and in tumor implants of diverse germ line origin.  The second fundamental change is the oxidative removal of lactate, via pyruvate, and the co-incident buffering of hydrogen ions by dehydrogenases located in the mitochondrial matrix.  Preclin. studies demonstrate that DCA has additive or synergistic effects when used in combination with std. agents designed to modify tumor oxidative stress, vascular remodeling, DNA integrity or immunity.  These findings and limited clin. results suggest that potentially fruitful areas for addnl. clin. trials include 1) adult and pediatric high grade astrocytomas; 2) BRAF-mutant cancers, such as melanoma, perhaps combined with other pro-oxidants; 3) tumors in which resistance to std. platinum-class drugs alone may be overcome with combination therapy; and 4) tumors of endodermal origin, in which extensive exptl. research has demonstrated significant anti-proliferative, pro-apoptotic effects of DCA, leading to improved host survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCeCvyY6yPTLVg90H21EOLACvtfcHk0lgfXefeIOa8RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKntLfE&md5=10775e6b8162c6ec11b1b28d98175deb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DKankotia%26aufirst%3DS.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DDichloroacetate%2520and%2520cancer%253A%2520new%2520home%2520for%2520an%2520orphan%2520drug%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26spage%3D617%26epage%3D629%26doi%3D10.1016%2Fj.bbcan.2014.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">kurtz, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langaee, T.</span><span> </span><span class="NLM_article-title">Role of dichloroacetate in the treatment of genetic mitochondrial diseases</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.addr.2008.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1478-1487&author=P.+W.+Stacpooleauthor=T.+L.+kurtzauthor=Z.+Hanauthor=T.+Langaee&title=Role+of+dichloroacetate+in+the+treatment+of+genetic+mitochondrial+diseases&doi=10.1016%2Fj.addr.2008.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3Dkurtz%26aufirst%3DT.%2BL.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DLangaee%26aufirst%3DT.%26atitle%3DRole%2520of%2520dichloroacetate%2520in%2520the%2520treatment%2520of%2520genetic%2520mitochondrial%2520diseases%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1478%26epage%3D1487%26doi%3D10.1016%2Fj.addr.2008.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pathak, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrache, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harn, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span><span class="refDoi"> DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0lgfXefeIOa8RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">22199</span><span class="NLM_x">–</span> <span class="NLM_lpage">22204</span><span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0ljLcYj8rGS4rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celeghini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secchiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zauli, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=147-156&author=C.+Trapellaauthor=R.+Voltanauthor=E.+Melloniauthor=V.+Tisatoauthor=C.+Celeghiniauthor=S.+Biancoauthor=A.+Fantinatiauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Secchieroauthor=G.+Zauli&title=Design%2C+synthesis%2C+and+biological+characterization+of+novel+mitochondria+targeted+dichloroacetate-loaded+compounds+with+antileukemic+activity&doi=10.1021%2Facs.jmedchem.5b01165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01165%26sid%3Dliteratum%253Aachs%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DVoltan%26aufirst%3DR.%26aulast%3DMelloni%26aufirst%3DE.%26aulast%3DTisato%26aufirst%3DV.%26aulast%3DCeleghini%26aufirst%3DC.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSecchiero%26aufirst%3DP.%26aulast%3DZauli%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520novel%2520mitochondria%2520targeted%2520dichloroacetate-loaded%2520compounds%2520with%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Facs.jmedchem.5b01165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohschein, R.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2741</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm9902584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2741-2746&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=G.+R.+Bebernitzauthor=G.+M.+Coppolaauthor=C.+F.+Jewellauthor=D.+C.+Knorrauthor=C.+Liuauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=R.J.+Strohscheinauthor=J.+Gaoauthor=C.+C.+Vinluanauthor=S.+S.+Shettyauthor=C.+Draglandauthor=E.+L.+Kaplanauthor=D.+DelGrandeauthor=A.+Islamauthor=X.+Liuauthor=R.+J.+Lozitoauthor=W.+M.+Maniaraauthor=R.+E.+Walterauthor=W.+R.+Mann&title=%28R%29-3%2C3%2C3-Trifluoro-2-hydroxy-2-methylpropionamides+are+orally+active+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm9902584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9902584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902584%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DJewell%26aufirst%3DC.%2BF.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DStrohschein%26aufirst%3DR.J.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DDragland%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3D%2528R%2529-3%252C3%252C3-Trifluoro-2-hydroxy-2-methylpropionamides%2520are%2520orally%2520active%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2741%26epage%3D2746%26doi%3D10.1021%2Fjm9902584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mayers, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, B. R.</span><span> </span><span class="NLM_article-title">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span><span class="refDoi"> DOI: 10.1042/bst0311165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1042%2Fbst0311165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=14641018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1165-1167&author=R.+M.+Mayersauthor=R.+J.+Butlinauthor=E.+Kilgourauthor=B.+Leightonauthor=D.+Martinauthor=J.+Myattauthor=J.+P.+Ormeauthor=B.+R.+Holloway&title=AZD7545%2C+a+novel+inhibitor+of+pyruvate+dehydrogenase+kinase+2+%28PDHK2%29%2C+activates+pyruvate+dehydrogenase+in+vivo+and+improves+blood+glucose+control+in+obese+%28fa%2Ffa%29+Zucker+rats&doi=10.1042%2Fbst0311165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span></div><div class="casAuthors">Mayers, R. M.; Butlin, R. J.; Kilgour, E.; Leighton, B.; Martin, D.; Myatt, J.; Orme, J. P.; Holloway, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1167</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PDH (pyruvate dehydrogenase) is a key enzyme controlling the rate of glucose oxidn., and the availability of gluconeogenic precursors.  Activation of PDH in skeletal muscle and liver may increase glucose uptake and reduce glucose prodn.  This study describes the properties of AZD7545, a novel, small-mol. inhibitor of PDHK (PDH kinase).  In the presence of PDHK2, AZD7545 increased PDH activity with an EC50 value of 5.2 nM.  In rat hepatocytes, the rate of pyruvate oxidn. was stimulated 2-fold (EC50 105 nM).  A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%.  A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa / fa) rats.  Obese, insulin-resistant, Zucker rats show elevated postprandial glucose levels compared with their lean counterparts (8.7 vs. 6.1 mM at 12 wk old).  AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose.  These results suggest that PDHK inhibitors may be beneficial agents for improving glucose control in the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Q4M5QmmjLVg90H21EOLACvtfcHk0lissV1uZY31Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D&md5=409b3a21f3cd550e2c04311446e5d0a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2Fbst0311165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311165%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DB.%2BR.%26atitle%3DAZD7545%252C%2520a%2520novel%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520%2528PDHK2%2529%252C%2520activates%2520pyruvate%2520dehydrogenase%2520in%2520vivo%2520and%2520improves%2520blood%2520glucose%2520control%2520in%2520obese%2520%2528fa%252Ffa%2529%2520Zucker%2520rats%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1165%26epage%3D1167%26doi%3D10.1042%2Fbst0311165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zachar, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marecek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maturo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schauble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piramzadian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P. M.</span><span> </span><span class="NLM_article-title">Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1007/s00109-011-0785-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1007%2Fs00109-011-0785-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21769686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=1137-1148&author=Z.+Zacharauthor=J.+Marecekauthor=C.+Maturoauthor=S.+Guptaauthor=S.+D.+Stuartauthor=K.+Howellauthor=A.+Schaubleauthor=J.+Lemauthor=A.+Piramzadianauthor=S.+Karnikauthor=K.+Leeauthor=R.+Rodriguezauthor=R.+Shorrauthor=P.+M.+Bingham&title=Non-redox-active+lipoate+derivates+disrupt+cancer+cell+mitochondrial+metabolism+and+are+potent+anticancer+agents+in+vivo&doi=10.1007%2Fs00109-011-0785-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo</span></div><div class="casAuthors">Zachar, Zuzana; Marecek, James; Maturo, Claudia; Gupta, Sunita; Stuart, Shawn D.; Howell, Katy; Schauble, Alexandra; Lem, Joanna; Piramzadian, Arin; Karnik, Sameer; Lee, King; Rodriguez, Robert; Shorr, Robert; Bingham, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We report the anal. of CPI-613, the first member of a large set of analogs of lipoic acid (lipoate) we have investigated as potential anticancer agents.  CPI-613 strongly disrupts mitochondrial metab., with selectivity for tumor cells in culture.  This mitochondrial disruption includes activation of the well-characterized, lipoate-responsive regulatory phosphorylation of the E1α pyruvate dehydrogenase (PDH) subunit.  This phosphorylation inactivates flux of glycolysis-derived carbon through this enzyme complex and implicates the PDH regulatory kinases (PDKs) as a possible drug target.  Supporting this hypothesis, RNAi knockdown of the PDK protein levels substantially attenuates CPI-613 cancer cell killing.  In both cell culture and in vivo tumor environments, the obsd. strong mitochondrial metabolic disruption is expected to significantly compromise cell survival.  Consistent with this prediction, CPI-613 disruption of tumor mitochondrial metab. is followed by efficient commitment to cell death by multiple, apparently redundant pathways, including apoptosis, in all tested cancer cell lines.  Further, CPI-613 shows strong antitumor activity in vivo against human non-small cell lung and pancreatic cancers in xenograft models with low side-effect toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGb-6-HcuD7Vg90H21EOLACvtfcHk0lissV1uZY31Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrtLnN&md5=cf5cc13477d8f8d5225a5e97c5870f8a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00109-011-0785-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-011-0785-8%26sid%3Dliteratum%253Aachs%26aulast%3DZachar%26aufirst%3DZ.%26aulast%3DMarecek%26aufirst%3DJ.%26aulast%3DMaturo%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DStuart%26aufirst%3DS.%2BD.%26aulast%3DHowell%26aufirst%3DK.%26aulast%3DSchauble%26aufirst%3DA.%26aulast%3DLem%26aufirst%3DJ.%26aulast%3DPiramzadian%26aufirst%3DA.%26aulast%3DKarnik%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DRodriguez%26aufirst%3DR.%26aulast%3DShorr%26aufirst%3DR.%26aulast%3DBingham%26aufirst%3DP.%2BM.%26atitle%3DNon-redox-active%2520lipoate%2520derivates%2520disrupt%2520cancer%2520cell%2520mitochondrial%2520metabolism%2520and%2520are%2520potent%2520anticancer%2520agents%2520in%2520vivo%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2011%26volume%3D89%26spage%3D1137%26epage%3D1148%26doi%3D10.1007%2Fs00109-011-0785-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kukimoto-Niino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokmakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiromizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1107/S090744491102405X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1107%2FS090744491102405X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=763-773&author=M.+Kukimoto-Niinoauthor=A.+Tokmakovauthor=T.+Teradaauthor=N.+Ohbayashiauthor=T.+Fujimotoauthor=S.+Gomiauthor=I.+Shiromizuauthor=M.+Kawamotoauthor=T.+Matsusueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Inhibitor-bound+structures+of+human+pyruvate+dehydrogenase+kinase+4&doi=10.1107%2FS090744491102405X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS090744491102405X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491102405X%26sid%3Dliteratum%253Aachs%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DTokmakov%26aufirst%3DA.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DGomi%26aufirst%3DS.%26aulast%3DShiromizu%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DInhibitor-bound%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25204%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D763%26epage%3D773%26doi%3D10.1107%2FS090744491102405X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernstedt-Asterholm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlock, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambar, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span><span class="refDoi"> DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williamsauthor=U.+K.+Tambarauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 μm for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0lg3v2rMXDR7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ramadas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janarthanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritha, N.</span><span> </span><span class="NLM_article-title">A comparative study of oxidants on thiols</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1080/00304949609356543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1080%2F00304949609356543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaK28Xjt1Gjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=352-355&author=K.+Ramadasauthor=N.+Srinivasanauthor=N.+Janarthananauthor=N.+Pritha&title=A+comparative+study+of+oxidants+on+thiols&doi=10.1080%2F00304949609356543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of oxidants on thiols</span></div><div class="casAuthors">Ramadas, K.; Srinivasan, N.; Janarthanan, N.; Pritha, R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-355</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">Oxidn. of thiols to disulfides with thionyl chloride, ceric ammonium nitrate, ferric chloride, sodium metaperiodate, ammonium persulfate, chlorine, sodium nitrite, hydrogen peroxide, or sodium chlorite were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj3YsiF8CPtLVg90H21EOLACvtfcHk0lg3v2rMXDR7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjt1Gjur0%253D&md5=28b1fdf03c94f29feb0281fdc39997f6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00304949609356543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304949609356543%26sid%3Dliteratum%253Aachs%26aulast%3DRamadas%26aufirst%3DK.%26aulast%3DSrinivasan%26aufirst%3DN.%26aulast%3DJanarthanan%26aufirst%3DN.%26aulast%3DPritha%26aufirst%3DN.%26atitle%3DA%2520comparative%2520study%2520of%2520oxidants%2520on%2520thiols%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D1996%26volume%3D28%26spage%3D352%26epage%3D355%26doi%3D10.1080%2F00304949609356543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Neelakantan, L.</span><span> </span><span class="NLM_article-title">Disulfides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1021/jo01100a630</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01100a630" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaG1MXms12h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1958&pages=938-939&author=L.+Neelakantan&title=Disulfides&doi=10.1021%2Fjo01100a630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfides</span></div><div class="casAuthors">Neelakantan, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">938-9</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Some disulfides were prepd. as possible potential antimalarials, since they may be active in oxidizing some of the SH groups essential to the parasite.  The potency of thiuram disulfides as bacterial poisons led to the prepn. of some analogous disulfides.  Various amines were treated with CS2 and aq. KOH and the thiocarbamido deriv. oxidized with NaNO2, MeOH, and HCl.  ο-, m-, p-H2NC6H4CO2H, and the 3 aminobenzenesulfonic acids were thus treated to give the corresponding diaryl thiuram disulfides.  The dixanthogens (I) were related in structure and hence some derivs. were prepd. to see their effect on exptl. malaria.  Salicylic acid (7 g.), 4 g. CS2, 6 g. KOH, and 250 ml. H2O was heated 6 hrs., treated with 3 g. NaNO2, 3 ml. MeOH, and under strong cooling 10 ml. concd. HCl, the pptd. product collected, and crystd. from H2O.  The following I were thus prepd. (R in RC6H4OCSSSCSOC6H4R, m.p., and % yield given): H, 182-3°, 60; 2-CO2H, 154-5°, 66; 3-CO2H, 198-200°, 70; 4-CO2H, 339-40°, 60; 2-SO3H, 360° (decompn.), 48; 3-SO3H, 360° (decompn.), 56; 4-SO3H, 360° (decompn.), 40; 4-Cl, 128°, 70.  The following RC6H4NHCSSSCSNHC6H4R were similarly prepd. (R, m.p., and % yield given): H, 183° 66; 2-CO2H, 236-8°, 75; 3-CO2H, 224.5°, 57; 4-CO2H, 238-40°, 57; 2-SO3H, 360° (decompn.), 53; 3-SO3H, 360° (decompn.), 49; 4-SO3H, 360° (decompn.), 65; 4-Cl, 100°, 70.  I were quite active in inhibiting the respiration of Plasmodium gallinaceum in vitro.  However only I (R = 4-SO3H) and N,N'-diphenylthiuram disulfide-p,p'-disulfonic acid were active in vivo against P. gallinaceum in chicks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjV_vZJyfS7Vg90H21EOLACvtfcHk0lg3v2rMXDR7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXms12h&md5=740749e1b378b83fb31b2ebfa46f7079</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01100a630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01100a630%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DL.%26atitle%3DDisulfides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1958%26volume%3D23%26spage%3D938%26epage%3D939%26doi%3D10.1021%2Fjo01100a630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Brown, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foubister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, B.</span><span> </span><span class="NLM_article-title">Chiral synthesis of 3-substituted morpholines via serine enantiomers and reductions of 5-oxomorpholine-3-carboxylates</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2580</span><span class="refDoi"> DOI: 10.1039/p19850002577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1039%2Fp19850002577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=2577-2580&author=G.+R.+Brownauthor=A.+J.+Foubisterauthor=B.+Wright&title=Chiral+synthesis+of+3-substituted+morpholines+via+serine+enantiomers+and+reductions+of+5-oxomorpholine-3-carboxylates&doi=10.1039%2Fp19850002577"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fp19850002577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19850002577%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BR.%26aulast%3DFoubister%26aufirst%3DA.%2BJ.%26aulast%3DWright%26aufirst%3DB.%26atitle%3DChiral%2520synthesis%2520of%25203-substituted%2520morpholines%2520via%2520serine%2520enantiomers%2520and%2520reductions%2520of%25205-oxomorpholine-3-carboxylates%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1985%26spage%3D2577%26epage%3D2580%26doi%3D10.1039%2Fp19850002577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, J.</span><span> </span><span class="NLM_article-title">Novel benzamides as selective and potent gastric prokinetic agents. 1. synthesis and structure-activity relationships of <i>N</i>-[(2-morpholinyl)alkyl]benzamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1406</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span><span class="refDoi"> DOI: 10.1021/jm00167a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00167a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1406-1413&author=S.+Katoauthor=T.+Morieauthor=K.+Hinoauthor=T.+Konauthor=S.+Narutoauthor=N.+Yoshidaauthor=T.+Karasawaauthor=J.+Matsumoto&title=Novel+benzamides+as+selective+and+potent+gastric+prokinetic+agents.+1.+synthesis+and+structure-activity+relationships+of+N-%5B%282-morpholinyl%29alkyl%5Dbenzamides&doi=10.1021%2Fjm00167a020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00167a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00167a020%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DS.%26aulast%3DMorie%26aufirst%3DT.%26aulast%3DHino%26aufirst%3DK.%26aulast%3DKon%26aufirst%3DT.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKarasawa%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DJ.%26atitle%3DNovel%2520benzamides%2520as%2520selective%2520and%2520potent%2520gastric%2520prokinetic%2520agents.%25201.%2520synthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%255B%25282-morpholinyl%2529alkyl%255Dbenzamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1406%26epage%3D1413%26doi%3D10.1021%2Fjm00167a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Schwartz, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1073/pnas.1313733111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1073%2Fpnas.1313733111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24347635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=173-178&author=P.+A.+Schwartzauthor=P.+Kuzmicauthor=J.+Solowiejauthor=S.+Bergqvistauthor=B.+Bolanosauthor=C.+Almadenauthor=A.+Nagataauthor=K.+Ryanauthor=J.+Fengauthor=D.+Dalvieauthor=J.+C.+Kathauthor=M.+Xuauthor=R.+Waniauthor=B.+W.+Murray&title=Covalent+EGFR+inhibitor+analysis+reveals+importance+of+reversible+interactions+to+potency+and+mechanisms+of+drug+resistance&doi=10.1073%2Fpnas.1313733111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span></div><div class="casAuthors">Schwartz, Phillip A.; Kuzmic, Petr; Solowiej, James; Bergqvist, Simon; Bolanos, Ben; Almaden, Chau; Nagata, Asako; Ryan, Kevin; Feng, Junli; Dalvie, Deepak; Kath, John C.; Xu, Meirong; Wani, Revati; Murray, Brion William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-178</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Covalent inhibition is a reemerging paradigm in kinase drug design, but the roles of inhibitor binding affinity and chem. reactivity in overall potency are not well-understood.  To characterize the underlying mol. processes at a microscopic level and det. the appropriate kinetic consts., specialized exptl. design and advanced numerical integration of differential equations are developed.  Previously uncharacterized investigational covalent drugs reported here are shown to be extremely effective epidermal growth factor receptor (EGFR) inhibitors (kinact/Ki in the range 105-107 M-1s-1), despite their low specific reactivity (kinact ≤ 2.1 × 10-3 s-1), which is compensated for by high binding affinities (Ki < 1 nM).  For inhibitors relying on reactivity to achieve potency, noncovalent enzyme-inhibitor complex partitioning between inhibitor dissocn. and bond formation is central.  Interestingly, reversible binding affinity of EGFR covalent inhibitors is highly correlated with antitumor cell potency.  Furthermore, cellular potency for a subset of covalent inhibitors can be accounted for solely through reversible interactions.  One reversible interaction is between EGFR-Cys797 nucleophile and the inhibitor's reactive group, which may also contribute to drug resistance.  Because covalent inhibitors target a cysteine residue, the effects of its oxidn. on enzyme catalysis and inhibitor pharmacol. are characterized.  Oxidn. of the EGFR cysteine nucleophile does not alter catalysis but has widely varied effects on inhibitor potency depending on the EGFR context (e.g., oncogenic mutations), type of oxidn. (sulfinylation or glutathiolation), and inhibitor architecture.  These methods, parameters, and insights provide a rational framework for assessing and designing effective covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpPuRq8MwCLVg90H21EOLACvtfcHk0ljvkCdNaccbJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D&md5=47197c5e7876a238eefb2e8e7de305ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1313733111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1313733111%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DKuzmic%26aufirst%3DP.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCovalent%2520EGFR%2520inhibitor%2520analysis%2520reveals%2520importance%2520of%2520reversible%2520interactions%2520to%2520potency%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D173%26epage%3D178%26doi%3D10.1073%2Fpnas.1313733111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0ljvkCdNaccbJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0lgWY2rrZ-cKZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Knoechel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span> </span><span class="NLM_article-title">Regulatory roles of the <i>N</i>-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+pyruvate+dehydrogenase+kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide β and γ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lgWY2rrZ-cKZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fsj.emboj.7600663" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1763-1774&author=M.+Katoauthor=J.+L.+Chuangauthor=S.+C.+Tsoauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Crystal+structure+of+pyruvate+dehydrogenase+kinase+3+bound+to+lipoyl+domain+2+of+human+pyruvate+dehydrogenase+complex&doi=10.1038%2Fsj.emboj.7600663"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600663%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DCrystal%2520structure%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520bound%2520to%2520lipoyl%2520domain%25202%2520of%2520human%2520pyruvate%2520dehydrogenase%2520complex%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D1763%26epage%3D1774%26doi%3D10.1038%2Fsj.emboj.7600663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+an+empirical+binding+free+energy+function&doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0liOXSMY4SCJSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520an%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662%26doi%3D10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Biao Zhang, Donghan Liu, Yulin Sun, Yajing Zhang, Jiayi Feng, <span class="NLM_string-name hlFld-ContribAuthor">Fuchao Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Thiazole-2-thiones through TBPB-Promoted Oxidative Cascade Cyclization of Enaminones with Elemental Sulfur. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (8)
                                     , 3076-3082. <a href="https://doi.org/10.1021/acs.orglett.1c00751" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00751%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPreparation%252Bof%252BThiazole-2-thiones%252Bthrough%252BTBPB-Promoted%252BOxidative%252BCascade%252BCyclization%252Bof%252BEnaminones%252Bwith%252BElemental%252BSulfur%26aulast%3DZhang%26aufirst%3DBiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04032021%26date%3D26032021%26volume%3D23%26issue%3D8%26spage%3D3076%26epage%3D3082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yunyuan Huang, Yixiang Xu, Rongrong Song, Shuaishuai Ni, Jiaqi Liu, Yanhong Xu, Yanliang Ren, Li Rao, Yingjie Wang, Lin Wei, Lingling Feng, Chen Su, Chao Peng, Jian Li, <span class="NLM_string-name hlFld-ContribAuthor">Jian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 6238-6247. <a href="https://doi.org/10.1021/acs.jmedchem.0c00699" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00699%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bthe%252BNew%252BCovalent%252BAllosteric%252BBinding%252BSite%252Bof%252BFructose-1%25252C6-bisphosphatase%252Bwith%252BDisulfiram%252BDerivatives%252Btoward%252BGlucose%252BReduction%26aulast%3DHuang%26aufirst%3DYunyuan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27042020%26date%3D19052020%26date%3D07052020%26volume%3D63%26issue%3D11%26spage%3D6238%26epage%3D6247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hanna Cho, Injae Shin, Kyungseon Cho, Hojong Yoon, Eun Kyung Yoo, Mi-Jin Kim, Sungmi Park, In-Kyu Lee, Nam Doo Kim, <span class="NLM_string-name hlFld-ContribAuthor">Taebo Sim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8461-8479. <a href="https://doi.org/10.1021/acs.jmedchem.9b00565" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00565%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BResorcinol%252BAmide%252BDerivatives%252Bas%252BPotent%252Band%252BSpecific%252BPyruvate%252BDehydrogenase%252BKinase%252B%252528PDHK%252529%252BInhibitors%26aulast%3DCho%26aufirst%3DHanna%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02042019%26date%3D13092019%26date%3D30082019%26volume%3D62%26issue%3D18%26spage%3D8461%26epage%3D8479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyuan Zhao, Qiao Li, Jun Xu, Donghua Wang, Daisy Zhang-Negrerie, <span class="NLM_string-name hlFld-ContribAuthor">Yunfei Du</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade Synthesis of Benzothieno[3,2-b]indoles under Oxidative Conditions Mediated by CuBr and tert-Butyl Hydroperoxide. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (18)
                                     , 5933-5937. <a href="https://doi.org/10.1021/acs.orglett.8b02614" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b02614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b02614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b02614%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCascade%252BSynthesis%252Bof%252BBenzothieno%25255B3%25252C2-b%25255Dindoles%252Bunder%252BOxidative%252BConditions%252BMediated%252Bby%252BCuBr%252Band%252Btert-Butyl%252BHydroperoxide%26aulast%3DZhao%26aufirst%3DXiaoyuan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15082018%26date%3D13092018%26volume%3D20%26issue%3D18%26spage%3D5933%26epage%3D5937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Ni</span>, <span class="hlFld-ContribAuthor ">Xinyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Manjiong  Wang</span>, <span class="hlFld-ContribAuthor ">Keting  Bao</span>, <span class="hlFld-ContribAuthor ">Dazheng  Ling</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Jian  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 328-345. <a href="https://doi.org/10.1021/acschemneuro.7b00345" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BOrally%252BAvailable%252BFirst-Generation%252BDual-Target%252BSelective%252BInhibitors%252Bof%252BAcetylcholinesterase%252B%252528AChE%252529%252Band%252BPhosphodiesterase%252B5%252B%252528PDE5%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMao%26aufirst%3DFei%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07092017%26date%3D25102017%26date%3D09112017%26date%3D21022018%26date%3D25102017%26volume%3D9%26issue%3D2%26spage%3D328%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleha  Anwar</span>, <span class="hlFld-ContribAuthor ">Anas  Shamsi</span>, <span class="hlFld-ContribAuthor ">Taj  Mohammad</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2021,</strong> <em>1876 </em>
                                    (1)
                                     , 188568. <a href="https://doi.org/10.1016/j.bbcan.2021.188568" title="DOI URL">https://doi.org/10.1016/j.bbcan.2021.188568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2021.188568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2021.188568%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DTargeting%252Bpyruvate%252Bdehydrogenase%252Bkinase%252Bsignaling%252Bin%252Bthe%252Bdevelopment%252Bof%252Beffective%252Bcancer%252Btherapy%26aulast%3DAnwar%26aufirst%3DSaleha%26date%3D2021%26volume%3D1876%26issue%3D1%26spage%3D188568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuandong  Cao</span>, <span class="hlFld-ContribAuthor ">Aidi  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Li</span>, <span class="hlFld-ContribAuthor ">Han  Min</span>, <span class="hlFld-ContribAuthor ">Chao  He</span>, <span class="hlFld-ContribAuthor ">Xinchen  Sun</span>, <span class="hlFld-ContribAuthor ">Wei‐Qun  Ding</span>, <span class="hlFld-ContribAuthor ">Jundong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation. </span><span class="cited-content_cbyCitation_journal-name">Cancer Medicine</span><span> <strong>2021,</strong> <em>10 </em>
                                    (9)
                                     , 3101-3112. <a href="https://doi.org/10.1002/cam4.3879" title="DOI URL">https://doi.org/10.1002/cam4.3879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cam4.3879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcam4.3879%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Medicine%26atitle%3DElevated%252BTAB182%252Benhances%252Bthe%252Bradioresistance%252Bof%252Besophageal%252Bsquamous%252Bcell%252Bcarcinoma%252Bthrough%252BG2%2525E2%252580%252590M%252Bcheckpoint%252Bmodulation%26aulast%3DCao%26aufirst%3DYuandong%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D9%26spage%3D3101%26epage%3D3112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuxiu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Shen</span>, <span class="hlFld-ContribAuthor ">Yuting  Yan</span>, <span class="hlFld-ContribAuthor ">Hongmin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications. </span><span class="cited-content_cbyCitation_journal-name">Bioscience Reports</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     <a href="https://doi.org/10.1042/BSR20204402" title="DOI URL">https://doi.org/10.1042/BSR20204402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BSR20204402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBSR20204402%26sid%3Dliteratum%253Aachs%26jtitle%3DBioscience%2520Reports%26atitle%3DPyruvate%252Bdehydrogenase%252Bkinases%252B%252528PDKs%252529%25253A%252Ban%252Boverview%252Btoward%252Bclinical%252Bapplications%26aulast%3DWang%26aufirst%3DXiuxiu%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Kumar</span>, <span class="hlFld-ContribAuthor ">Mamta  Singh</span>, <span class="hlFld-ContribAuthor ">Dolly  Sharma</span>, <span class="hlFld-ContribAuthor ">Vinit  Kumar</span>, <span class="hlFld-ContribAuthor ">Reshma  Rani</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Metabolism: Focused on Tumor Glycolysis, Progress, and Prospects in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-33. <a href="https://doi.org/10.1002/0471266949.bmc286" title="DOI URL">https://doi.org/10.1002/0471266949.bmc286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc286%26sid%3Dliteratum%253Aachs%26atitle%3DTumor%252BMetabolism%25253A%252BFocused%252Bon%252BTumor%252BGlycolysis%25252C%252BProgress%25252C%252Band%252BProspects%252Bin%252BCancer%252BTherapy%26aulast%3DKumar%26aufirst%3DAtul%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D33%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhi-Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Qingwang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xuemin  Li</span>, <span class="hlFld-ContribAuthor ">Ding  Huang</span>, <span class="hlFld-ContribAuthor ">Yanfei  Qiu</span>, <span class="hlFld-ContribAuthor ">Kin Yip  Tam</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113225. <a href="https://doi.org/10.1016/j.ejmech.2021.113225" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113225%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bstructure-activity%252Brelationship%252Bof%252Bnovel%252Bdichloroacetophenones%252Btargeting%252Bpyruvate%252Bdehydrogenase%252Bkinases%252Bwith%252Bpotent%252Banticancer%252Bactivity%26aulast%3DXu%26aufirst%3DBiao%26date%3D2021%26volume%3D214%26spage%3D113225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengnan  Jin</span>, <span class="hlFld-ContribAuthor ">Shi‐Jun  Li</span>, <span class="hlFld-ContribAuthor ">Xingxing  Ma</span>, <span class="hlFld-ContribAuthor ">Jianke  Su</span>, <span class="hlFld-ContribAuthor ">Haohua  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Qiuling  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Elemental‐Sulfur‐Enabled Divergent Synthesis of Disulfides, Diselenides, and Polythiophenes from β‐CF
              3
              ‐1,3‐Enynes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (2)
                                     , 881-888. <a href="https://doi.org/10.1002/anie.202009194" title="DOI URL">https://doi.org/10.1002/anie.202009194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202009194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202009194%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DElemental%2525E2%252580%252590Sulfur%2525E2%252580%252590Enabled%252BDivergent%252BSynthesis%252Bof%252BDisulfides%25252C%252BDiselenides%25252C%252Band%252BPolythiophenes%252Bfrom%252B%2525CE%2525B2%2525E2%252580%252590CF%252B3%252B%2525E2%252580%2525901%25252C3%2525E2%252580%252590Enynes%26aulast%3DJin%26aufirst%3DShengnan%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D2%26spage%3D881%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengnan  Jin</span>, <span class="hlFld-ContribAuthor ">Shi‐Jun  Li</span>, <span class="hlFld-ContribAuthor ">Xingxing  Ma</span>, <span class="hlFld-ContribAuthor ">Jianke  Su</span>, <span class="hlFld-ContribAuthor ">Haohua  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Lan</span>, <span class="hlFld-ContribAuthor ">Qiuling  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Elemental‐Sulfur‐Enabled Divergent Synthesis of Disulfides, Diselenides, and Polythiophenes from β‐CF
              3
              ‐1,3‐Enynes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (2)
                                     , 894-901. <a href="https://doi.org/10.1002/ange.202009194" title="DOI URL">https://doi.org/10.1002/ange.202009194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202009194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202009194%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DElemental%2525E2%252580%252590Sulfur%2525E2%252580%252590Enabled%252BDivergent%252BSynthesis%252Bof%252BDisulfides%25252C%252BDiselenides%25252C%252Band%252BPolythiophenes%252Bfrom%252B%2525CE%2525B2%2525E2%252580%252590CF%252B3%252B%2525E2%252580%2525901%25252C3%2525E2%252580%252590Enynes%26aulast%3DJin%26aufirst%3DShengnan%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D2%26spage%3D894%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangita Dattatray  Shinde</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into medicinal attributes of dithiocarbamates: Bird’s eye view. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104346. <a href="https://doi.org/10.1016/j.bioorg.2020.104346" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104346%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Binsight%252Binto%252Bmedicinal%252Battributes%252Bof%252Bdithiocarbamates%25253A%252BBird%2525E2%252580%252599s%252Beye%252Bview%26aulast%3DShinde%26aufirst%3DSangita%2BDattatray%26date%3D2020%26volume%3D105%26spage%3D104346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-xiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yun-yuan  Huang</span>, <span class="hlFld-ContribAuthor ">Rong-rong  Song</span>, <span class="hlFld-ContribAuthor ">Yan-liang  Ren</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Xiao-kang  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Shuai-shuai  Ni</span>, <span class="hlFld-ContribAuthor ">Jian  Wan</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112500. <a href="https://doi.org/10.1016/j.ejmech.2020.112500" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112500%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bdisulfide-derived%252Bfructose-1%25252C6-bisphosphatase%252B%252528FBPase%252529%252Bcovalent%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DXu%26aufirst%3DYi-xiang%26date%3D2020%26volume%3D203%26spage%3D112500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga А.  Savchenko</span>, <span class="hlFld-ContribAuthor ">Vera V.  Musiyak</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Goncharov</span>, <span class="hlFld-ContribAuthor ">Yulia P.  Bogza</span>, <span class="hlFld-ContribAuthor ">Anton L.  Shatsauskas</span>, <span class="hlFld-ContribAuthor ">Valentin P.  Talzi</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Evdokimov</span>, <span class="hlFld-ContribAuthor ">Evgeny B.  Ulyankin</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Fisyuk</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular cyclization of 2-(heteroarylsulfanyl)-N-(3-oxoalkenyl)acetamides: synthesis of 3-(heteroarylsulfanyl)- and 3-sulfanylpyridin-2(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (9)
                                     , 1180-1186. <a href="https://doi.org/10.1007/s10593-020-02795-1" title="DOI URL">https://doi.org/10.1007/s10593-020-02795-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02795-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02795-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DIntramolecular%252Bcyclization%252Bof%252B2-%252528heteroarylsulfanyl%252529-N-%2525283-oxoalkenyl%252529acetamides%25253A%252Bsynthesis%252Bof%252B3-%252528heteroarylsulfanyl%252529-%252Band%252B3-sulfanylpyridin-2%2525281H%252529-ones%26aulast%3DSavchenko%26aufirst%3DOlga%2B%25D0%2590.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D9%26spage%3D1180%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuaishuai  Ni</span>, <span class="hlFld-ContribAuthor ">Baoli  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting virulence factors as an antimicrobial approach: Pigment inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 293-338. <a href="https://doi.org/10.1002/med.21621" title="DOI URL">https://doi.org/10.1002/med.21621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21621%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bvirulence%252Bfactors%252Bas%252Ban%252Bantimicrobial%252Bapproach%25253A%252BPigment%252Binhibitors%26aulast%3DNi%26aufirst%3DShuaishuai%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D293%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dawei  Yang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Baomin  Wang</span>, <span class="hlFld-ContribAuthor ">Jingping  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Biomimetic catalytic oxidative coupling of thiols using thiolate-bridged dinuclear metal complexes containing iron in water under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2019,</strong> <em>9 </em>
                                    (22)
                                     , 6492-6502. <a href="https://doi.org/10.1039/C9CY01667H" title="DOI URL">https://doi.org/10.1039/C9CY01667H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CY01667H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CY01667H%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DBiomimetic%252Bcatalytic%252Boxidative%252Bcoupling%252Bof%252Bthiols%252Busing%252Bthiolate-bridged%252Bdinuclear%252Bmetal%252Bcomplexes%252Bcontaining%252Biron%252Bin%252Bwater%252Bunder%252Bmild%252Bconditions%26aulast%3DZhang%26aufirst%3DYahui%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D22%26spage%3D6492%26epage%3D6502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Huang  Xu</span>, <span class="hlFld-ContribAuthor ">Shumin  Ding</span>, <span class="hlFld-ContribAuthor ">Dongyan  Wang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Song</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>153 </em>, 223-231. <a href="https://doi.org/10.1016/j.brainresbull.2019.09.001" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DPhosphodiesterase%252B5%252Binhibitors%252Bas%252Bnovel%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiu%26aufirst%3DLi%26date%3D2019%26volume%3D153%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin L.  Woolbright</span>, <span class="hlFld-ContribAuthor ">Ganeshkumar  Rajendran</span>, <span class="hlFld-ContribAuthor ">Robert A.  Harris</span>, <span class="hlFld-ContribAuthor ">John A.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1673-1681. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0079" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0079%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMetabolic%252BFlexibility%252Bin%252BCancer%25253A%252BTargeting%252Bthe%252BPyruvate%252BDehydrogenase%252BKinase%25253APyruvate%252BDehydrogenase%252BAxis%26aulast%3DWoolbright%26aufirst%3DBenjamin%2BL.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1673%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Han  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of novel dithiocarbamates containing α,β-unsaturated ketone fragment as potent anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (7)
                                     , 1027-1038. <a href="https://doi.org/10.1007/s00044-019-02356-y" title="DOI URL">https://doi.org/10.1007/s00044-019-02356-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02356-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02356-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructure-activity%252Brelationships%252Bof%252Bnovel%252Bdithiocarbamates%252Bcontaining%252B%2525CE%2525B1%25252C%2525CE%2525B2-unsaturated%252Bketone%252Bfragment%252Bas%252Bpotent%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DYuanqiang%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D7%26spage%3D1027%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hojat  Veisi</span>, <span class="hlFld-ContribAuthor ">Taibeh  Tamoradi</span>, <span class="hlFld-ContribAuthor ">Bikash  Karmakar</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient clean methodology for the C–S coupling to aryl thioethers and S–S homocoupling to aromatic disulfides catalyzed over a Ce(
              iv
              )-leucine complex immobilized on mesoporous MCM-41. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (26)
                                     , 10343-10351. <a href="https://doi.org/10.1039/C9NJ02270H" title="DOI URL">https://doi.org/10.1039/C9NJ02270H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ02270H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ02270H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DAn%252Befficient%252Bclean%252Bmethodology%252Bfor%252Bthe%252BC%2525E2%252580%252593S%252Bcoupling%252Bto%252Baryl%252Bthioethers%252Band%252BS%2525E2%252580%252593S%252Bhomocoupling%252Bto%252Baromatic%252Bdisulfides%252Bcatalyzed%252Bover%252Ba%252BCe%252528%252Biv%252B%252529-leucine%252Bcomplex%252Bimmobilized%252Bon%252Bmesoporous%252BMCM-41%26aulast%3DVeisi%26aufirst%3DHojat%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D26%26spage%3D10343%26epage%3D10351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Li</span>, <span class="hlFld-ContribAuthor ">Zhubin  Hu</span>, <span class="hlFld-ContribAuthor ">Yanrong  Jiang</span>, <span class="hlFld-ContribAuthor ">Qinqin  Yuan</span>, <span class="hlFld-ContribAuthor ">Haitao  Sun</span>, <span class="hlFld-ContribAuthor ">Xue-Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenrong  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Electronic structures and binding motifs of sodium polysulfide clusters NaSn− (
              n
              = 5–9): A joint negative ion photoelectron spectroscopy and computational investigation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Chemical Physics</span><span> <strong>2019,</strong> <em>150 </em>
                                    (24)
                                     , 244305. <a href="https://doi.org/10.1063/1.5100733" title="DOI URL">https://doi.org/10.1063/1.5100733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1063/1.5100733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1063%2F1.5100733%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Chemical%2520Physics%26atitle%3DElectronic%252Bstructures%252Band%252Bbinding%252Bmotifs%252Bof%252Bsodium%252Bpolysulfide%252Bclusters%252BNaSn%2525E2%252588%252592%252B%252528%252Bn%252B%25253D%252B5%2525E2%252580%2525939%252529%25253A%252BA%252Bjoint%252Bnegative%252Bion%252Bphotoelectron%252Bspectroscopy%252Band%252Bcomputational%252Binvestigation%26aulast%3DLi%26aufirst%3DZhipeng%26date%3D2019%26volume%3D150%26issue%3D24%26spage%3D244305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing  Cong</span>, <span class="hlFld-ContribAuthor ">Xiao‐Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming‐Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying‐Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Cong‐Jian  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2019,</strong> <em>234 </em>
                                    (5)
                                     , 6361-6370. <a href="https://doi.org/10.1002/jcp.27369" title="DOI URL">https://doi.org/10.1002/jcp.27369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.27369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.27369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DPyruvate%252Bdehydrogenase%252Bkinase%252B1%252Bcontributes%252Bto%252Bcisplatin%252Bresistance%252Bof%252Bovarian%252Bcancer%252Bthrough%252BEGFR%252Bactivation%26aulast%3DZhang%26aufirst%3DMeng%26date%3D2019%26date%3D2018%26volume%3D234%26issue%3D5%26spage%3D6361%26epage%3D6370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Arshad</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Lalit Mohan  Nainwal</span>, <span class="hlFld-ContribAuthor ">Sumit Kumar  Kaushik</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Suhel  Parvez</span>, <span class="hlFld-ContribAuthor ">Syed Misbahul  Hasan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing quinquennial anticancer journey of morpholine: A SAR based review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 324-356. <a href="https://doi.org/10.1016/j.ejmech.2019.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevealing%252Bquinquennial%252Banticancer%252Bjourney%252Bof%252Bmorpholine%25253A%252BA%252BSAR%252Bbased%252Breview%26aulast%3DArshad%26aufirst%3DFatima%26date%3D2019%26volume%3D167%26spage%3D324%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Mei  Wu</span>, <span class="hlFld-ContribAuthor ">Yong-Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Shao-Hua  Fan</span>, <span class="hlFld-ContribAuthor ">Zi-Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qun  Shan</span>, <span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Gui-Quan  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Lin  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 252-262. <a href="https://doi.org/10.1016/j.ejmech.2018.12.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-throughput%252Bscreening%252Bof%252Bnovel%252Bpyruvate%252Bdehydrogenase%252Bkinases%252Binhibitors%252Band%252Bbiological%252Bevaluation%252Bof%252Btheir%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bantiproliferative%252Bactivity%26aulast%3DWu%26aufirst%3DDong-Mei%26date%3D2019%26volume%3D164%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuyun  Guo</span>, <span class="hlFld-ContribAuthor ">Shufen  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiao'e  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (2)
                                     , 291-296. <a href="https://doi.org/10.1016/j.bmcl.2018.11.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpyruvate%252Bdehydrogenase%252Bkinases%252Binhibitors%252Bby%252Bscreening%252Bof%252Ban%252Bin-house%252Bsmall%252Bmolecule%252Blibrary%252Bfor%252Banti-lung%252Bcancer%252Btherapeutics%26aulast%3DGuo%26aufirst%3DFuyun%26date%3D2019%26volume%3D29%26issue%3D2%26spage%3D291%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Xiao</span>, <span class="hlFld-ContribAuthor ">Jiahui  Xue</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Polysulfurating reagent design for unsymmetrical polysulfide construction. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-04306-5" title="DOI URL">https://doi.org/10.1038/s41467-018-04306-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-04306-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-04306-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DPolysulfurating%252Breagent%252Bdesign%252Bfor%252Bunsymmetrical%252Bpolysulfide%252Bconstruction%26aulast%3DXiao%26aufirst%3DXiao%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronghua  Yang</span>, <span class="hlFld-ContribAuthor ">Caihong  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1843-1849. <a href="https://doi.org/10.1039/C8MD00453F" title="DOI URL">https://doi.org/10.1039/C8MD00453F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00453F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00453F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bpotent%252Bpyruvate%252Bdehydrogenase%252Bkinase%252Binhibitors%252Band%252Bevaluation%252Bof%252Btheir%252Banti-lung%252Bcancer%252Bactivity%252Bunder%252Bhypoxia%26aulast%3DYang%26aufirst%3DRonghua%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D11%26spage%3D1843%26epage%3D1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Hu</span>, <span class="hlFld-ContribAuthor ">Kin Yip  Tam</span>. </span><span class="cited-content_cbyCitation_article-title">Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (21)
                                     , 3441-3445. <a href="https://doi.org/10.1016/j.bmcl.2018.09.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.09.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.09.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDichloroacetophenones%252Btargeting%252Bat%252Bpyruvate%252Bdehydrogenase%252Bkinase%252B1%252Bwith%252Bimproved%252Bselectivity%252Band%252Bantiproliferative%252Bactivity%25253A%252BSynthesis%252Band%252Bstructure-activity%252Brelationships%26aulast%3DZhang%26aufirst%3DShao-Lin%26date%3D2018%26volume%3D28%26issue%3D21%26spage%3D3441%26epage%3D3445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guorong  Lu</span>, <span class="hlFld-ContribAuthor ">Mary R.  Tandang-Silvas</span>, <span class="hlFld-ContribAuthor ">Alyssa C.  Dawson</span>, <span class="hlFld-ContribAuthor ">Trenton J.  Dawson</span>, <span class="hlFld-ContribAuthor ">Jay C.  Groppe</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification. </span><span class="cited-content_cbyCitation_journal-name">Bone</span><span> <strong>2018,</strong> <em>112 </em>, 71-89. <a href="https://doi.org/10.1016/j.bone.2018.03.027" title="DOI URL">https://doi.org/10.1016/j.bone.2018.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bone.2018.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bone.2018.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBone%26atitle%3DHypoxia-selective%252Ballosteric%252Bdestabilization%252Bof%252Bactivin%252Breceptor-like%252Bkinases%25253A%252BA%252Bpotential%252Btherapeutic%252Bavenue%252Bfor%252Bprophylaxis%252Bof%252Bheterotopic%252Bossification%26aulast%3DLu%26aufirst%3DGuorong%26date%3D2018%26volume%3D112%26spage%3D71%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhimei  Yu</span>, <span class="hlFld-ContribAuthor ">Sichuan  Xiang</span>, <span class="hlFld-ContribAuthor ">Yunshan  Li</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 275-284. <a href="https://doi.org/10.1016/j.ejmech.2018.06.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252Bmitochondria-targeted%252Bpyruvate%252Bdehydrogenase%252Bkinase%252B1%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Band%252Bantiproliferative%252Bactivity%26aulast%3DXu%26aufirst%3DBiao%26date%3D2018%26volume%3D155%26spage%3D275%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur–Sulfur Bond Construction. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2018,</strong> <em>376 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-018-0192-5" title="DOI URL">https://doi.org/10.1007/s41061-018-0192-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-018-0192-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-018-0192-5%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSulfur%2525E2%252580%252593Sulfur%252BBond%252BConstruction%26aulast%3DWang%26aufirst%3DMing%26date%3D2018%26date%3D2018%26volume%3D376%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shilpi  Balgotra</span>, <span class="hlFld-ContribAuthor ">Praveen  Kumar Verma</span>, <span class="hlFld-ContribAuthor ">Jaspreet  Kour</span>, <span class="hlFld-ContribAuthor ">Sorav  Gupta</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Sanghapal D.  Sawant</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Approach to Access Aryl Iodides and Disulfides via Dehydrazination of Arylhydrazines and Arylsulfonylhydrazides. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (10)
                                     , 2800-2804. <a href="https://doi.org/10.1002/slct.201800188" title="DOI URL">https://doi.org/10.1002/slct.201800188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800188%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BNovel%252BApproach%252Bto%252BAccess%252BAryl%252BIodides%252Band%252BDisulfides%252Bvia%252BDehydrazination%252Bof%252BArylhydrazines%252Band%252BArylsulfonylhydrazides%26aulast%3DBalgotra%26aufirst%3DShilpi%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D10%26spage%3D2800%26epage%3D2804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Christopher J.T.  Hyland</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Steven-Alan G.  Abel</span>, <span class="hlFld-ContribAuthor ">Melissa J.  Bird</span>, <span class="hlFld-ContribAuthor ">Isabel K.  Hyland</span>, <span class="hlFld-ContribAuthor ">Hoang  Pham</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 493-550. <a href="https://doi.org/10.1016/B978-0-08-102788-2.00016-7" title="DOI URL">https://doi.org/10.1016/B978-0-08-102788-2.00016-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102788-2.00016-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102788-2.00016-7%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DMeyer%26aufirst%3DAdam%2BG.%26date%3D2018%26spage%3D493%26epage%3D550%26pub%3DElsevier%26date%3D2018%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian-Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 16
              H
              -dibenzo[2,3:6,7][1,4]oxazepino[5,4-
              b
              ]quinazolin-16-ones
              via
              an Ullmann reaction catalyzed by CuI. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (10)
                                     , 1679-1685. <a href="https://doi.org/10.1039/C8OB00005K" title="DOI URL">https://doi.org/10.1039/C8OB00005K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00005K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00005K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B16%252BH%252B-dibenzo%25255B2%25252C3%25253A6%25252C7%25255D%25255B1%25252C4%25255Doxazepino%25255B5%25252C4-%252Bb%252B%25255Dquinazolin-16-ones%252Bvia%252Ban%252BUllmann%252Breaction%252Bcatalyzed%252Bby%252BCuI%26aulast%3DZhang%26aufirst%3DYan%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D10%26spage%3D1679%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael H.  Lee</span>, <span class="hlFld-ContribAuthor ">Marita  Chakhtoura</span>, <span class="hlFld-ContribAuthor ">Uma  Sriram</span>, <span class="hlFld-ContribAuthor ">Roberto  Caricchio</span>, <span class="hlFld-ContribAuthor ">Stefania  Gallucci</span>. </span><span class="cited-content_cbyCitation_article-title">Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Immunology Research</span><span> <strong>2018,</strong> <em>2018 </em>, 1-21. <a href="https://doi.org/10.1155/2018/1601079" title="DOI URL">https://doi.org/10.1155/2018/1601079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/1601079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F1601079%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Immunology%2520Research%26atitle%3DConventional%252BDCs%252Bfrom%252BMale%252Band%252BFemale%252BLupus-Prone%252BB6.NZM%252BSle1%25252FSle2%25252FSle3%252BMice%252BExpress%252Ban%252BIFN%252BSignature%252Band%252BHave%252Ba%252BHigher%252BImmunometabolism%252BThat%252BAre%252BEnhanced%252Bby%252BEstrogen%26aulast%3DLee%26aufirst%3DMichael%2BH.%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiping  Fang</span>, <span class="hlFld-ContribAuthor ">Huiqiang  Luo</span>, <span class="hlFld-ContribAuthor ">Liping  Liu</span>, <span class="hlFld-ContribAuthor ">Haibo  Fan</span>, <span class="hlFld-ContribAuthor ">Yaying  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuqin  Yao</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (24)
                                     , 5450-5453. <a href="https://doi.org/10.1016/j.bmcl.2017.10.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpyruvate%252Bdehydrogenase%252Bkinase%252B1%252Binhibitors%252Bwith%252Banti-osteosarcoma%252Bactivity%26aulast%3DFang%26aufirst%3DAiping%26date%3D2017%26volume%3D27%26issue%3D24%26spage%3D5450%26epage%3D5453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the PDK1 inhibitors reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffold hopping (<b>1</b>) and three chemical modification strategies (<b>2</b>–<b>3</b>) of lead compound <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Analogues <b>1b</b>–<b>m</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4,</sub> 0 °C to rt; (c) ammonium dithiocarbamate, EtOH, reflux, 1 h; (d) LiOH, H<sub>2</sub>O, THF, rt, 1 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Analogues <b>2a</b>–<b>g</b> and <b>3a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (b) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (c) H<sub>2</sub>SO<sub>4</sub>, MeOH, rt, overnight.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Analogues <b>2h</b>, <b>2j</b>, <b>2k</b>, and <b>2s</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) iodoethane, NaH, DMF, 80 °C, overnight; (b) SOCl<sub>2</sub>, DCM, rt, 2 h; (c) MeONa, NaI, MeOH, reflux, overnight; (d) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (e) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Analogues <b>2i</b> and <b>2l</b>–<b>r</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeONa, NaI, MeOH, reflux overnight; (b) R<sup>4</sup>OH, NaH, DMF, 120 °C, overnight; (c) formamide, H<sub>2</sub>O, 190 °C, overnight; (d) iodoethane, NaH, DMF, 80 °C, overnight; (e) acetyl chloride, TEA, DCM, rt, overnight; (f) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (g) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (h) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (i) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, rt, overnight; (j) dimethylcarbamic chloride, TEA, DCM, rt, overnight; (k) HCl, dioxane, rt, 1 h.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Analogues <b>3b</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeONa, NaI, MeOH, reflux overnight; (b) R<sup>5</sup>OH, NaH, DMF, 120 °C, overnight; (c) formamide, H<sub>2</sub>O, 190 °C, overnight; (d) R<sup>5</sup>-I, NaH, DMF, 80 °C, overnight; (e) H<sub>2</sub>, Pd/C, MeOH, rt, overnight; (f) (1) CS<sub>2</sub>, KOH, H<sub>2</sub>O, 50 °C, overnight, (2) NaNO<sub>2</sub>, H<sub>2</sub>O, MeOH, HCl, 0 °C; (g) (1) CS<sub>2</sub>, THF, rt, 1 h, (2) (NH<sub>4</sub>)<sub>2</sub>S<sub>2</sub>O<sub>8</sub>, H<sub>2</sub>O, THF, rt, 0.5 h; (h) (Boc)<sub>2</sub>O, NaHCO<sub>3</sub>,THF, H<sub>2</sub>O, rt, overnight; (i) dimethylcarbamic chloride, TEA, DCM, rt, overnight; (j) HCl, dioxane, rt, 1 h.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative inhibitors characterization based on kinetic properties with PDK1: quadrant I, low affinity and high reactivity; quadrant II, high affinity and high reactivity; quandrant III, high affinity and moderate reactivity; quadrant IV, weak affinity and moderate to low reactivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cellular potencies of representative analogues on PDK1 inhibition evaluated by downstream PDHE1 phosphorylation in A549 cells. (A) Screening of analogues at 10 μM. (B) Screening of analogues at 1 and 0.3 μM. (C) Analogues <b>2k</b>, <b>3a</b>, and <b>16</b> inhibited PDHE1 phosphorylation in a dose-dependent manner, and the comparison was determined by semiquantitative analysis of the Gray-Scale. All cells treated for 24 h with the analogues at the indicated concentrations were lysed and subjected to immunoblotting analysis. Error bars represent the average ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition curves of analogues <b>2k</b> (A) and <b>3a</b> (B) toward PDK1 at different concentrations of GSH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular docking of <b>16</b>, <b>2k</b>, and <b>3a</b> with PDK1–4. (A–C) The binding pocket of <b>3a</b> (white sticks) in PDK1–3 (green surface) and the detailed interactions between inhibitors and their surrounding residues (green sticks) in PDK1–3. (D) No obvious binding pockets for <b>16</b>, <b>2k</b>, and <b>3a</b> in PDK4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Metabolic alteration caused by <b>2k</b>, <b>3a</b>, and <b>16</b> on A549 cells. (A) Effect on the extracellular acidification rate (ECAR) in a dose-dependent manner. (B) Effect on the reactive oxygen species (ROS) in a dose-dependent manner. Cells were treated with compounds at the indicated concentrations for 24 h. Error bars represent the average ± SD of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/medium/jm-2016-01245k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>2k</b>, <b>3a</b>, and <b>16</b> inhibit tumor growth in vivo. A549 xenograft mouse models were treated with inhibitors or vehicle control daily at indicated dosages for 21 consecutive days. (A–C) The tumor growth inhibition values (TGI) were measured on the final day of the study. (D) Tumor weight after last dosing. (E) Body weight change of <b>16</b> and <b>3a</b>. One-way ANOVA analysis, *, <i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-6/acs.jmedchem.6b01245/20170317/images/large/jm-2016-01245k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01245&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span><span class="refDoi"> DOI: 10.1126/science.1160809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation&doi=10.1126%2Fscience.1160809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0lhQSxpjqxAdGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033%26doi%3D10.1126%2Fscience.1160809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span> </span><span class="NLM_article-title">Targeting cancer metabolism: a therapeutic window opens</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1038/nrd3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnrd3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21878982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=671-684&author=M.+G.+Vander+Heiden&title=Targeting+cancer+metabolism%3A+a+therapeutic+window+opens&doi=10.1038%2Fnrd3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer metabolism: a therapeutic window opens</span></div><div class="casAuthors">Vander Heiden, Matthew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">671-684</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic events in cancer activate signalling pathways that alter cell metab.  Clin. evidence has linked cell metab. with cancer outcomes.  Together, these observations have raised interest in targeting metabolic enzymes for cancer therapy, but they have also raised concerns that these therapies would have unacceptable effects on normal cells.  However, some of the first cancer therapies that were developed target the specific metabolic needs of cancer cells and remain effective agents in the clinic today.  Research into how changes in cell metab. promote tumor growth has accelerated in recent years.  This has refocused efforts to target metabolic dependencies of cancer cells as a selective anticancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwef_xmbtRrVg90H21EOLACvtfcHk0lhQSxpjqxAdGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSltb3J&md5=5051a52f70ba7dd0cd99cf6ffce7f4c6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3504%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26atitle%3DTargeting%2520cancer%2520metabolism%253A%2520a%2520therapeutic%2520window%2520opens%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D671%26epage%3D684%26doi%3D10.1038%2Fnrd3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wieland, O. H.</span><span> </span><span class="NLM_article-title">The mammalian pyruvate dehydrogenase complex: structure and regulation</span> <span class="citation_source-journal">Rev. Physiol., Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1007/BFb0031008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1007%2FBFb0031008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=6338572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaL3sXmslGltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1983&pages=123-170&author=O.+H.+Wieland&title=The+mammalian+pyruvate+dehydrogenase+complex%3A+structure+and+regulation&doi=10.1007%2FBFb0031008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The mammalian pyruvate dehydrogenase complex:  structure and regulation</span></div><div class="casAuthors">Wieland, Otto H.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews of Physiology, Biochemistry and Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-70</span>CODEN:
                <span class="NLM_cas:coden">RPBEA5</span>;
        ISSN:<span class="NLM_cas:issn">0303-4240</span>.
    </div><div class="casAbstract">A review with 246 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJSVMTkdjEobVg90H21EOLACvtfcHk0ljXWmJ9rGUc3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXmslGltg%253D%253D&md5=1bd06610b823cbd0a7fb058d5cc11c9c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBFb0031008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBFb0031008%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DO.%2BH.%26atitle%3DThe%2520mammalian%2520pyruvate%2520dehydrogenase%2520complex%253A%2520structure%2520and%2520regulation%26jtitle%3DRev.%2520Physiol.%252C%2520Biochem.%2520Pharmacol.%26date%3D1983%26volume%3D96%26spage%3D123%26epage%3D170%26doi%3D10.1007%2FBFb0031008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Saunier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortoli, S.</span><span> </span><span class="NLM_article-title">The pyruvate dehydrogenase complex in cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">817</span><span class="refDoi"> DOI: 10.1002/ijc.29564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1002%2Fijc.29564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=25868605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=809-817&author=E.+Saunierauthor=C.+Benelliauthor=S.+Bortoli&title=The+pyruvate+dehydrogenase+complex+in+cancer%3A+an+old+metabolic+gatekeeper+regulated+by+new+pathways+and+pharmacological+agents&doi=10.1002%2Fijc.29564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents</span></div><div class="casAuthors">Saunier, Elise; Benelli, Chantal; Bortoli, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cancer cells exhibit an altered metab. which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidn. of pyruvate.  This provides anabolic support and selective growth advantage for cancer cells.  Recently, a new concept has arisen suggesting that these metabolic changes may be due, in part, to an attenuated mitochondrial function which results from the inhibition of the pyruvate dehydrogenase complex (PDC).  This mitochondrial complex links glycolysis to the Krebs cycle and the current understanding of its regulation involves the cyclic phosphorylation and dephosphorylation by specific pyruvate dehydrogenase kinases (PDKs) and pyruvate dehydrogenase phosphatases (PDPs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHoUftek7vjrVg90H21EOLACvtfcHk0ljXWmJ9rGUc3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFCktr0%253D&md5=5ed6990e7c6e5d4619149746338f5582</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fijc.29564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29564%26sid%3Dliteratum%253Aachs%26aulast%3DSaunier%26aufirst%3DE.%26aulast%3DBenelli%26aufirst%3DC.%26aulast%3DBortoli%26aufirst%3DS.%26atitle%3DThe%2520pyruvate%2520dehydrogenase%2520complex%2520in%2520cancer%253A%2520an%2520old%2520metabolic%2520gatekeeper%2520regulated%2520by%2520new%2520pathways%2520and%2520pharmacological%2520agents%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2016%26volume%3D138%26spage%3D809%26epage%3D817%26doi%3D10.1002%2Fijc.29564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Popov, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawes, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span> </span><span class="NLM_article-title">Mitochondrial alpha-ketoacid dehydrogenase kinases: a new family of protein kinases</span> <span class="citation_source-journal">Adv. Second Messenger Phosphoprotein Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/S1040-7952(97)80012-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2FS1040-7952%2897%2980012-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=9344245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A280%3ADyaK1c%252Fgt12gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1997&pages=105-111&author=K.+M.+Popovauthor=J.+W.+Hawesauthor=R.+A.+Harris&title=Mitochondrial+alpha-ketoacid+dehydrogenase+kinases%3A+a+new+family+of+protein+kinases&doi=10.1016%2FS1040-7952%2897%2980012-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial alpha-ketoacid dehydrogenase kinases: a new family of protein kinases</span></div><div class="casAuthors">Popov K M; Hawes J W; Harris R A</div><div class="citationInfo"><span class="NLM_cas:title">Advances in second messenger and phosphoprotein research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-11</span>
        ISSN:<span class="NLM_cas:issn">1040-7952</span>.
    </div><div class="casAbstract">Four mitochondrial protein kinases have been cloned.  These proteins represent a new family of protein kinases, related by sequence to the bacterial protein kinases but by function to the eukaryotic serine protein kinases.  Arg288 is required for recognition by BCKDK of the phosphorylation site on the E1alpha subunit of the BCKDH complex.  BCKDK inhibits the dehydrogenase activity of the BCKDH complex by introducing a negative charge into the active-site pocket of the E1 component.  Protein starvation of rats induces an increase in the amount of BCKDK bound to the BCKDH complex.  This causes inactivation of the BCKDH complex and conserves branched-chain amino acids for protein synthesis in the protein-starved state.  Expression of the different PDK isoenzymes is tissue specific, and the different PDK isoenzymes are unique with respect to kinetic parameters for ATP and ADP and sensitivity to allosteric effectors (NADH, NAD+, coenzyme A, acetyl-CoA, pyruvate, and dichloroacetate).  Preliminary experiments indicate that an increased amount of PDK2 protein partly explains the increase in PDK activity that occurs in rat liver in response to chemically induced diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8xuWltsjY2e-MdeMhXAHkfW6udTcc2eZj_g6LUaLQ8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252Fgt12gsg%253D%253D&md5=aa02cbcd0a055cb467530bc2aa42fcc2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1040-7952%2897%2980012-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-7952%252897%252980012-2%26sid%3Dliteratum%253Aachs%26aulast%3DPopov%26aufirst%3DK.%2BM.%26aulast%3DHawes%26aufirst%3DJ.%2BW.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26atitle%3DMitochondrial%2520alpha-ketoacid%2520dehydrogenase%2520kinases%253A%2520a%2520new%2520family%2520of%2520protein%2520kinases%26jtitle%3DAdv.%2520Second%2520Messenger%2520Phosphoprotein%2520Res.%26date%3D1997%26volume%3D31%26spage%3D105%26epage%3D111%26doi%3D10.1016%2FS1040-7952%2897%2980012-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gudi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowker-Kinley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedishvili, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Diversity of the pyruvate dehydrogenase kinase gene family in humans</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">28989</span><span class="NLM_x">–</span> <span class="NLM_lpage">28994</span><span class="refDoi"> DOI: 10.1074/jbc.270.48.28989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.270.48.28989" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=28989-28994&author=R.+Gudiauthor=M.+Bowker-Kinleyauthor=N.+Y.+Kedishviliauthor=Y.+Zhaoauthor=K.+M.+Popov&title=Diversity+of+the+pyruvate+dehydrogenase+kinase+gene+family+in+humans&doi=10.1074%2Fjbc.270.48.28989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.48.28989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.48.28989%26sid%3Dliteratum%253Aachs%26aulast%3DGudi%26aufirst%3DR.%26aulast%3DBowker-Kinley%26aufirst%3DM.%26aulast%3DKedishvili%26aufirst%3DN.%2BY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DDiversity%2520of%2520the%2520pyruvate%2520dehydrogenase%2520kinase%2520gene%2520family%2520in%2520humans%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D28989%26epage%3D28994%26doi%3D10.1074%2Fjbc.270.48.28989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bajotto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, Y.</span><span> </span><span class="NLM_article-title">Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1016/j.metabol.2005.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.metabol.2005.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16483874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=317-323&author=G.+Bajottoauthor=T.+Murakamiauthor=M.+Nagasakiauthor=B.+Qinauthor=Y.+Matsuoauthor=K.+Maedaauthor=M.+Ohashiauthor=Y.+Oshidaauthor=Y.+Satoauthor=Y.+Shimomura&title=Increased+expression+of+hepatic+pyruvate+dehydrogenase+kinases+2+and+4+in+young+and+middle-aged+Otsuka+Long-Evans+Tokushima+Fatty+rats%3A+induction+by+elevated+levels+of+free+fatty+acids&doi=10.1016%2Fj.metabol.2005.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids</span></div><div class="casAuthors">Bajotto, Gustavo; Murakami, Taro; Nagasaki, Masaru; Qin, Bolin; Matsuo, Yoshiyuki; Maeda, Ken; Ohashi, Masayo; Oshida, Yoshiharu; Sato, Yuzo; Shimomura, Yoshiharu</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-323</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The activity of the pyruvate dehydrogenase complex (PDC) is regulated by covalent modification of its E1 component, which is catalyzed by specific pyruvate dehydrogenase kinases (PDKs) and phosphatases.  In the liver, PDK2 and PDK4 are the most abundant PDK isoforms, which are responsible for inactivation of PDC when glucose availability is scarce in the body.  In the present study, regulatory mechanisms of hepatic PDC were examd. before and after the onset of type 2 diabetes mellitus in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, using Long-Evans Tokushima Otsuka (LETO) rats as controls.  Plasma glucose and insulin concns. were at normal levels in rats aged 8 wk, but were significantly higher in OLETF than in LETO rats aged 25 wk, indicating insulin resistance in OLETF rats.  Plasma free fatty acids (FFAs) were 1.6-fold concd., and the liver PDC activity was significantly lower in OLETF than in LETO rats at both ages, suggesting suppression of pyruvate oxidative decarboxylation in OLETF rats before and after the onset of diabetes.  Pyruvate dehydrogenase kinase activity and abundance of PDK2 and PDK4 proteins, as well as mRNAs, were greater in OLETF rats at both ages.  These results suggest that persistently elevated levels of circulating free fatty acid in normal and diabetic OLETF rats play an important role in stimulating PDK2 and PDK4 expression in liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pJNpKoDCJ7Vg90H21EOLACvtfcHk0lhKTvvHjvMz4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOiu7o%253D&md5=1e489a7aa8f8894ecaa0e711f1675c56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2005.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2005.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DBajotto%26aufirst%3DG.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DNagasaki%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DOhashi%26aufirst%3DM.%26aulast%3DOshida%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DShimomura%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520hepatic%2520pyruvate%2520dehydrogenase%2520kinases%25202%2520and%25204%2520in%2520young%2520and%2520middle-aged%2520Otsuka%2520Long-Evans%2520Tokushima%2520Fatty%2520rats%253A%2520induction%2520by%2520elevated%2520levels%2520of%2520free%2520fatty%2520acids%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2006%26volume%3D55%26spage%3D317%26epage%3D323%26doi%3D10.1016%2Fj.metabol.2005.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kolobova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuganova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulatnikov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, K. M.</span><span> </span><span class="NLM_article-title">Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1042/bj3580069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1042%2Fbj3580069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=69-77&author=E.+Kolobovaauthor=A.+Tuganovaauthor=I.+Boulatnikovauthor=K.+M.+Popov&title=Regulation+of+pyruvate+dehydrogenase+activity+through+phosphorylation+at+multiple+sites&doi=10.1042%2Fbj3580069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2Fbj3580069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3580069%26sid%3Dliteratum%253Aachs%26aulast%3DKolobova%26aufirst%3DE.%26aulast%3DTuganova%26aufirst%3DA.%26aulast%3DBoulatnikov%26aufirst%3DI.%26aulast%3DPopov%26aufirst%3DK.%2BM.%26atitle%3DRegulation%2520of%2520pyruvate%2520dehydrogenase%2520activity%2520through%2520phosphorylation%2520at%2520multiple%2520sites%26jtitle%3DBiochem.%2520J.%26date%3D2001%26volume%3D358%26spage%3D69%26epage%3D77%26doi%3D10.1042%2Fbj3580069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">McFate, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohyeldin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teahan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Califano, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeoung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, A.</span><span> </span><span class="NLM_article-title">Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">22700</span><span class="NLM_x">–</span> <span class="NLM_lpage">22708</span><span class="refDoi"> DOI: 10.1074/jbc.M801765200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.M801765200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=22700-22708&author=T.+McFateauthor=A.+Mohyeldinauthor=H.+Luauthor=J.+Thakarauthor=J.+Henriquesauthor=N.+D.+Halimauthor=H.+Wuauthor=M.+J.+Schellauthor=T.+M.+Tsangauthor=O.+Teahanauthor=S.+Zhouauthor=J.+A.+Califanoauthor=N.+H.+Jeoungauthor=R.+A.+Harrisauthor=A.+Verma&title=Pyruvate+dehydrogenase+complex+activity+controls+metabolic+and+malignant+phenotype+in+cancer+cells&doi=10.1074%2Fjbc.M801765200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M801765200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M801765200%26sid%3Dliteratum%253Aachs%26aulast%3DMcFate%26aufirst%3DT.%26aulast%3DMohyeldin%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DThakar%26aufirst%3DJ.%26aulast%3DHenriques%26aufirst%3DJ.%26aulast%3DHalim%26aufirst%3DN.%2BD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BM.%26aulast%3DTeahan%26aufirst%3DO.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DCalifano%26aufirst%3DJ.%2BA.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DVerma%26aufirst%3DA.%26atitle%3DPyruvate%2520dehydrogenase%2520complex%2520activity%2520controls%2520metabolic%2520and%2520malignant%2520phenotype%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D22700%26epage%3D22708%26doi%3D10.1074%2Fjbc.M801765200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kim, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchernyshyov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenza, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.cmet.2006.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16517405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=177-185&author=J.+W.+Kimauthor=I.+Tchernyshyovauthor=G.+L.+Semenzaauthor=C.+V.+Dang&title=HIF-1-mediated+expression+of+pyruvate+dehydrogenase+kinase%3A+a+metabolic+switch+required+for+cellular+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2006.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</span></div><div class="casAuthors">Kim, Jung-whan; Tchernyshyov, Irina; Semenza, Gregg L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">177-185</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of glycolytic genes by HIF-1 is considered crit. for metabolic adaptation to hypoxia through increased conversion of glucose to pyruvate and subsequently to lactate.  We found that HIF-1 also actively suppresses metab. through the tricarboxylic acid cycle (TCA) by directly trans-activating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 inactivates the TCA cycle enzyme, pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA.  Forced PDK1 expression in hypoxic HIF-1α null cells increases ATP levels, attenuates hypoxic ROS generation, and rescues these cells from hypoxia-induced apoptosis.  These studies reveal a hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP prodn. and to prevent toxic ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkmBOJaCXUx7Vg90H21EOLACvtfcHk0lghx3n02W5Lew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtrw%253D&md5=783b85071f8a48f5262ba9522d1715b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DTchernyshyov%26aufirst%3DI.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DHIF-1-mediated%2520expression%2520of%2520pyruvate%2520dehydrogenase%2520kinase%253A%2520a%2520metabolic%2520switch%2520required%2520for%2520cellular%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D177%26epage%3D185%26doi%3D10.1016%2Fj.cmet.2006.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Papandreou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denko, N. C.</span><span> </span><span class="NLM_article-title">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.cmet.2006.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=16517406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=187-197&author=I.+Papandreouauthor=R.+A.+Cairnsauthor=L.+Fontanaauthor=A.+L.+Limauthor=N.+C.+Denko&title=HIF-1+mediates+adaptation+to+hypoxia+by+actively+downregulating+mitochondrial+oxygen+consumption&doi=10.1016%2Fj.cmet.2006.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</span></div><div class="casAuthors">Papandreou, Ioanna; Cairns, Rob A.; Fontana, Lucrezia; Lim, Ai Lin; Denko, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-197</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF-1 transcription factor drives hypoxic gene expression changes that are thought to be adaptive for cells exposed to a reduced-oxygen environment.  For example, HIF-1 induces the expression of glycolytic genes.  It is presumed that increased glycolysis is necessary to produce energy when low oxygen will not support oxidative phosphorylation at the mitochondria.  However, we find that while HIF-1 stimulates glycolysis, it also actively represses mitochondrial function and oxygen consumption by inducing pyruvate dehydrogenase kinase 1 (PDK1).  PDK1 phosphorylates and inhibits pyruvate dehydrogenase from using pyruvate to fuel the mitochondrial TCA cycle.  This causes a drop in mitochondrial oxygen consumption and results in a relative increase in intracellular oxygen tension.  We show by genetic means that HIF-1-dependent block to oxygen utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death in response to the hypoxic cytotoxin tirapazamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIkKC5qqbwLVg90H21EOLACvtfcHk0lghx3n02W5Lew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr0%253D&md5=1e6d9a6dcf39366211043e1f37cd9716</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DI.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DFontana%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DA.%2BL.%26aulast%3DDenko%26aufirst%3DN.%2BC.%26atitle%3DHIF-1%2520mediates%2520adaptation%2520to%2520hypoxia%2520by%2520actively%2520downregulating%2520mitochondrial%2520oxygen%2520consumption%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.cmet.2006.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kaplon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaneton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selivanov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Burg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdegaal, E. M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottlieb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeper, D. S.</span><span> </span><span class="NLM_article-title">A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1038/nature12154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnature12154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2013&pages=109-112&author=J.+Kaplonauthor=L.+Zhengauthor=K.+Meisslauthor=B.+Chanetonauthor=V.+A.+Selivanovauthor=G.+Mackayauthor=S.+H.+van+der+Burgauthor=E.+M.+E.+Verdegaalauthor=M.+Cascanteauthor=T.+Shlomiauthor=E.+Gottliebauthor=D.+S.+Peeper&title=A+key+role+for+mitochondrial+gatekeeper+pyruvate+dehydrogenase+in+oncogene-induced+senescence&doi=10.1038%2Fnature12154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature12154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12154%26sid%3Dliteratum%253Aachs%26aulast%3DKaplon%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMeissl%26aufirst%3DK.%26aulast%3DChaneton%26aufirst%3DB.%26aulast%3DSelivanov%26aufirst%3DV.%2BA.%26aulast%3DMackay%26aufirst%3DG.%26aulast%3Dvan%2Bder%2BBurg%26aufirst%3DS.%2BH.%26aulast%3DVerdegaal%26aufirst%3DE.%2BM.%2BE.%26aulast%3DCascante%26aufirst%3DM.%26aulast%3DShlomi%26aufirst%3DT.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DPeeper%26aufirst%3DD.%2BS.%26atitle%3DA%2520key%2520role%2520for%2520mitochondrial%2520gatekeeper%2520pyruvate%2520dehydrogenase%2520in%2520oncogene-induced%2520senescence%26jtitle%3DNature%26date%3D2013%26volume%3D498%26spage%3D109%26epage%3D112%26doi%3D10.1038%2Fnature12154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Pate, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stringari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprowl-Tanio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TeSlaa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoverter, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuade, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. L.</span><span> </span><span class="NLM_article-title">Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1454</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span><span class="refDoi"> DOI: 10.15252/embj.201488598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.15252%2Fembj.201488598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24825347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=1454-1473&author=K.+T.+Pateauthor=C.+Stringariauthor=S.+Sprowl-Tanioauthor=K.+Wangauthor=T.+TeSlaaauthor=N.+P.+Hoverterauthor=M.+M.+McQuadeauthor=C.+Garnerauthor=M.+A.+Digmanauthor=M.+A.+Teitellauthor=R.+A.+Edwardsauthor=E.+Grattonauthor=M.+L.+Waterman&title=Wnt+signaling+directs+a+metabolic+program+of+glycolysis+and+angiogenesis+in+colon+cancer&doi=10.15252%2Fembj.201488598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer</span></div><div class="casAuthors">Pate, Kira T.; Stringari, Chiara; Sprowl-Tanio, Stephanie; Wang, Kehui; TeSlaa, Tara; Hoverter, Nate P.; McQuade, Miriam M.; Garner, Chad; Digman, Michelle A.; Teitell, Michael A.; Edwards, Robert A.; Gratton, Enrico; Waterman, Marian L.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1454-1473</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Much of the mechanism by which Wnt signaling drives proliferation during oncogenesis is attributed to its regulation of the cell cycle.  Here, we show how Wnt/β-catenin signaling directs another hallmark of tumorigenesis, namely Warburg metab.  Using biochem. assays and fluorescence lifetime imaging microscopy (FLIM) to probe metab. in vitro and in living tumors, we observe that interference with Wnt signaling in colon cancer cells reduces glycolytic metab. and results in small, poorly perfused tumors.  We identify pyruvate dehydrogenase kinase 1 (PDK1) as an important direct target within a larger gene program for metab.  PDK1 inhibits pyruvate flux to mitochondrial respiration and a rescue of its expression in Wnt-inhibited cancer cells rescues glycolysis as well as vessel growth in the tumor microenvironment.  Thus, we identify an important mechanism by which Wnt-driven Warburg metab. directs the use of glucose for cancer cell proliferation and links it to vessel delivery of oxygen and nutrients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKyVhMDd5z8rVg90H21EOLACvtfcHk0liGORk2fxTHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWrtLzF&md5=cf588b1ec7223933110102c34318bf0b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.15252%2Fembj.201488598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201488598%26sid%3Dliteratum%253Aachs%26aulast%3DPate%26aufirst%3DK.%2BT.%26aulast%3DStringari%26aufirst%3DC.%26aulast%3DSprowl-Tanio%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DTeSlaa%26aufirst%3DT.%26aulast%3DHoverter%26aufirst%3DN.%2BP.%26aulast%3DMcQuade%26aufirst%3DM.%2BM.%26aulast%3DGarner%26aufirst%3DC.%26aulast%3DDigman%26aufirst%3DM.%2BA.%26aulast%3DTeitell%26aufirst%3DM.%2BA.%26aulast%3DEdwards%26aufirst%3DR.%2BA.%26aulast%3DGratton%26aufirst%3DE.%26aulast%3DWaterman%26aufirst%3DM.%2BL.%26atitle%3DWnt%2520signaling%2520directs%2520a%2520metabolic%2520program%2520of%2520glycolysis%2520and%2520angiogenesis%2520in%2520colon%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D1454%26epage%3D1473%26doi%3D10.15252%2Fembj.201488598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hitosugi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lythgoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakiewicz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span> </span><span class="NLM_article-title">Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1016/j.molcel.2011.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.molcel.2011.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=22195962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=864-877&author=T.+Hitosugiauthor=J.+Fanauthor=T.+W.+Chungauthor=K.+Lythgoeauthor=X.+Wangauthor=J.+Xieauthor=Q.+Geauthor=T.+L.+Guauthor=R.+D.+Polakiewiczauthor=J.+L.+Roeselauthor=G.+Z.+Chenauthor=T.+J.+Boggonauthor=S.+Lonialauthor=H.+Fuauthor=F.+R.+Khuriauthor=S.+Kangauthor=J.+Chen&title=Tyrosine+phosphorylation+of+mitochondrial+pyruvate+dehydrogenase+kinase+1+is+important+for+cancer+metabolism&doi=10.1016%2Fj.molcel.2011.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism</span></div><div class="casAuthors">Hitosugi, Taro; Fan, Jun; Chung, Tae-Wook; Lythgoe, Katherine; Wang, Xu; Xie, Jianxin; Ge, Qingyuan; Gu, Ting-Lei; Polakiewicz, Roberto D.; Roesel, Johannes L.; Chen, Georgia Z.; Boggon, Titus J.; Lonial, Sagar; Fu, Haian; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">864-877</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Many tumor cells rely on aerobic glycolysis instead of oxidative phosphorylation for their continued proliferation and survival.  Myc and HIF-1 are believed to promote such a metabolic switch by, in part, upregulating gene expression of pyruvate dehydrogenase (PDH) kinase 1 (PDHK1), which phosphorylates and inactivates mitochondrial PDH and consequently pyruvate dehydrogenase complex (PDC).  Here we report that tyrosine phosphorylation enhances PDHK1 kinase activity by promoting ATP and PDC binding.  Functional PDC can form in mitochondria outside of the matrix in some cancer cells and PDHK1 is commonly tyrosine phosphorylated in human cancers by diverse oncogenic tyrosine kinases localized to different mitochondrial compartments.  Expression of phosphorylation-deficient, catalytic hypomorph PDHK1 mutants in cancer cells leads to decreased cell proliferation under hypoxia and increased oxidative phosphorylation with enhanced mitochondrial utilization of pyruvate and reduced tumor growth in xenograft nude mice.  Together, tyrosine phosphorylation activates PDHK1 to promote the Warburg effect and tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt7BASuMHOGLVg90H21EOLACvtfcHk0liGORk2fxTHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OqsL7L&md5=d022eae26590b3fed9009260a692d67c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2011.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2011.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DHitosugi%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DLythgoe%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DT.%2BL.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DRoesel%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DG.%2BZ.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLonial%26aufirst%3DS.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTyrosine%2520phosphorylation%2520of%2520mitochondrial%2520pyruvate%2520dehydrogenase%2520kinase%25201%2520is%2520important%2520for%2520cancer%2520metabolism%26jtitle%3DMol.%2520Cell%26date%3D2011%26volume%3D44%26spage%3D864%26epage%3D877%26doi%3D10.1016%2Fj.molcel.2011.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kamarajugadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemboroski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span> </span><span class="NLM_article-title">Glucose oxidation modulates anoikis and tumor metastasis</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1907</span><span class="refDoi"> DOI: 10.1128/MCB.06248-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1128%2FMCB.06248-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=22431524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmsl2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1893-1907&author=S.+Kamarajugaddaauthor=L.+Stemboroskiauthor=Q.+Caiauthor=N.+E.+Simpsonauthor=S.+Nayakauthor=M.+Tanauthor=J.+Lu&title=Glucose+oxidation+modulates+anoikis+and+tumor+metastasis&doi=10.1128%2FMCB.06248-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose oxidation modulates anoikis and tumor metastasis</span></div><div class="casAuthors">Kamarajugadda, Sushama; Stemboroski, Lauren; Cai, Qingsong; Simpson, Nicholas E.; Nayak, Sushrusha; Tan, Ming; Lu, Jianrong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1893-1907</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cancer cells exhibit altered glucose metab. characterized by a preference for aerobic glycolysis or the Warburg effect, and the cells resist matrix detachment-induced apoptosis, which is called anoikis, a barrier to metastasis.  It remains largely unclear whether tumor metab. influences anoikis and metastasis.  Here we show that when detached from the matrix, untransformed mammary epithelial cells undergo metabolic reprogramming by markedly upregulating pyruvate dehydrogenase (PDH) kinase 4 (PDK4) through estrogen-related receptor γ (ERRγ), thereby inhibiting PDH and attenuating the flux of glycolytic C into mitochondrial oxidn.  To decipher the significance of this metabolic response, we found that depletion of PDK4 or activation of PDH increased mitochondrial respiration and oxidative stress in suspended cells, resulting in heightened anoikis.  Conversely, overexpression of PDKs prolonged survival of cells in suspension.  Therefore, decreased glucose oxidn. following cell detachment confers anoikis resistance.  Unlike untransformed cells, most cancer cells demonstrate reduced glucose oxidn. even under attached conditions, and thus they inherently possess a survival advantage when suspended.  Normalization of glucose metab. by stimulating PDH in cancer cells restores their susceptibility to anoikis and impairs their metastatic potential.  These results suggest that the Warburg effect, more specifically, diminished glucose oxidn., promotes anoikis resistance and metastasis and that PDKs are potential targets for antimetastasis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpFxw6qsEULrVg90H21EOLACvtfcHk0lheiJja2dca6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmsl2juro%253D&md5=1de2802defdabbdabe06209ccf1d61bb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FMCB.06248-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.06248-11%26sid%3Dliteratum%253Aachs%26aulast%3DKamarajugadda%26aufirst%3DS.%26aulast%3DStemboroski%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSimpson%26aufirst%3DN.%2BE.%26aulast%3DNayak%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DGlucose%2520oxidation%2520modulates%2520anoikis%2520and%2520tumor%2520metastasis%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D1893%26epage%3D1907%26doi%3D10.1128%2FMCB.06248-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9832</span><span class="NLM_x">–</span> <span class="NLM_lpage">9843</span><span class="refDoi"> DOI: 10.1021/jm5010144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9832-9843&author=T.+Mengauthor=D.+Zhangauthor=Z.+Xieauthor=T.+Yuauthor=S.+Wuauthor=L.+Wyderauthor=U.+Regenassauthor=K.+Hilpertauthor=M.+Huangauthor=M.+Gengauthor=J.+Shen&title=Discovery+and+optimization+of+4%2C5-diarylisoxazoles+as+potent+dual+inhibitors+of+pyruvate+dehydrogenase+kinase+and+heat+shock+protein+90&doi=10.1021%2Fjm5010144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of 4,5-diarylisoxazoles as potent dual inhibitors of pyruvate dehydrogenase kinase and heat shock protein 90</span></div><div class="casAuthors">Meng, Tao; Zhang, Dadong; Xie, Zuoquan; Yu, Ting; Wu, Shuchao; Regenass, Urs; Hilpert, Kurt; Huang, Min; Geng, Meiyu; Shen, Jingkang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9832-9843</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Upregulation of pyruvate dehydrogenase kinase (PDHK) has been obsd. in a variety of cancers.  Inhibition of PDHK offers an attractive opportunity for the development of novel cancer therapies.  To obtain novel PDHK inhibitors, the authors took advantage of the homol. of the ATP-binding pocket between Heat Shock Protein 90 (HSP90) and PDHK, and utilized 4,5-diarylisoxazole based HSP90 inhibitor for structural design.  The efforts led to the identification of I that inhibited PDHK1 with an IC50 value of 17 nM, which, however, showed marginal cellular activity.  Further structural optimization resulted in compd. II with improved cellular activity which could effectively modulate the metabolic profile of cancer cells and lead to the inhibition of cancer cell proliferation, evidenced by the increased oxidative phosphorylation and decreased glycolysis and assocd. oxidative stress.  The results suggested II as an excellent lead compd. and a favorable biol. tool to further evaluate the therapeutic potential of PDHK and HSP90 dual inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpX1cvlKuuz7Vg90H21EOLACvtfcHk0lheiJja2dca6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrurnK&md5=ab2f08b46344868b81247a228b149755</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5010144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010144%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWyder%26aufirst%3DL.%26aulast%3DRegenass%26aufirst%3DU.%26aulast%3DHilpert%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25204%252C5-diarylisoxazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520and%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9832%26epage%3D9843%26doi%3D10.1021%2Fjm5010144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, M.</span><span> </span><span class="NLM_article-title">JX06 selectively inhibits pyruvate dehydrogenase kinase PDK1 by a covalent cysteine modification</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">4923</span><span class="NLM_x">–</span> <span class="NLM_lpage">4936</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-1023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1158%2F0008-5472.CAN-15-1023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=4923-4936&author=W.+Sunauthor=Z.+Xieauthor=Y.+Liuauthor=D.+Zhaoauthor=Z.+Wuauthor=D.+Zhangauthor=H.+Lvauthor=S.+Tangauthor=N.+Jinauthor=H.+Jiangauthor=M.+Tanauthor=J.+Dingauthor=C.+Luoauthor=J.+Liauthor=M.+Huangauthor=M.+Geng&title=JX06+selectively+inhibits+pyruvate+dehydrogenase+kinase+PDK1+by+a+covalent+cysteine+modification&doi=10.1158%2F0008-5472.CAN-15-1023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-1023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-1023%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DM.%26atitle%3DJX06%2520selectively%2520inhibits%2520pyruvate%2520dehydrogenase%2520kinase%2520PDK1%2520by%2520a%2520covalent%2520cysteine%2520modification%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D4923%26epage%3D4936%26doi%3D10.1158%2F0008-5472.CAN-15-1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kankotia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span> </span><span class="NLM_article-title">Dichloroacetate and cancer: new home for an orphan drug?</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1846</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2014.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.bbcan.2014.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=25157892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKntLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=617-629&author=S.+Kankotiaauthor=P.+W.+Stacpoole&title=Dichloroacetate+and+cancer%3A+new+home+for+an+orphan+drug%3F&doi=10.1016%2Fj.bbcan.2014.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate and cancer: New home for an orphan drug?</span></div><div class="casAuthors">Kankotia, Shyam; Stacpoole, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  We reviewed the anti-cancer effects of DCA, an orphan drug long used as an investigational treatment for various acquired and congenital disorders of mitochondrial intermediary metab.  Inhibition by DCA of mitochondrial pyruvate dehydrogenase kinases and subsequent reactivation of the pyruvate dehydrogenase complex and oxidative phosphorylation is the common mechanism accounting for the drug's anti-neoplastic effects.  At least two fundamental changes in tumor metab. are induced by DCA that antagonize tumor growth, metastases and survival: the first is the redirection of glucose metab. from glycolysis to oxidn. (reversal of the Warburg effect), leading to inhibition of proliferation and induction of caspase-mediated apoptosis.  These effects have been replicated in both human cancer cell lines and in tumor implants of diverse germ line origin.  The second fundamental change is the oxidative removal of lactate, via pyruvate, and the co-incident buffering of hydrogen ions by dehydrogenases located in the mitochondrial matrix.  Preclin. studies demonstrate that DCA has additive or synergistic effects when used in combination with std. agents designed to modify tumor oxidative stress, vascular remodeling, DNA integrity or immunity.  These findings and limited clin. results suggest that potentially fruitful areas for addnl. clin. trials include 1) adult and pediatric high grade astrocytomas; 2) BRAF-mutant cancers, such as melanoma, perhaps combined with other pro-oxidants; 3) tumors in which resistance to std. platinum-class drugs alone may be overcome with combination therapy; and 4) tumors of endodermal origin, in which extensive exptl. research has demonstrated significant anti-proliferative, pro-apoptotic effects of DCA, leading to improved host survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCeCvyY6yPTLVg90H21EOLACvtfcHk0lheiJja2dca6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKntLfE&md5=10775e6b8162c6ec11b1b28d98175deb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DKankotia%26aufirst%3DS.%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26atitle%3DDichloroacetate%2520and%2520cancer%253A%2520new%2520home%2520for%2520an%2520orphan%2520drug%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26spage%3D617%26epage%3D629%26doi%3D10.1016%2Fj.bbcan.2014.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stacpoole, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">kurtz, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langaee, T.</span><span> </span><span class="NLM_article-title">Role of dichloroacetate in the treatment of genetic mitochondrial diseases</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span><span class="refDoi"> DOI: 10.1016/j.addr.2008.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.addr.2008.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1478-1487&author=P.+W.+Stacpooleauthor=T.+L.+kurtzauthor=Z.+Hanauthor=T.+Langaee&title=Role+of+dichloroacetate+in+the+treatment+of+genetic+mitochondrial+diseases&doi=10.1016%2Fj.addr.2008.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3Dkurtz%26aufirst%3DT.%2BL.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DLangaee%26aufirst%3DT.%26atitle%3DRole%2520of%2520dichloroacetate%2520in%2520the%2520treatment%2520of%2520genetic%2520mitochondrial%2520diseases%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1478%26epage%3D1487%26doi%3D10.1016%2Fj.addr.2008.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pathak, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrache, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harn, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1187</span><span class="refDoi"> DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0lj2WwD-xxwprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippard, S. J.</span><span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">22199</span><span class="NLM_x">–</span> <span class="NLM_lpage">22204</span><span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lj2WwD-xxwprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisato, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celeghini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantinati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secchiero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zauli, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=147-156&author=C.+Trapellaauthor=R.+Voltanauthor=E.+Melloniauthor=V.+Tisatoauthor=C.+Celeghiniauthor=S.+Biancoauthor=A.+Fantinatiauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Secchieroauthor=G.+Zauli&title=Design%2C+synthesis%2C+and+biological+characterization+of+novel+mitochondria+targeted+dichloroacetate-loaded+compounds+with+antileukemic+activity&doi=10.1021%2Facs.jmedchem.5b01165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01165%26sid%3Dliteratum%253Aachs%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DVoltan%26aufirst%3DR.%26aulast%3DMelloni%26aufirst%3DE.%26aulast%3DTisato%26aufirst%3DV.%26aulast%3DCeleghini%26aufirst%3DC.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSecchiero%26aufirst%3DP.%26aulast%3DZauli%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520novel%2520mitochondria%2520targeted%2520dichloroacetate-loaded%2520compounds%2520with%2520antileukemic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D147%26epage%3D156%26doi%3D10.1021%2Facs.jmedchem.5b01165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Aicher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knorr, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperbeck, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strohschein, R.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinluan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shetty, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelGrande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozito, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, W. R.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2741</span><span class="NLM_x">–</span> <span class="NLM_lpage">2746</span><span class="refDoi"> DOI: 10.1021/jm9902584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2741-2746&author=T.+D.+Aicherauthor=R.+C.+Andersonauthor=G.+R.+Bebernitzauthor=G.+M.+Coppolaauthor=C.+F.+Jewellauthor=D.+C.+Knorrauthor=C.+Liuauthor=D.+M.+Sperbeckauthor=L.+J.+Brandauthor=R.J.+Strohscheinauthor=J.+Gaoauthor=C.+C.+Vinluanauthor=S.+S.+Shettyauthor=C.+Draglandauthor=E.+L.+Kaplanauthor=D.+DelGrandeauthor=A.+Islamauthor=X.+Liuauthor=R.+J.+Lozitoauthor=W.+M.+Maniaraauthor=R.+E.+Walterauthor=W.+R.+Mann&title=%28R%29-3%2C3%2C3-Trifluoro-2-hydroxy-2-methylpropionamides+are+orally+active+inhibitors+of+pyruvate+dehydrogenase+kinase&doi=10.1021%2Fjm9902584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9902584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902584%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DAnderson%26aufirst%3DR.%2BC.%26aulast%3DBebernitz%26aufirst%3DG.%2BR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DJewell%26aufirst%3DC.%2BF.%26aulast%3DKnorr%26aufirst%3DD.%2BC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DSperbeck%26aufirst%3DD.%2BM.%26aulast%3DBrand%26aufirst%3DL.%2BJ.%26aulast%3DStrohschein%26aufirst%3DR.J.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DVinluan%26aufirst%3DC.%2BC.%26aulast%3DShetty%26aufirst%3DS.%2BS.%26aulast%3DDragland%26aufirst%3DC.%26aulast%3DKaplan%26aufirst%3DE.%2BL.%26aulast%3DDelGrande%26aufirst%3DD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLozito%26aufirst%3DR.%2BJ.%26aulast%3DManiara%26aufirst%3DW.%2BM.%26aulast%3DWalter%26aufirst%3DR.%2BE.%26aulast%3DMann%26aufirst%3DW.%2BR.%26atitle%3D%2528R%2529-3%252C3%252C3-Trifluoro-2-hydroxy-2-methylpropionamides%2520are%2520orally%2520active%2520inhibitors%2520of%2520pyruvate%2520dehydrogenase%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2741%26epage%3D2746%26doi%3D10.1021%2Fjm9902584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mayers, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myatt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orme, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, B. R.</span><span> </span><span class="NLM_article-title">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span><span class="refDoi"> DOI: 10.1042/bst0311165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1042%2Fbst0311165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=14641018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1165-1167&author=R.+M.+Mayersauthor=R.+J.+Butlinauthor=E.+Kilgourauthor=B.+Leightonauthor=D.+Martinauthor=J.+Myattauthor=J.+P.+Ormeauthor=B.+R.+Holloway&title=AZD7545%2C+a+novel+inhibitor+of+pyruvate+dehydrogenase+kinase+2+%28PDHK2%29%2C+activates+pyruvate+dehydrogenase+in+vivo+and+improves+blood+glucose+control+in+obese+%28fa%2Ffa%29+Zucker+rats&doi=10.1042%2Fbst0311165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7545, a novel inhibitor of pyruvate dehydrogenase kinase 2 (PDHK2), activates pyruvate dehydrogenase in vivo and improves blood glucose control in obese (fa/fa) Zucker rats</span></div><div class="casAuthors">Mayers, R. M.; Butlin, R. J.; Kilgour, E.; Leighton, B.; Martin, D.; Myatt, J.; Orme, J. P.; Holloway, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1165-1167</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">PDH (pyruvate dehydrogenase) is a key enzyme controlling the rate of glucose oxidn., and the availability of gluconeogenic precursors.  Activation of PDH in skeletal muscle and liver may increase glucose uptake and reduce glucose prodn.  This study describes the properties of AZD7545, a novel, small-mol. inhibitor of PDHK (PDH kinase).  In the presence of PDHK2, AZD7545 increased PDH activity with an EC50 value of 5.2 nM.  In rat hepatocytes, the rate of pyruvate oxidn. was stimulated 2-fold (EC50 105 nM).  A single dose of AZD7545 to Wistar rats increased the proportion of liver PDH in its active, dephosphorylated form in a dose-related manner from 24.7 to 70.3% at 30 mg/kg; and in skeletal muscle from 21.1 to 53.3%.  A single dose of 10 mg/kg also significantly elevated muscle PDH activity in obese Zucker (fa / fa) rats.  Obese, insulin-resistant, Zucker rats show elevated postprandial glucose levels compared with their lean counterparts (8.7 vs. 6.1 mM at 12 wk old).  AZD7545 (10 mg/kg) twice daily for 7 days markedly improved the 24-h glucose profile, by eliminating the postprandial elevation in blood glucose.  These results suggest that PDHK inhibitors may be beneficial agents for improving glucose control in the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg3Q4M5QmmjLVg90H21EOLACvtfcHk0lgB0yzz5jE0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsr4%253D&md5=409b3a21f3cd550e2c04311446e5d0a0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2Fbst0311165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311165%26sid%3Dliteratum%253Aachs%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DLeighton%26aufirst%3DB.%26aulast%3DMartin%26aufirst%3DD.%26aulast%3DMyatt%26aufirst%3DJ.%26aulast%3DOrme%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DB.%2BR.%26atitle%3DAZD7545%252C%2520a%2520novel%2520inhibitor%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520%2528PDHK2%2529%252C%2520activates%2520pyruvate%2520dehydrogenase%2520in%2520vivo%2520and%2520improves%2520blood%2520glucose%2520control%2520in%2520obese%2520%2528fa%252Ffa%2529%2520Zucker%2520rats%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1165%26epage%3D1167%26doi%3D10.1042%2Fbst0311165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zachar, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marecek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maturo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schauble, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piramzadian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, P. M.</span><span> </span><span class="NLM_article-title">Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1007/s00109-011-0785-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1007%2Fs00109-011-0785-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21769686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=1137-1148&author=Z.+Zacharauthor=J.+Marecekauthor=C.+Maturoauthor=S.+Guptaauthor=S.+D.+Stuartauthor=K.+Howellauthor=A.+Schaubleauthor=J.+Lemauthor=A.+Piramzadianauthor=S.+Karnikauthor=K.+Leeauthor=R.+Rodriguezauthor=R.+Shorrauthor=P.+M.+Bingham&title=Non-redox-active+lipoate+derivates+disrupt+cancer+cell+mitochondrial+metabolism+and+are+potent+anticancer+agents+in+vivo&doi=10.1007%2Fs00109-011-0785-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo</span></div><div class="casAuthors">Zachar, Zuzana; Marecek, James; Maturo, Claudia; Gupta, Sunita; Stuart, Shawn D.; Howell, Katy; Schauble, Alexandra; Lem, Joanna; Piramzadian, Arin; Karnik, Sameer; Lee, King; Rodriguez, Robert; Shorr, Robert; Bingham, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We report the anal. of CPI-613, the first member of a large set of analogs of lipoic acid (lipoate) we have investigated as potential anticancer agents.  CPI-613 strongly disrupts mitochondrial metab., with selectivity for tumor cells in culture.  This mitochondrial disruption includes activation of the well-characterized, lipoate-responsive regulatory phosphorylation of the E1α pyruvate dehydrogenase (PDH) subunit.  This phosphorylation inactivates flux of glycolysis-derived carbon through this enzyme complex and implicates the PDH regulatory kinases (PDKs) as a possible drug target.  Supporting this hypothesis, RNAi knockdown of the PDK protein levels substantially attenuates CPI-613 cancer cell killing.  In both cell culture and in vivo tumor environments, the obsd. strong mitochondrial metabolic disruption is expected to significantly compromise cell survival.  Consistent with this prediction, CPI-613 disruption of tumor mitochondrial metab. is followed by efficient commitment to cell death by multiple, apparently redundant pathways, including apoptosis, in all tested cancer cell lines.  Further, CPI-613 shows strong antitumor activity in vivo against human non-small cell lung and pancreatic cancers in xenograft models with low side-effect toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVGb-6-HcuD7Vg90H21EOLACvtfcHk0lgB0yzz5jE0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrtLnN&md5=cf5cc13477d8f8d5225a5e97c5870f8a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00109-011-0785-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-011-0785-8%26sid%3Dliteratum%253Aachs%26aulast%3DZachar%26aufirst%3DZ.%26aulast%3DMarecek%26aufirst%3DJ.%26aulast%3DMaturo%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DStuart%26aufirst%3DS.%2BD.%26aulast%3DHowell%26aufirst%3DK.%26aulast%3DSchauble%26aufirst%3DA.%26aulast%3DLem%26aufirst%3DJ.%26aulast%3DPiramzadian%26aufirst%3DA.%26aulast%3DKarnik%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DRodriguez%26aufirst%3DR.%26aulast%3DShorr%26aufirst%3DR.%26aulast%3DBingham%26aufirst%3DP.%2BM.%26atitle%3DNon-redox-active%2520lipoate%2520derivates%2520disrupt%2520cancer%2520cell%2520mitochondrial%2520metabolism%2520and%2520are%2520potent%2520anticancer%2520agents%2520in%2520vivo%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2011%26volume%3D89%26spage%3D1137%26epage%3D1148%26doi%3D10.1007%2Fs00109-011-0785-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kukimoto-Niino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokmakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiromizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsusue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span> </span><span class="NLM_article-title">Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1107/S090744491102405X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1107%2FS090744491102405X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=763-773&author=M.+Kukimoto-Niinoauthor=A.+Tokmakovauthor=T.+Teradaauthor=N.+Ohbayashiauthor=T.+Fujimotoauthor=S.+Gomiauthor=I.+Shiromizuauthor=M.+Kawamotoauthor=T.+Matsusueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Inhibitor-bound+structures+of+human+pyruvate+dehydrogenase+kinase+4&doi=10.1107%2FS090744491102405X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS090744491102405X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491102405X%26sid%3Dliteratum%253Aachs%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DTokmakov%26aufirst%3DA.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DGomi%26aufirst%3DS.%26aulast%3DShiromizu%26aufirst%3DI.%26aulast%3DKawamoto%26aufirst%3DM.%26aulast%3DMatsusue%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DInhibitor-bound%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25204%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D763%26epage%3D773%26doi%3D10.1107%2FS090744491102405X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernstedt-Asterholm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlock, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambar, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span><span class="refDoi"> DOI: 10.1074/jbc.M113.533885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1074%2Fjbc.M113.533885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24356970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4432-4443&author=S.+C.+Tsoauthor=X.+Qiauthor=W.+J.+Guiauthor=C.+Y.+Wuauthor=J.+L.+Chuangauthor=I.+Wernstedt-Asterholmauthor=L.+K.+Morlockauthor=K.+R.+Owensauthor=P.+E.+Schererauthor=N.+S.+Williamsauthor=U.+K.+Tambarauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Structure-guided+development+of+specific+pyruvate+dehydrogenase+kinase+inhibitors+targeting+the+ATP-binding+pocket&doi=10.1074%2Fjbc.M113.533885"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket</span></div><div class="casAuthors">Tso, Shih-Chia; Qi, Xiangbing; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Wernstedt-Asterholm, Ingrid; Morlock, Lorraine K.; Owens, Kyle R.; Scherer, Philipp E.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4432-4443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase isoforms (PDKs 1-4) neg. regulate activity of the mitochondrial pyruvate dehydrogenase complex by reversible phosphorylation.  PDK isoforms are up-regulated in obesity, diabetes, heart failure, and cancer and are potential therapeutic targets for these important human diseases.  Here, the authors employed a structure-guided design to convert a known Hsp90 inhibitor to a series of highly specific PDK inhibitors, based on structural conservation in the ATP-binding pocket.  The key step involved the substitution of a carbonyl group in the parent compd. with a sulfonyl in the PDK inhibitors.  The final compd. of this series, 2-[(2,4-dihydroxyphenyl)sulfonyl]isoindoline-4,6-diol, designated PS10, inhibits all four PDK isoforms with IC50 = 0.8 μm for PDK2.  The administration of PS10 (70 mg/kg) to diet-induced obese mice significantly augments pyruvate dehydrogenase complex activity with reduced phosphorylation in different tissues.  Prolonged PS10 treatments result in improved glucose tolerance and notably lessened hepatic steatosis in the mouse model.  The results support the pharmacol. approach of targeting PDK to control both glucose and fat levels in obesity and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEmYMKZrXKTrVg90H21EOLACvtfcHk0lgB0yzz5jE0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFSgs7w%253D&md5=e3bd48326cc1ab39c76f7bd19734a361</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.533885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.533885%26sid%3Dliteratum%253Aachs%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DGui%26aufirst%3DW.%2BJ.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DWernstedt-Asterholm%26aufirst%3DI.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DOwens%26aufirst%3DK.%2BR.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DStructure-guided%2520development%2520of%2520specific%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520targeting%2520the%2520ATP-binding%2520pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4432%26epage%3D4443%26doi%3D10.1074%2Fjbc.M113.533885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ramadas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janarthanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritha, N.</span><span> </span><span class="NLM_article-title">A comparative study of oxidants on thiols</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1080/00304949609356543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1080%2F00304949609356543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaK28Xjt1Gjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1996&pages=352-355&author=K.+Ramadasauthor=N.+Srinivasanauthor=N.+Janarthananauthor=N.+Pritha&title=A+comparative+study+of+oxidants+on+thiols&doi=10.1080%2F00304949609356543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of oxidants on thiols</span></div><div class="casAuthors">Ramadas, K.; Srinivasan, N.; Janarthanan, N.; Pritha, R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-355</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">Oxidn. of thiols to disulfides with thionyl chloride, ceric ammonium nitrate, ferric chloride, sodium metaperiodate, ammonium persulfate, chlorine, sodium nitrite, hydrogen peroxide, or sodium chlorite were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj3YsiF8CPtLVg90H21EOLACvtfcHk0lhVLVEVhjxnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjt1Gjur0%253D&md5=28b1fdf03c94f29feb0281fdc39997f6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00304949609356543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304949609356543%26sid%3Dliteratum%253Aachs%26aulast%3DRamadas%26aufirst%3DK.%26aulast%3DSrinivasan%26aufirst%3DN.%26aulast%3DJanarthanan%26aufirst%3DN.%26aulast%3DPritha%26aufirst%3DN.%26atitle%3DA%2520comparative%2520study%2520of%2520oxidants%2520on%2520thiols%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D1996%26volume%3D28%26spage%3D352%26epage%3D355%26doi%3D10.1080%2F00304949609356543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Neelakantan, L.</span><span> </span><span class="NLM_article-title">Disulfides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">938</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1021/jo01100a630</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01100a630" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaG1MXms12h" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1958&pages=938-939&author=L.+Neelakantan&title=Disulfides&doi=10.1021%2Fjo01100a630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfides</span></div><div class="casAuthors">Neelakantan, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">938-9</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Some disulfides were prepd. as possible potential antimalarials, since they may be active in oxidizing some of the SH groups essential to the parasite.  The potency of thiuram disulfides as bacterial poisons led to the prepn. of some analogous disulfides.  Various amines were treated with CS2 and aq. KOH and the thiocarbamido deriv. oxidized with NaNO2, MeOH, and HCl.  ο-, m-, p-H2NC6H4CO2H, and the 3 aminobenzenesulfonic acids were thus treated to give the corresponding diaryl thiuram disulfides.  The dixanthogens (I) were related in structure and hence some derivs. were prepd. to see their effect on exptl. malaria.  Salicylic acid (7 g.), 4 g. CS2, 6 g. KOH, and 250 ml. H2O was heated 6 hrs., treated with 3 g. NaNO2, 3 ml. MeOH, and under strong cooling 10 ml. concd. HCl, the pptd. product collected, and crystd. from H2O.  The following I were thus prepd. (R in RC6H4OCSSSCSOC6H4R, m.p., and % yield given): H, 182-3°, 60; 2-CO2H, 154-5°, 66; 3-CO2H, 198-200°, 70; 4-CO2H, 339-40°, 60; 2-SO3H, 360° (decompn.), 48; 3-SO3H, 360° (decompn.), 56; 4-SO3H, 360° (decompn.), 40; 4-Cl, 128°, 70.  The following RC6H4NHCSSSCSNHC6H4R were similarly prepd. (R, m.p., and % yield given): H, 183° 66; 2-CO2H, 236-8°, 75; 3-CO2H, 224.5°, 57; 4-CO2H, 238-40°, 57; 2-SO3H, 360° (decompn.), 53; 3-SO3H, 360° (decompn.), 49; 4-SO3H, 360° (decompn.), 65; 4-Cl, 100°, 70.  I were quite active in inhibiting the respiration of Plasmodium gallinaceum in vitro.  However only I (R = 4-SO3H) and N,N'-diphenylthiuram disulfide-p,p'-disulfonic acid were active in vivo against P. gallinaceum in chicks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppjV_vZJyfS7Vg90H21EOLACvtfcHk0lhVLVEVhjxnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXms12h&md5=740749e1b378b83fb31b2ebfa46f7079</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01100a630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01100a630%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DL.%26atitle%3DDisulfides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1958%26volume%3D23%26spage%3D938%26epage%3D939%26doi%3D10.1021%2Fjo01100a630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Brown, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foubister, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, B.</span><span> </span><span class="NLM_article-title">Chiral synthesis of 3-substituted morpholines via serine enantiomers and reductions of 5-oxomorpholine-3-carboxylates</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">2577</span><span class="NLM_x">–</span> <span class="NLM_lpage">2580</span><span class="refDoi"> DOI: 10.1039/p19850002577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1039%2Fp19850002577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=2577-2580&author=G.+R.+Brownauthor=A.+J.+Foubisterauthor=B.+Wright&title=Chiral+synthesis+of+3-substituted+morpholines+via+serine+enantiomers+and+reductions+of+5-oxomorpholine-3-carboxylates&doi=10.1039%2Fp19850002577"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2Fp19850002577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19850002577%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BR.%26aulast%3DFoubister%26aufirst%3DA.%2BJ.%26aulast%3DWright%26aufirst%3DB.%26atitle%3DChiral%2520synthesis%2520of%25203-substituted%2520morpholines%2520via%2520serine%2520enantiomers%2520and%2520reductions%2520of%25205-oxomorpholine-3-carboxylates%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1985%26spage%3D2577%26epage%3D2580%26doi%3D10.1039%2Fp19850002577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, J.</span><span> </span><span class="NLM_article-title">Novel benzamides as selective and potent gastric prokinetic agents. 1. synthesis and structure-activity relationships of <i>N</i>-[(2-morpholinyl)alkyl]benzamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1406</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span><span class="refDoi"> DOI: 10.1021/jm00167a020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00167a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1406-1413&author=S.+Katoauthor=T.+Morieauthor=K.+Hinoauthor=T.+Konauthor=S.+Narutoauthor=N.+Yoshidaauthor=T.+Karasawaauthor=J.+Matsumoto&title=Novel+benzamides+as+selective+and+potent+gastric+prokinetic+agents.+1.+synthesis+and+structure-activity+relationships+of+N-%5B%282-morpholinyl%29alkyl%5Dbenzamides&doi=10.1021%2Fjm00167a020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00167a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00167a020%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DS.%26aulast%3DMorie%26aufirst%3DT.%26aulast%3DHino%26aufirst%3DK.%26aulast%3DKon%26aufirst%3DT.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DKarasawa%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DJ.%26atitle%3DNovel%2520benzamides%2520as%2520selective%2520and%2520potent%2520gastric%2520prokinetic%2520agents.%25201.%2520synthesis%2520and%2520structure-activity%2520relationships%2520of%2520N-%255B%25282-morpholinyl%2529alkyl%255Dbenzamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1406%26epage%3D1413%26doi%3D10.1021%2Fjm00167a020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Schwartz, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzmic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B. W.</span><span> </span><span class="NLM_article-title">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1073/pnas.1313733111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1073%2Fpnas.1313733111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=24347635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=173-178&author=P.+A.+Schwartzauthor=P.+Kuzmicauthor=J.+Solowiejauthor=S.+Bergqvistauthor=B.+Bolanosauthor=C.+Almadenauthor=A.+Nagataauthor=K.+Ryanauthor=J.+Fengauthor=D.+Dalvieauthor=J.+C.+Kathauthor=M.+Xuauthor=R.+Waniauthor=B.+W.+Murray&title=Covalent+EGFR+inhibitor+analysis+reveals+importance+of+reversible+interactions+to+potency+and+mechanisms+of+drug+resistance&doi=10.1073%2Fpnas.1313733111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance</span></div><div class="casAuthors">Schwartz, Phillip A.; Kuzmic, Petr; Solowiej, James; Bergqvist, Simon; Bolanos, Ben; Almaden, Chau; Nagata, Asako; Ryan, Kevin; Feng, Junli; Dalvie, Deepak; Kath, John C.; Xu, Meirong; Wani, Revati; Murray, Brion William</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-178</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Covalent inhibition is a reemerging paradigm in kinase drug design, but the roles of inhibitor binding affinity and chem. reactivity in overall potency are not well-understood.  To characterize the underlying mol. processes at a microscopic level and det. the appropriate kinetic consts., specialized exptl. design and advanced numerical integration of differential equations are developed.  Previously uncharacterized investigational covalent drugs reported here are shown to be extremely effective epidermal growth factor receptor (EGFR) inhibitors (kinact/Ki in the range 105-107 M-1s-1), despite their low specific reactivity (kinact ≤ 2.1 × 10-3 s-1), which is compensated for by high binding affinities (Ki < 1 nM).  For inhibitors relying on reactivity to achieve potency, noncovalent enzyme-inhibitor complex partitioning between inhibitor dissocn. and bond formation is central.  Interestingly, reversible binding affinity of EGFR covalent inhibitors is highly correlated with antitumor cell potency.  Furthermore, cellular potency for a subset of covalent inhibitors can be accounted for solely through reversible interactions.  One reversible interaction is between EGFR-Cys797 nucleophile and the inhibitor's reactive group, which may also contribute to drug resistance.  Because covalent inhibitors target a cysteine residue, the effects of its oxidn. on enzyme catalysis and inhibitor pharmacol. are characterized.  Oxidn. of the EGFR cysteine nucleophile does not alter catalysis but has widely varied effects on inhibitor potency depending on the EGFR context (e.g., oncogenic mutations), type of oxidn. (sulfinylation or glutathiolation), and inhibitor architecture.  These methods, parameters, and insights provide a rational framework for assessing and designing effective covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTpPuRq8MwCLVg90H21EOLACvtfcHk0lgzMDRpfc8Y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1eluw%253D%253D&md5=47197c5e7876a238eefb2e8e7de305ea</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1313733111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1313733111%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DKuzmic%26aufirst%3DP.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBolanos%26aufirst%3DB.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DCovalent%2520EGFR%2520inhibitor%2520analysis%2520reveals%2520importance%2520of%2520reversible%2520interactions%2520to%2520potency%2520and%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D173%26epage%3D178%26doi%3D10.1073%2Fpnas.1313733111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lgzMDRpfc8Y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1016/j.str.2007.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1016%2Fj.str.2007.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=17683942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=992-1004&author=M.+Katoauthor=J.+Liauthor=J.+L.+Chuangauthor=D.+T.+Chuang&title=Distinct+structural+mechanisms+for+inhibition+of+pyruvate+dehydrogenase+kinase+isoforms+by+AZD7545%2C+dichloroacetate%2C+and+radicicol&doi=10.1016%2Fj.str.2007.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase Kinase Isoforms by AZD7545, Dichloroacetate, and Radicicol</span></div><div class="casAuthors">Kato, Masato; Li, Jun; Chuang, Jacinta L.; Chuang, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDK) isoforms are mol. switches that downregulate the pyruvate dehydrogenase complex (PDC) by reversible phosphorylation in mitochondria.  We have detd. structures of human PDK1 or PDK3 bound to the inhibitors AZD7545, dichloroacetate (DCA), and radicicol.  We show that the trifluoromethylpropanamide end of AZD7545 projects into the lipoyl-binding pocket of PDK1.  This interaction results in inhibition of PDK1 and PDK3 activities by aborting kinase binding to the PDC scaffold.  Paradoxically, AZD7545 at satg. concns. robustly increases scaffold-free PDK3 activity, similar to the inner lipoyl domain.  Good DCA d. is present in the helix bundle in the N-terminal domain of PDK1.  Bound DCA promotes local conformational changes that are communicated to both nucleotide-binding and lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity. Finally, radicicol inhibits kinase activity by binding directly to the ATP-binding pocket of PDK3, similar to Hsp90 and Topo VI from the same ATPase/kinase superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpzfnlsNVarVg90H21EOLACvtfcHk0lgzMDRpfc8Y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFyjsbo%253D&md5=3efc7e8b434566932ef28ca3486c401a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DDistinct%2520structural%2520mechanisms%2520for%2520inhibition%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520isoforms%2520by%2520AZD7545%252C%2520dichloroacetate%252C%2520and%2520radicicol%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.str.2007.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Knoechel, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span> </span><span class="NLM_article-title">Regulatory roles of the <i>N</i>-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1021/bi051402s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi051402s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=402-415&author=T.+R.+Knoechelauthor=A.+D.+Tuckerauthor=C.+M.+Robinsonauthor=C.+Phillipsauthor=W.+Taylorauthor=P.+J.+Bungayauthor=S.+A.+Kastenauthor=T.+E.+Rocheauthor=D.+G.+Brown&title=Regulatory+roles+of+the+N-terminal+domain+based+on+crystal+structures+of+human+pyruvate+dehydrogenase+kinase+2+containing+physiological+and+synthetic+ligands&doi=10.1021%2Fbi051402s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands</span></div><div class="casAuthors">Knoechel, Thorsten R.; Tucker, Alec D.; Robinson, Colin M.; Phillips, Chris; Taylor, Wendy; Bungay, Peter J.; Kasten, Shane A.; Roche, Thomas E.; Brown, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-415</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pyruvate dehydrogenase kinase (PDHK) regulates the activity of the pyruvate dehydrogenase multienzyme complex.  PDHK inhibition provides a route for therapeutic intervention in diabetes and cardiovascular disorders.  We report crystal structures of human PDHK isoenzyme 2 (PDHK2) complexed with physiol. and synthetic ligands.  Several of the PDHK2 structures disclosed have C-terminal cross arms that span a large trough region between the N-terminal regulatory (R) domains of the PDHK2 dimers.  The structures contg. bound ATP and ADP demonstrate variation in the conformation of the active site lid, residues 316-321, which enclose the nucleotide β and γ phosphates at the active site in the C-terminal catalytic domain.  We have identified three novel ligand binding sites located in the R domain of PDHK2.  Dichloroacetate (DCA) binds at the pyruvate binding site in the center of the R domain, which together with ADP, induces significant changes at the active site.  Nov3r and AZ12 inhibitors bind at the lipoamide binding site that is located at one end of the R domain.  Pfz3 (an allosteric inhibitor) binds in an extended site at the other end of the R domain.  We conclude that the N-terminal domain of PDHK has a key regulatory function and propose that the different inhibitor classes act by discrete mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI0BAYhcMgn7Vg90H21EOLACvtfcHk0lhERzkpafcUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlajtr7L&md5=62e6162ff1191e7b5ae88014dcb71830</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi051402s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi051402s%26sid%3Dliteratum%253Aachs%26aulast%3DKnoechel%26aufirst%3DT.%2BR.%26aulast%3DTucker%26aufirst%3DA.%2BD.%26aulast%3DRobinson%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DW.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DKasten%26aufirst%3DS.%2BA.%26aulast%3DRoche%26aufirst%3DT.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26atitle%3DRegulatory%2520roles%2520of%2520the%2520N-terminal%2520domain%2520based%2520on%2520crystal%2520structures%2520of%2520human%2520pyruvate%2520dehydrogenase%2520kinase%25202%2520containing%2520physiological%2520and%2520synthetic%2520ligands%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D402%26epage%3D415%26doi%3D10.1021%2Fbi051402s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tso, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. T.</span><span> </span><span class="NLM_article-title">Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1038%2Fsj.emboj.7600663" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=1763-1774&author=M.+Katoauthor=J.+L.+Chuangauthor=S.+C.+Tsoauthor=R.+M.+Wynnauthor=D.+T.+Chuang&title=Crystal+structure+of+pyruvate+dehydrogenase+kinase+3+bound+to+lipoyl+domain+2+of+human+pyruvate+dehydrogenase+complex&doi=10.1038%2Fsj.emboj.7600663"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600663%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DM.%26aulast%3DChuang%26aufirst%3DJ.%2BL.%26aulast%3DTso%26aufirst%3DS.%2BC.%26aulast%3DWynn%26aufirst%3DR.%2BM.%26aulast%3DChuang%26aufirst%3DD.%2BT.%26atitle%3DCrystal%2520structure%2520of%2520pyruvate%2520dehydrogenase%2520kinase%25203%2520bound%2520to%2520lipoyl%2520domain%25202%2520of%2520human%2520pyruvate%2520dehydrogenase%2520complex%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26spage%3D1763%26epage%3D1774%26doi%3D10.1038%2Fsj.emboj.7600663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+an+empirical+binding+free+energy+function&doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0lhERzkpafcUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520an%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662%26doi%3D10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Q8F','PDB','2Q8F'); return false;">PDB: 2Q8F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTZ','PDB','2BTZ'); return false;">PDB: 2BTZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8N','PDB','1Y8N'); return false;">PDB: 1Y8N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2E0A','PDB','2E0A'); return false;">PDB: 2E0A</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01245">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_73830"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01245">10.1021/acs.jmedchem.6b01245</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">The HPLC reports for the purity check of analogues <b>1a</b>–<b>m</b>, <b>2a</b>–<b>s</b>, and <b>3a</b>–<b>j</b>, and the source and chemical data of intermediates <b>4a</b>–<b>k</b>, <b>5a</b>–<b>g</b>, <b>6a</b>–<b>f</b>, <b>7</b>, <b>8a</b>–<b>c</b>, <b>9</b>–<b>10</b>, <b>11a</b>, <b>11c</b>–<b>d</b>, <b>13</b>, <b>14a</b>–<b>i</b>, and <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_001.pdf">jm6b01245_si_001.pdf (87.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01245/suppl_file/jm6b01245_si_002.csv">jm6b01245_si_002.csv (3.32 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01245&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01245%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-6" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01245" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679994e17b8f3c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
